Mississippi State University

Scholars Junction
Theses and Dissertations

Theses and Dissertations

4-30-2021

Impact of altered polyamine metabolism on Streptococcus
pneumoniae capsule
Moses Babatunde Ayoola
ayoola_moses@yahoo.com

Follow this and additional works at: https://scholarsjunction.msstate.edu/td

Recommended Citation
Ayoola, Moses Babatunde, "Impact of altered polyamine metabolism on Streptococcus pneumoniae
capsule" (2021). Theses and Dissertations. 5078.
https://scholarsjunction.msstate.edu/td/5078

This Dissertation - Open Access is brought to you for free and open access by the Theses and Dissertations at
Scholars Junction. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of
Scholars Junction. For more information, please contact scholcomm@msstate.libanswers.com.

Template C v4.3 (beta): Created by T. Robinson 01/2021

Impact of altered polyamine metabolism on Streptococcus pneumoniae capsule
By
TITLE PAGE
Moses Babatunde Ayoola

Approved by:
Bindu Nanduri (Major Professor/Graduate Coordinator)
Andy Perkins
Justin Thornton
Edwin Swiatlo
Kent Hoblet (Dean, College of Veterinary Medicine)

A Dissertation
Submitted to the Faculty of
Mississippi State University
in Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy
in Computational Biology
in the Department of Computational Biology
Mississippi State, Mississippi
April 2021

Copyright by
COPYRIGHT PAGE
Moses Babatunde Ayoola
2021

Name: Moses Babatunde Ayoola
ABSTRACT
Date of Degree: April 30, 2021
Institution: Mississippi State University
Major Field: Computational Biology
Major Professor: Bindu Nanduri
Title of Study: Impact of altered polyamine metabolism on Streptococcus pneumoniae capsule
Pages in Study: 158
Candidate for Degree of Doctor of Philosophy
This dissertation is a compilation of published works and a manuscript that seek to
understand the possible role of polyamines in the regulation of capsule in Streptococcus
pneumoniae (Spn, pneumococcus). Spn remains a major health risk worldwide while the capsule
is widely recognized as the principal virulence factor. Polyamines on the other hand are small
hydrocarbon molecules known to regulate a number of cellular processes in bacteria. This work
investigates the impact of deletion of polyamine biosynthesis gene, SP_0916 (cadA, lysine
decarboxylase at the time of first and second publication), on protein expression and the capsule
biosynthesis of virulent pneumococcal serotype 4 (TIGR4). We identify loss of capsular
polysaccharide (CPS) in the deletion strain and based on proteomics results, we hypothesized
that a shift in metabolism that favors the pentose phosphate pathway (PPP) over glycolytic
pathway, that could reduce the availability of precursors for CPS had occurred. Comparison of
transcriptomic and untargeted metabolomics profile of ∆SP_0916 with TIGR4 shows impaired
glycolysis and Leloir pathways that provide CPS precursors, in the mutant strain. Furthermore,
gene expression changes indicate possible reduction of common polyamines (cadaverine,
putrescine, spermidine and spermine). Targeted metabolomics analysis confirmed reduced levels
of polyamines in SP_0916. However, the result suggests that SP_0916 encodes an arginine

decarboxylase, contrary to its existing annotation as a lysine decarboxylase in many
bioinformatics databases. Biochemical characterization of the purified protein encoded by
SP_0916 confirms that it is indeed catalyzes arginine decarboxylation, and exogenous
supplementation of agmatine, the product of the reaction, successfully restores capsule
biosynthesis. This study fixes an error in annotation of the TIGR4 genome and further
establishes the essentiality of agmatine, a product of arginine decarboxylation as the key
polyamine molecule modulating pneumococcal capsule. We later compared the impact of
deletion of polyamine synthesis by gene deletion (ΔSP_0916) with chemical inhibition of
synthesis using α- difluoromethylornithine (DFMO), in multiple pneumococcal serotypes.
Results of this dissertation confirmed that pneumococcal pathways impacted by the disruption of
polyamine biosynthesis either by gene deletion or chemical intervention are conserved and could
regulate capsule synthesis.
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CHAPTER I
INTRODUCTION
1.1

Streptococcus pneumoniae
Streptococcus pneumoniae (pneumococcus) is a gram-positive bacterium and one of the

leading causative agents of infectious diseases worldwide. Pneumococci cause both noninvasive
and invasive infections including sinusitis, otitis media, pneumonia, bacteremia, and meningitis
(Henriques-Normark & Tuomanen, 2013). Despite a century of research, total eradication of this
pathogen still remains elusive. Limited coverage of the available vaccines and serotype
replacement confounds preventive measures. Furthermore, selective pressure from common
antibiotics and increase in resistant strains render complicate therapeutic intervention (Cilloniz,
Martin-Loeches, Garcia-Vidal, San Jose, & Torres, 2016; Whitney et al., 2000). Some of the
common antibiotics used in treatment of pneumococcal infections includes β-lactams such as
penicillin and cephalosporins, macrolides such as erythromycin and azithromycin,
fluoroquinolones such as levofloxacin and gemifloxacin, chloramphenicol and tetracycline.
World-wide, pneumonia is the leading cause of death of children under five years of age
(O'Brien et al., 2009) and there are currently 100 identified serotypes (Ganaie et al., 2020).
Conventional identification of pneumococci is by phenotypic methods which include catalase,
bile solubility, and susceptibility to optochin (Aguiar, Frias, Santos, Melo-Cristino, & Ramirez,
2006; Martín-Galiano, Balsalobre, Fenoll, & de la Campa, 2003). However, immunological
methods using specific antisera, PCR, and sequencing methods for more accurate verification of
serotype also exist (Sadowy & Hryniewicz, 2020).
1

1.2

Pneumococcal virulence factors
Success of pneumococci in colonizing host tissue and causing infections is dependent on

arrays of both intracellular and extracellular virulence factors used to interfere with host immune
system (Brooks & Mias, 2018). A description of common virulence factors is given below.
a) Pneumolysin: is a toxin found in all clinically important serotypes of S. pneumoniae. It
helps the organism invade the lung by disrupting its capillarity boundary and cell junction
(Jedrzejas, 2001; Rayner et al., 1995). It also increases inflammation thereby promoting
shedding and bacterial transmission (Zafar, Wang, Hamaguchi, & Weiser, 2017).
Pneumolysin in combination with H2O2 induces apoptosis of brain cells during
experimental S. pneumoniae meningitis (Braun et al., 2002).
b) IgA1 protease: S. pneumoniae secrete this enzyme that is capable of cleaving IgA1, an
antibody largely found in respiratory secretions. Breaking of the proline-threonine or
proline-serine peptide bonds causes separation of Fab Fragment (antigen-binding domain)
from Fc fragment thereby reducing the inhibition of adherence and leading to S.
pneumoniae adhesion to the host cell (Jeffrey N. Weiser et al., 2003).
c) Phosphorylcholine: Phosphorylcholine (PCho) residues are found both in teichoic acid
(TA) and lipoteichoic acid (LTA) which are constituent of S. pneumoniae cell wall
alongside peptidoglycan. In S. pneumoniae, PCho has increased affinity for host cell
surface receptors, platelets activating factor receptors (PAF-R), which are present on the
activated cells. This enhances S. pneumoniae adherence in the presence of inflammation
during invasive infection (Iuchi, Ohori, Kyutoku, Ito, & Kurono, 2019).
d) Neuraminidases (NanA, NanB, NanC): these are group of enzymes that degrade host cell
surfaces and facilitate pneumococcal adhesion and invasion of the host cells. They do this
by cleaving sialic acid of glycans, mucins and glycoprotein. NanA and NanB are found in
all S. pneumoniae strains (Pettigrew, Fennie, York, Daniels, & Ghaffar, 2006). Except
NanC, NanA and NanB are crucial for colonization, pneumonia and sepsis (Manco et al.,
2006).
e) Exogylcosidases: this group of enzymes cleaves glycosylated surface of the host epithelium
layer of the nasopharynx and facilitate the binding of the bacteria. They include βgalactosidase that cleaves terminal β(1-4) galactose linked to N-Acetylglucosamine, and
2

β-N-acetylglucosaminidase that cleaves the terminal β-1-linked N-acetylglucosamine
residues on the host cell surfaces (King, Hippe, & Weiser, 2006; Zähner & Hakenbeck,
2000)
f) Pneumococcal surface adhesion (PsaA): is a lipoprotein component of S. pneumoniae ABC
transporter responsible for ATP binding and uptake of manganese. It has been shown to be
important in adhesion and colonization of S. pneumoniae to the nasopharynx (RomeroSteiner et al., 2003).
g) Pneumococcal surface protein C / Choline binding proteinA (PspC / CbpA): the presence
of free secretory IgA and IgB increase the chances of binding of CbpA and facilitate the
binding of S. pneumoniae (Elm, Rohde, Vaerman, Chhatwal, & Hammerschmidt, 2004).
h) Pneumococcal adhesion and virulence factor A (PavA): it is a surface protein that binds
immobilized human glycoproteins. pavA- strains of S. pneumoniae showed reduced
adherence to A549 and Hep-2 epithelial cells in an in vitro experiment suggesting a role in
pneumococcal adhesion in the nasopharynx (Pracht et al., 2005). It was also found to be
important for the movement of the pathogen across cell membranes.
i) Hyaluronidase: this enzyme degrades hyaluronic acid component of the host connective
tissue and allows the passage of the bacteria into the blood causing an invasive disease
such as meningitis (Kostyukova, Volkova, Ivanova, & Kvetnaya, 1995).

In addition to these virulence factors, pneumococcal capsule is widely accepted as the most
critical virulence factor of all (Paton & Trappetti, 2019).
1.3

Capsule and Streptococcus pneumoniae
Capsule is the polysaccharide structure found on the outermost part of many pathogenic

bacteria especially the gram-positive (Rajagopal & Walker, 2017), and it is the most important
virulence factor in pneumococcus (Paton & Trappetti, 2019). The capsule is usually covalently
linked to peptidoglycan component of the bacterial cell wall by a ligase. Pneumococcal serotypes
are based on the unique biochemical structure and composition of the sugars in the repeat unit of
the capsular polysaccharide (CPS) and the arrangements of chemical bonds between them. Two
3

important clinical serotypes, 4 (TIGR4) and 2 (D39) are the focus of this dissertation. TIGR4
capsule repeat unit contains N-acetylgalactosamine, N-acetylfucosamine, N-acetylmannosamine
and galactose that are linked together by 1-3-glycosidic bonds and pyruvate attached to galactose
at carbon position 2 and 3. D39 has 2 glucose, 3 rhamnose and 1 glucuronic acid with 1-4-, 1-3-,
1-2-, and 1-6-glycosidic bonds.
CPS synthesis in majority of pneumococcal serotypes is by a Wzy-dependent mechanism
with the exception of serotypes 3 and 37 that follow a synthase-dependent mechanism (Luck,
Tettelin, & Orihuela, 2020). In Wzy-dependent mechanism, 3 to 4 monosaccharides are linked
by glycosidic bonds. The Wzy pathway for biosynthesis of capsule starts on the inner side of the
cell membrane with reaction between phosphate sugar, oftentimes glucose-1-phosphate, and
undecaprenol phosphate catalyzed by glycosyltransferase. Further addition of sugars is carried
out by diverse glycosyltransferases based on the type of sugar being added. The growing chain is
flipped to the outside the cell by a flippase, and polymerization of the repeat unit is carried out
by a polymerase. Ligase attaches synthesized CPS to the cell wall via covalent bonding. Genes
encoding capsule biosynthesis enzymes including kinases for sugar phosphorylation and those
involved in nucleotide sugar biosynthesis are usually located between dexB and aliA genes on the
chromosomes (Llull, Munoz, Lopez, & Garcia, 1999).
In serotypes 3 and 37, CPS synthesis starts with the attachment of monosaccharide to the
cell wall through phosphatidylglycerol linkage by the synthase. Synthase-dependent serotypes
have fewer sugars in their repeat units compared to those with Wzy-dependent biosynthesis
pathway. Only glucose and glucuronic acid are found in serotype 3 capsule, and either UDPglucose or UDP-galactose in serotype 37. UDP-glucose dehydrogenase (cps3D) for the synthesis
of UDP-glucuronic acid from UDP-glucose and synthase (cps3S) are essential for capsule
4

synthesis in serotype 3 (Dillard, Vandersea, & Yother, 1995). Synthase encoded by tts carries out
capsule synthesis in serotype 37, although tts is located far away from the capsule locus on the
chromosome with respect to other serotypes (Llull, Muñoz, López, & García, 1999).
Capsule regulation by the conserved tyrosine-phosphorylated regulon CpsBCD has been
reported in some Wzy-dependent strains while either the regulon is not expressed or contains
mutations in strains with synthase mechanism. CpsB encodes a tyrosine phosphatase while
CpsCD encode a tyrosine kinase and have tyrosine dephosphorylation and autophosphorylation
activities, respectively. They have been shown to be essential for capsule biosynthesis as their
deletion led to reduced capsule (Morona, Miller, Morona, & Paton, 2004). However, CpsB
activity was later shown to be dependent on oxygen availability and dispensable for capsule
biosynthesis in parental strain (K. Aaron Geno, Hauser, Gupta, & Yother, 2014). In contrast,
CpsD can either negatively (Morona, Paton, Miller, & Morona, 2000) or positively regulate
pneumococcal capsule (J. N. Weiser et al., 2001), though the mechanisms of regulations are not
well understood. Changes in the pneumococcal capsule biosynthesis and CPS levels in response
to altered metabolic profile is a growing and interesting area of research in recent years. For
example, inactivation of pyruvate oxidase that catalyzes the production of hydrogen peroxide has
been reported to increase the level of capsule by increasing the level of glucuronic acid, a
precursor of capsule synthesis in serotype 2 pneumococci (Carvalho, Farshchi Andisi, et al.,
2013). Also, deletion of arginine transporter resulted in significant reduction in the level of
capsule suggesting that arginine may have a role in capsule regulation (Gupta et al., 2013). Till
now, a comprehensive description of the molecular mechanisms that regulate CPS in
pneumococci is lacking.

5

1.3.1

Serotypes
Capsule is the basis for the classification of a total of 100 serotypes identified so far

(Ganaie et al., 2020). Serotypes are numbered based on the order of discovery. Twenty-four of
these serotypes that cause invasive disease are covered by the existing licensed vaccines
(Daniels, Rogers, & Shelton, 2016). Detection of capsule is usually by specific antiserum, and
the main source of the pneumococcal sera is the Statens Serum Institut in Copenhagen, Denmark.
However, pneumococci are also capable of capsular switching in which the capsular locus in a
particular serotype is replaced by the locus from another serotype. In pneumococcal pangenome,
there are about 800 core orthologs and 6000 pangenome orthologs on average, representing
around 13% similarities in the pangenome of pneumococci leaving huge variations in the genetic
composition (Hiller & Sá-Leão, 2018). The reason for this large variation is still not known.
However, it is expected to have an impact on protein expression in different strains and,
ultimately, virulence. This genome variability may be the reason why capsule switching does not
always result in virulence, as the recipient genome may not encode other proteins for full
virulence.
1.3.1

Evading mucus entrapment and establishing colonization
One of the strategies employed by pneumococci to evade host defense include prevention

of entrapment by mucus in the nasopharynx and airway thereby averting mucociliary clearance.
CPS is generally negatively charged as a result of chemical entities such as pyruvate, phosphate,
or acidic sugars, with the exception of about 5 serotypes that are neutrally charged (Y. Li,
Weinberger, Thompson, Trzciński, & Lipsitch, 2013). Since mucus is also negatively charged
due to sialic acid (Nelson et al., 2007), this ultimately leads to electrostatic repulsion and
prevention of binding of the host mucus to Spn. This enables pneumococci to reach human
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epithelial cells where they colonize. Interestingly, pneumococci usually reduce capsule
production during colonization in order to facilitate binding of their surface proteins such as
choline binding proteins A, D and E to host tissues (Magee & Yother, 2001). Transparent (less)
capsule and opaque (more) capsule variants are common with colonization and invasive diseases,
respectively (Oliver, Basu Roy, Kumar, Lefkowitz, & Swords, 2017).
1.3.2

Escape of host defense during invasive infection
The potential of Spn to cause disease varies based on the capsule type. The thickness of

capsule varies among the serotypes such as serotype 2, 4 and 3 with about 100, 200 and 300 nm
in thickness respectively (C. Hyams, Camberlein, Cohen, Bax, & Brown, 2010). Pneumococcus
has been shown to be capable of upregulating the expression cpsA up to fourfold during invasive
infections (Ogunniyi, Giammarinaro, & Paton, 2002). Capsules have been found to inhibit both
classical and alternative pathways of complement activation (C. Hyams et al., 2010). In the
classical pathway, CPS prevents binding of Immunoglobulin G, Immunoglobulin M, and Creactive protein (Andre et al., 2017). Capsule prevents iC3b bound to pneumococci from
interacting with receptors on phagocytic cells thereby reducing opsonization, preventing uptake
and killing. Other mechanism involving alteration of capsular biosynthesis enzymes that could
allow pneumococci to synthesize different types of capsule to aid immune invasion have been
described. Serotype 11D strain encodes bispecific glycosyltransferase that could either add
glucose or N-Acetylglucosamine as the fourth sugar of the repeat unit (Oliver et al., 2013).
1.3.3

Pneumococcal vaccines
CPS is the antigenic component of currently existing and licensed vaccines. The first

clinical trials with CPS were completed in 1945 (Macleod, Hodges, Heidelberger, & Bernhard,
1945). Pneumococcal polysaccharide vaccines PPSV14 and PPSV23 were licensed only 1977
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and 1983, respectively (Mirsaeidi & Schraufnagel, 2014), with the number in the vaccine
annotation corresponding to the number of serotypes covered by the vaccine. Immunological
response to the vaccines enhances phagocytosis by macrophages and neutrophils by promoting
complement deposition (AlonsoDeVelasco, Verheul, Verhoef, & Snippe, 1995). PPSVs are poor
in eliciting T helper type 1 (Th1) response required to defend against pneumococci and for
immunological memory in children below five years. Introduction of pneumococcal conjugate
vaccine PCV7 in 2000, and later PCV10 and PCV13, helped overcome the lack of Th1 response
with PPSVs. PCVs conferred not just protection against invasive disease but also significant
protection against otitis media (Black et al., 2002; Fireman et al., 2003). However, this protection
only covers the 7 - 13 serotypes whose polysaccharides are included in the vaccines. Reduced
carriage of serotypes included in the vaccines inadvertently leads to an increase in the nonvaccine serotypes in a process known as serotype replacement. Co-colonization with different
serotypes and the capsular switching have been proposed as contributing factors to serotype
replacement (Brugger, Frey, Aebi, Hinds, & Mühlemann, 2010; Jefferies, Smith, Clarke,
Dowson, & Mitchell, 2004). Therefore, non-capsule-based approaches such as protein-based
vaccines are warranted. Efforts to develop a protein-based vaccine that will confer protection
against all pneumococcal serotypes is ongoing. Protein-based vaccines are expected to elicit
immune memory, be cost effective, and ultimately have broader protection than PPSV23 and
PCV13. Examples of proteins that are vaccine candidates include but are not limited to certain
choline-binding proteins (PspA and PcpA), lipoproteins (PsaA, PhtE, PhtD, PhtB, PhtA and
PotD), and LPXTG proteins (Lagousi, Basdeki, Routsias, & Spoulou, 2019). However, proteinbased vaccines are either at the testing, pre-clinical or clinical trial phase. Anti-virulence strategy
such as modulation of polyamine metabolic pathways which is capable of impacting
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genes/proteins that are necessary for pneumococcal fitness during infection could offer serotypeindependent prevention and treatment.
1.4

Polyamines
Polyamines are small hydrocarbons that are found in almost all living cells and are

positively charged at physiological pH. Common polyamines in bacteria are diamines putrescine
and cadaverine, and a triamine spermidine (Figure 1.1). Their intracellular concentrations are
tightly controlled by synthesis, transport, and degradation. The biosynthesis is via pyridoxal 5'phosphate dependent decarboxylation of amino acids ornithine, arginine, and lysine. When in
excess, polyamine acetyltransferase help catalyze and sequester the acetylated form or further
degraded by polyamine oxidase releasing hydrogen peroxide as byproduct (Miller-Fleming,
Olin-Sandoval, Campbell, & Ralser, 2015). For the uptake from extracellular milieu, there are
annotated transporters in most bacteria including PotABCD in pneumococci (Ware, Jiang, Lin,
& Swiatlo, 2006).

Figure 1.1

Structures and chemical compositions of commonest bacteria polyamines.
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Due to their positively charged nature, polyamines interact with negative molecules such
as RNA and protein and impact important cellular processes such as transcription and translation.
Many roles have been attributed to polyamines in bacteria that intersect with virulence. They
have been implicated in the growth of Pseudomonas aeruginosa and Campylobacter jejuni
(Hanfrey et al., 2011; Nakada & Itoh, 2003), biofilm formation in Bacillus subtilis and
Synechocystis sp.(Matthew Burrell, Colin C. Hanfrey, Ewan J. Murray, Nicola R. Stanley-Wall,
& Anthony J. Michael, 2010; Kera et al., 2018), autolysis in S. pneumoniae (Potter & Paton,
2014), and cellular redox balance (Murray Stewart, Dunston, Woster, & Casero, 2018). .
Our central working hypothesis is that altering intracellular polyamine concentrations by
modulation of polyamine synthesis will impact pneumococcal physiology and virulence. Earlier
studies from our lab showed that impaired polyamine transport (ΔpotABCD) and synthesis
(ΔspeE, ΔSP_0916) results in attenuation of virulence of S. pneumoniae in murine models of
colonization, pneumonia, and sepsis (Shah, Nanduri, Swiatlo, Ma, & Pendarvis, 2011). We later
showed that ΔpotABCD is more susceptible to neutrophil killing, which could explain its in vivo
attenuation (Rai et al., 2016b). The fact that opsonization with serotype specific antibody was not
required for neutrophil uptake of ΔpotABCD suggests that the mutant may lack or have reduced
capsule. Signature tagged mutagenesis screen with serotype 4 identified a putative polyamine
biosynthesis gene, SP_0916, as a virulence gene in lung infection (Hava & Camilli, 2002).
Despite many years of work, little is known about pneumococcal pathways that are responsive to
altered polyamine homeostasis in polyamine synthesis deficient pneumococci that impact
virulence. The goal of this dissertation work was to identify how polyamine biosynthesis
contributes to pneumococcal virulence, particularly, capsule biosynthesis.
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2.1

Abstract
Invasive infections caused by Streptococcus pneumoniae, a commensal in the

nasopharynx, pose significant risk to human health. Limited serotype coverage by the available
polysaccharide-based conjugate vaccines coupled with increasing incidence of antibiotic
resistance complicates therapeutic strategies. Bacterial physiology and metabolism that allows
pathogens to adapt to the host are a promising avenue for the discovery of novel therapeutics.
Intracellular polyamine concentrations are tightly regulated by biosynthesis, transport and
degradation. We previously reported that deletion of cadA, a gene that encodes for lysine
decarboxylase, an enzyme that catalyzes cadaverine synthesis results in an attenuated phenotype.
Here, we report the impact of cadA deletion on pneumococcal capsule and protein expression.
Our data show that genes for polyamine biosynthesis and transport are downregulated in ∆cadA.
Immunoblot assays show reduced capsule in ∆cadA. Reduced capsule synthesis could be due to
reduced transcription and availability of precursors for synthesis. The capsule is the predominant
virulence factor in pneumococci and is critical for evading opsonophagocytosis and its loss in
∆cadA could explain the reported attenuation. Results from this study show that capsule
synthesis in pneumococci is regulated by polyamine metabolism, which can be targeted for
developing novel therapies.

Keywords: Streptococcus pneumoniae; polyamines; pneumococcal pneumonia; proteomics;
capsule; complementation; metabolism; cadaverine.
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2.2

Introduction
Streptococcus pneumoniae (pneumococcus) is a Gram-positive encapsulated pathogen

that resides asymptomatically in the nasopharynx of healthy humans. In children, elderly, and
immunocompromised individuals, pneumococci can become pathogenic, causing mild to severe
infections such as sinusitis, meningitis, community acquired pneumonia and septicemia (BridyPappas, Margolis, Center, & Isaacman, 2005). Pneumococcal infections cause approximately 2
million deaths globally with about 900,000 reported cases in the United States alone, resulting in
approximately 400,000 hospitalizations annually (Huang et al., 2011). There are currently 100
pneumococcal serotypes with unique capsular polysaccharide structures (Ganaie et al., 2020) and
only 24 serotypes are included in the current existing polysaccharide-based vaccines, PCV13 and
PPSV23 (Hayward, Thompson, & McEachern, 2016), combined. Increased resistance to
antibiotics such as penicillin, cephalosporins, and fluoroquinolones also complicates treatment
(Felmingham, 2004; Gary V. Doern, 2005). The diversity of pneumococcal serotypes, coupled
with genomic plasticity and the increasing selection for non-vaccine serotypes, mandates the
development of novel protein-based vaccines that are conserved across serotypes and drives the
search for new antimicrobial targets.
Polyamines are small, ubiquitous polycationic molecules with hydrocarbon backbones
that are positively charged at physiological pH. Polyamines participate in many important
biological functions in both eukaryotes and prokaryotes (Igarashi & Kashiwagi, 2000). They
interact with negatively charged molecules such as nucleic acids and proteins and modulate
DNA replication, transcription and translation (Igarashi & Kashiwagi, 2010). The most common
cellular polyamines in prokaryotes are diamines, putrescine (1,4-diaminobutane) and cadaverine
(1,5-diaminopentane), and a triamine, spermidine (N-(3-aminopropyl) butane-1, 4-diamine)
(Michael, 2011, 2016a; Tabor & Tabor, 1985). Bacteria regulate intracellular polyamine levels
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by biosynthesis, import of extracellular polyamines through adenosine triphosphate (ATP)binding cassette transporters (ABC transporters) or antiporters and catabolism.
Polyamines are known to modulate virulence of pathogenic bacteria (Di Martino et al.,
2013). Spermine influences biofilm formation in Neisseria gonorrhoeae (Goytia, Dhulipala, &
Shafer, 2013), Bacillus subtilis (M. Burrell, C. C. Hanfrey, E. J. Murray, N. R. Stanley-Wall, &
A. J. Michael, 2010), Escherichia coli (Sakamoto et al., 2012), Yersinia pestis (Patel et al., 2006)
and Vibrio cholerae (Karatan, Duncan, & Watnick, 2005). Polyamines have been linked to
escape from phagolysosomes, bacteriocin production, toxin activity, and stress responses in
many pathogenic bacteria (Fernandez et al., 2001; Pan et al., 2006; Shah & Swiatlo, 2008;
Wortham BW, 2007.). Cadaverine inhibits multiplication of Shigella flexneri by preventing lysis
of phagolysosome (Fernandez et al., 2001). Cadaverine has also been shown to inhibit adherence
of toxin-producing E. coli (Torres, Vazquez-Juarez, Tutt, & Garcia-Gallegos, 2005).
Polyamine transport and synthesis genes are highly conserved across pneumococcal
serotypes (Ware et al., 2006), while polyamine catabolism is poorly annotated in the genome.
Our earlier studies show that intact polyamine transport and synthesis genes are necessary for
virulence of S. pneumoniae in murine models of colonization, pneumococcal pneumonia and
sepsis (Shah et al., 2011). Deletion of genes that code for a putative lysine decarboxylase (cadA),
and spermidine synthase (speE), enzymes that catalyze cadaverine and spermidine synthesis, and
polyamine transporter (potABCD) in pneumococci results in an attenuated phenotype in vivo
(Shah et al., 2011). We also demonstrated the therapeutic potential of targeting polyamine
metabolism genes in pneumococci. Immunization with PotD, the extracellular substrate binding
subunit of the polyamine transport operon potABCD, affords protection in mice against
colonization, pneumonia and sepsis (Shah, Briles, King, Hale, & Swiatlo, 2009; Shah & Swiatlo,
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2006). However, the impact of the deletion of polyamine biosynthesis on pneumococcal protein
expression, including virulence factor expression that ultimately regulates survival in the host in
a polyamine dependent manner is not known (Wortham BW, 2007.).
Here, we investigated the role of cadA on pneumococcal capsule and protein expression.
We hypothesized that the attenuated phenotype of lysine decarboxylase-deficient pneumococci is
due to reduced capsule production. Our results show loss of capsule and downregulation of
synthesis of putrescine and spermidine as well as transport. Our data strongly suggests that
polyamine metabolism plays a significant role in the regulation of capsular polysaccharide
biosynthesis in pneumococci, and is an attractive target for developing novel therapeutics.
2.3
2.3.1

Materials and Methods
Bacterial strains, and growth conditions

Streptococcus pneumoniae serotype 4 strain TIGR4 was used in this study (Herve Tettelin et al.,
2001). All strains were grown in Todd-Hewitt broth supplemented with 0.5% yeast extract
(THY) or on 5% sheep blood agar plates (BAP) in 5% CO2. An isogenic mutant of TIGR4
deficient in cadA was generated by polymerase chain reaction (PCR)-ligation mutagenesis as
described previously (Shah et al., 2011). Briefly, PCR primers were designed to amplify
upstream (600 nts 5′ to the start codon) and downstream (600 nts 3′ from the transcription
termination site) of cadA from TIGR4 chromosomal DNA (Table 2.1). Genomic pieces were
joined by gene splicing, and insertion of spectinomycin resistance gene (spec) amplified from
pORI280 (Kees Leenhouts, 1998) by overlap extension (SOEing) PCR (Shah et al., 2011). The
recombinant product was transformed into TIGR4 as described previously (Bricker & Camilli,
1999). Transformants were selected on BAP with spectinomycin (100 μg/mL) and cadA gene
deletion was confirmed by sequencing. To establish that cadaverine is responsible for loss of the
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capsule, we complemented the ΔcadA mutant in trans by cloning cadA gene amplified from
TIGR4 (Table 2.1) into pABG5 vector for analysis of transcription into ΔcadA (Alexander B.
Granok, Derek Parsonage, R. Paul Ross, and, & Caparon, 2000), complemented transformants
were selected on BAP with kanamycin (50 μg/mL) and confirmed by PCR.
Table 2.1

Sequences of primers used in this study

Primer

Sequence * (5′→3′)

Experiment

cadAF1

AGCAAATATAAACCCGAGTAAAAA

Mutagenesis

cadAR1

CAGGTACCGCTTGTGACCTGGAACATC

Mutagenesis

cadAF2

CAGAGCTCGTTTCGGTTTGCGATTTT

Mutagenesis

cadAR2

GATCTTCCGTCCCTTGGAG

Mutagenesis

cadAF-XbaI

TTCCCCGGGCCGTGCGAAAATCATCGCC

Complementation

cadAR-SacI

ATTCGAGGAAGACAGAGGTGTACTATTC

Complementation

gyrBF

CCGTCCTGCTGTTGAGACC

qRT-PCR

gyrBR

GTGAAGACCACCTGAAACCTTG

qRT-PCR

cps4AF

TCAAGTCAAGTCAGAATACCGATTTG

qRT-PCR

cps4AR

TCAAAGACACTATTTAGGACAATGGC

qRT-PCR

speEF

TGCGGATGATTTCGTCTACAATG

qRT-PCR

speER

CCAGTTCAGGATAGAGGGTTAATAC

qRT-PCR

aguAF

GCTTAGTCCTGGTCGCAATC

qRT-PCR

aguAR

CTGGGGATCATTTTCGTCAT

qRT-PCR

lys9F

GGCTTGACTGCTCTTCTTGG

qRT-PCR

lys9R

AGTAAGAACCTGGCGCAGAA

qRT-PCR

nspCF

ATGTATTTGCGCCTGCTTTC

qRT-PCR

nspCR

TGGTGCACAAGGGTCATAGA

qRT-PCR

* underlined sequence complementary to Streptococcus pneumoniae TIGR4 chromosomal DNA.
qRT-PCR: quantitative reverse transcription-PCR
2.3.2

In vitro growth of TIGR4 and ΔcadA
TIGR4 and ΔcadA were inoculated into THY (105 colony forming units (CFU)/mL) and

growth at 37 °C with 5% CO2 was monitored by measuring optical density at 600 nm (OD600
nm) using a Cytation 5 multifunction plate reader (BioTek, Winooski, VT, USA). We used
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Growth Rates (Hall, Acar et al. 2014), a software tool that uses the output of plate reader files to
automatically monitor growth rate in exponential phase, lag phase and maximal OD to compare
TIGR4 and ΔcadA growth curves. We also measured the viability of TIGR4 and ΔcadA in THY
by plating cells on BAP every 2 h for CFU enumeration. Morphology was compared by Gram
staining of mid-log phase (OD 0.4) cultures of bacteria.
2.3.3

Measurement of capsular polysaccharides
Capsular polysaccharide (CPS) was quantified by immunoblotting, as described

(Eberhardt et al., 2012). An isogenic capsular variant of TIGR4 in which the cps locus is
replaced with the Janus cassette resulting in an unencapsulated phenotype (T4R) (Rychli,
Guinane, Daly, Hill, & Cotter, 2014) was used as a control. Briefly, bacterial strains were
cultured in THY supplemented with 10% fetal bovine serum to an OD of 0.2, plated on BAP for
CFU enumeration and 1 mL bacteria was pelleted and stored at −20 °C until further use. The
CFUs for all strains were ~ 9.0 × 107 /mL. CPS was extracted in a lysis buffer (4%
deoxycholate, 50 μg/mL DNAseI and 50 μg/mL RNAse) at 37 °C for 10 min and centrifuged at
18,000× g for 10 min. Four threefold serial dilutions of the supernatant in phosphate-buffered
saline (PBS) were spotted in duplicate (2 μL) on 0.2-μm nitrocellulose membranes (Thermo
Fisher Scientific, Waltham, MA, USA) with suction and air dried at 60 °C for 15 min. The
membranes were blocked and incubated with rabbit anti-serotype 4 serum (Cedarlane,
Burlington, NC, USA) at 1:1000 and a horseradish peroxidase (HRP) conjugated goat anti-rabbit
secondary antibody (Thermo Fisher Scientific, Waltham, MA, USA) at 1:10,000. Membranes
were developed with enhanced chemiluminiscence (ECL) detection (ThermoFisher Scientific,
Waltham, MA, USA) and scanned using a ChemiDoc XRS+ with Image Lab software (Bio-Rad,
Hercules, CA, USA).
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2.3.4

Proteomics
Protein was isolated from mid-log phase (OD 0.4) TIGR4 and ΔcadA (n = 4) cultured in

THY and subjected to liquid chromatography–mass spectrometry (LC-MS/MS) analysis as
described earlier (Rai et al., 2016b; Shah et al., 2011). Briefly, proteins were isolated from
bacterial pellets sonicated in NP-40 lysis buffer (0.5% NP-40, 150 mM NaCl, 20 mM
CaCl2·2H2O, 50 mM Tris, pH 7.4) supplemented with 1X protease inhibitor
cocktail/ethylenediaminetetraacetic acid (EDTA) using a Covaris S220 focused-ultrasonicator
(Covaris, Woburn, MA, USA). Protein concentration from the supernatant was determined using
a Pierce bicinchoninic acid assay (BCA) Protein Assay Kit (Pierce Biotechnology, Rockford, IL,
USA) and 30 µg was precipitated with methanol and chloroform (4:1), solubilized in 8 M urea,
reduced (0.005 M dithiothreitol (DTT) at 65 °C for 10 min) and alkylated (0.01 M iodoacetamide
at 37 °C for 30 min) and digested with porcine trypsin (2 µg at 37 °C, overnight, 50:1 ratio of
protein: trypsin, Promega Corporation, Madison, WI, USA). Tryptic peptides were desalted
using a C18 spin column (Pierce Biotechnology) and analyzed by linear trap quadropole (LTQ)
Orbitrap Velos mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) equipped with
an Advion nanomate electrospray (ESI) source (Advion, Ithaca, NY, USA). Peptides (500 ng)
were eluted from a C18 column (100-μm id × 2 cm, Thermo Fisher Scientific) onto an analytical
column (75-μm ID × 10 cm, C18, Thermo Fisher Scientific) using a 180 min gradient with
99.9% acetonitrile, 0.1% formic acid at a flow rate of 400 nL/min and introduced into an LTQOrbit rap. Data dependent scanning was performed by the Xcalibur v 2.1.0 software (Andon,
Hollingworth et al. 2002) using a survey mass scan at 60,000 resolution in the Orbitrap analyzer
scanning mass/charge (m/z) 400–1600, followed by collision-induced dissociation (CID) tandem
mass spectrometry (MS/MS) of the 14 most intense ions in the linear ion trap analyzer. Precursor
ions were selected by the monoisotopic precursor selection (MIPS) setting with selection or
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rejection of ions held to a ±10 ppm window. Dynamic exclusion was set to place any selected
m/z on an exclusion list for 45 s after a single MS/MS. Tandem mass spectra were searched
against a Streptococcus pneumoniae serotype4 strain ATCC BAA/TIGR4 fasta protein database
downloaded from UniProtKB to which common contaminant proteins (e.g., human keratins
obtained at ftp://ftp.thegpm.org/fasta/cRAP) were appended. All MS/MS spectra were searched
using Thermo Proteome Discoverer 1.3 (Thermo Fisher Scientific) considering fully tryptic
peptides with up to two missed cleavage sites. Variable modifications considered during the
search included methionine oxidation (15.995 Da), and cysteine carbamidomethylation (57.021
Da). Peptides were identified at 99% confidence with XCorr score cutoffs (Qian et al., 2005)
based on a reversed database search. The protein and peptide identification results were
visualized with Scaffold v 3.6.1 (Proteome Software Inc., Portland, OR, USA). Protein
identifications with a minimum of two peptides identified at 0.1% peptide false discovery rate
(FDR) were deemed correct. Significant changes in protein expression between ΔcadA and
TIGR4 were identified by Fisher’s exact test at a p-value of ≤0.05 and fold change of ±1.3. Fold
changes in protein expression was calculated using weighted normalized spectra with 0.5
imputation value. Various bioinformatics resources such as DAVID (Huang da, Sherman, &
Lempicki, 2009), KEGG (Kanehisa, Goto, Sato, Furumichi, & Tanabe, 2012) and STRING
(Szklarczyk et al., 2017) were utilized to determine the functions of the identified proteins. The
PRoteomics IDEntifications (PRIDE) database is a centralized, standards compliant, public data
repository for proteomics data. The mass spectrometry proteomics data from this study is
deposited to the ProteomeXchange Consortium via the PRIDE partner repository (Vizcaíno et
al., 2016) with the dataset identifier PXD008621.
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2.3.5

Quantitative real time PCR
Gene expression in ΔcadA was measured by quantitative reverse transcription-PCR

(qRT-PCR). The primers used for qRT-PCR are listed in Table 2.1. All primers were validated
by performing a melt curve analysis with SYBR Green (Thermo Fisher Scientific, Waltham,
MA, USA) to ensure the amplification of a single specific product. In brief, total RNA was
purified from mid-log phase TIGR4 and ΔcadA grown in THY (n = 3) using the RNeasy Midi kit
and QIAcube (Qiagen, Valencia, CA, USA). Purified total RNA (7.5 ng/reaction) was
transcribed into cDNA and qRT-PCR was performed using the SuperScript III Platinum SYBR
Green One-Step qRT-PCR Kit (Thermo Fisher Scientific, Waltham, MA, USA) as previously
described (Rai et al., 2016b). Relative quantification of gene expression was determined by using
the Stratagene Mx3005P qPCR system (Agilent, Santa Clara, CA, USA). Expression of target
genes speE, potD, cps4A, aguA, lys9, and nspC was normalized to the expression of gyrB and
fold change determined by the comparative cycle threshold CT method.
2.4
2.4.1

Results
Impact of ∆cadA on pneumococcal growth
S. pneumoniae TIGR4 and ΔcadA had similar growth kinetics in THY, as reported

previously (Shah et al., 2011). The deletion mutant had a shorter lag phase than TIGR4 and had a
lower cell density at stationary phase (Figure 2.1A(i)). There is evidence that pneumococcal
serotypes with high colonization prevalence have a short lag phase in vitro when cultured in
complete medium compared to invasive serotypes (Battig, Hathaway, Hofer, & Muhlemann,
2006). The shorter lag phase in ΔcadA could have implications for its invasiveness and needs
confirmation in future studies. Since polyamines affect a number of cellular processes that can
impact growth, it is possible that deletion of ΔcadA impacts some of these processes that
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ultimately results in reduced cell density. However, there is no significant difference in the
exponential growth rate between TIGR4 (0.011 min−1) and ΔcadA (0.015 min−1). Both TIGR4
and ΔcadA had comparable CFUs during growth in THY (Figure 2.1A(ii)). Mid-log phase
TIGR4 (Figure 2.1B(i)) and ΔcadA cells (Figure 2.1B(ii)) showed no difference morphology as
determined by Gram staining. These results are comparable to our earlier observation that
deletion of cadA has no qualitative difference in pneumococcal growth in vitro. However, lysine
decarboxylase is indispensable for survival in murine models of colonization, pneumonia and
sepsis (Shah et al., 2011).

Figure 2.1

Growth of TIGR4 and ΔcadA and Gram stain morphology in vitro.

(A) Growth of TIGR4 and ΔcadA in THY (n = 3) was monitored by measuring absorbance 600
nm (i) and viability (ii) was estimated by plating on blood agar plates (BAP) for colony forming
units (CFU) enumeration. (B) Morphology of TIGR4 (i) and ΔcadA (ii) was observed by Gram
staining.
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2.4.2

Lysine decarboxylase is required for capsule production in S. pneumoniae
Isogenic deletion of lysine decarboxylase in S. pneumoniae TIGR4 led to attenuation in

murine models of colonization, pneumococcal pneumonia and sepsis (Shah et al., 2011). The
capsule renders pneumococci resistant to opsonophagocytosis and is essential for pneumococcal
virulence (Melin, Trzcinski, Meri, Kayhty, & Vakevainen, 2010). Loss of the capsule associated
with impaired cadaverine synthesis could explain the observed attenuation of virulence in S.
pneumoniae ∆cadA. We compared total CPS from TIGR4, T4R, ∆cadA and ∆cadA
complemented strains (ΔcadA (comp)) using serotype 4-specific CPS antibodies. Our results
(Figure 2.2) clearly show that deletion of cadA results in loss of the capsule in two independently
derived mutants that lack lysine decarboxylase (∆cadA1 (Shah et al., 2011) and ΔcadA2 (this
study) compared to TIGR4. Both ∆cadA deletion strains exhibit loss of the capsule (Figure 2.2)
ruling out the possibility that the observed phenotype is due to a random change in the genome
elsewhere and not specific to cadA deletion. This was further confirmed by complementation.
CPS in ΔcadA is fully restored to the levels comparable to that of TIGR4 by in trans
complementation of cadA. These results clearly demonstrate that deletion of lysine
decarboxylase in S. pneumoniae results in the loss of CPS. Loss of the capsule could render
ΔcadA susceptible to host defenses resulting in an attenuated phenotype in murine models of
colonization and invasive disease. Impact of lysine decarboxylase on capsule synthesis in vivo
needs to be evaluated in future studies.
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Figure 2.2

Immunoblot analysis of total capsule in TIGR4 and mutant strains.

All strains were cultured in THY supplemented with fetal bovine serum (FBS) to mid-log phase.
Total capsular polysaccharide (CPS) isolated from equal number of cells for each strain, and 3×
dilutions were spotted onto a nitrocellulose membrane. Membranes were probed with rabbit antiserotype 4 sera and immunoglobulins/horseradish peroxidase (HRP)-conjugated goat anti-rabbit
secondary antibody. Membranes were developed with enhanced chemiluminescence (ECL)
detection and scanned using a ChemiDoc XRS+ with Image Lab software (Bio-Rad, Hercules,
CA, USA). Representative immunoblot from two independent colonies for each strain are
shown.
2.4.3

Lysine decarboxylase effects on pneumococcal protein expression
To identify pneumococcal molecular mechanisms that are responsive to lysine

decarboxylase, we carried out mass spectrometry-based proteomics with TIGR4 and ∆cadA. A
total of 772 proteins were identified which represents 34.5% of the annotated protein coding
genes in the TIGR4 genome. We identified significant changes in the expression of 132 proteins
of which 52 are upregulated and 80 are downregulated in ∆cadA compared to TIGR4 (Table
A.1). Molecular functions and pathways represented by the differentially expressed proteins are
discussed in the following sections and shown in Table 2.2.
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Table 2.2

Significant changes in ΔcadA proteome compared to TIGR4
ΔcadA/TIGR4

Description

Protein

N-carbamoylputrescine amidase

SP_0922 *

−10.0

Putrescine biosynthesis

Carboxynorspermidine decarboxylase

NspC

−5.0

Spermidine biosynthesis

Homoserine dehydrogenase

Hom

−1.4

Lysine biosynthesis

DapA

−10.0

Lysine biosynthesis

DapB

−2.5

Lysine biosynthesis

N-acetyldiaminopimelate deacetylase

SP_2096

−2.5

Lysine biosynthesis

Saccharopine dehydrogenase

Lys9

−25.0

Lysine biosynthesis

Aspartate-semialdehyde dehydrogenase

Asd

−25.0

Lysine biosynthesis

DapH

−1.7

Lysine biosynthesis

Penicillin-binding protein 2x

PBP2x

−2.5

Choline kinase

Pck

−2.0

4-hydroxy-tetrahydrodipicolinate
synthase
4-hydroxy-tetrahydrodipicolinate
reductase

2,3,4,5-tetrahydropyridine-2carboxylate N-Succinyl transferase
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(Fold Change)

Function

Peptidoglycan
biosynthesis
Cell wall biosynthesis

Table 2.2

Significant changes in ΔcadA proteome compared to TIGR4 (continued)

UDP-glucose 4-epimerase

GalE-1

−1.3

Carbohydrate metabolism

Tagatose 1,6-diphosphate aldolase

LacD

1.4

Carbohydrate metabolism

Galactose-6-phosphate isomerase subunit

LacB

2.1

Carbohydrate metabolism

Catabolite control protein A

CcpA

−2.5

Carbohydrate metabolism

Bifunctional protein

GlmU

−1.7

UDP- GlcNAc synthesis

NagA

1.4

NagB

2.1

Transketolase, C-terminal subunit

TktC

67.0

Pentose phosphate pathway

Transketolase, N-terminal subunit

TktN

46.0

Pentose phosphate pathway

N-acetylglucosamine-6-phosphate
deacetylase
N-acetylglucosamine-6-phosphate
deaminase

N-acetylglucosamine
degradation
N-acetylglucosamine
degradation

* locus tag ID; ABC: ATP binding cassette; ATP: Adenosine triphosphate; UDP: uridine
diphosphate; GlcNAc: N-acetylglucosamine; PTS: phosphotransferase system.
2.4.3.2

Capsule biosynthesis
CPS synthesis in TIGR4 is by the Wzy polymerase-dependent mechanism. CPS synthesis

is a multistep process that begins with the transfer of sugar-1-phosphate on the cytosolic side
onto a C55 lipid undecaprenyl-phosphate (Und-P), followed by the addition of remaining sugars
by glycosyl transferases to form a repeat unit. The repeat unit structure of serotype 4 CPS
consists of galactose, N-acetylmannosamine, N-acetylfucosamine and N-acetylgalactosamine
(Bentley et al., 2006). Und-P oligosaccharide repeat units are translocated to the outer face of the
cytoplasmic membrane by Wzx transporter and polymerized into high molecular weight
polysaccharide by Wzy polymerase. All genes involved in capsule biosynthesis are present as a
single operon between dexB and aliA in pneumococcal genomes. The first four genes in the
operon cpsABCD are important for modulation of synthesis and are common to all serotypes (J.
Yother, 2011). The rest of the genes in the operon are serotype specific. Changes in the
expression of cpsA is a surrogate of cps locus transcription. We expected to see a significant
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reduction in ΔcadA in the expression of some of the enzymes that catalyze the multi-step CPS
biosynthesis. Our proteomics data showed reduced expression of uridine diphosphate UDPglucose-4-epimerase (Table 2.2) that catalyzes the conversion of UDP-glucose to UDP-galactose
in capsular biosynthesis (Zeng et al., 2016). While the reduced expression of this protein is
consistent with the observed loss of capsule, it is unlikely that this marginal change can explain
the magnitude of the loss of CPS comparable to unencapsulated T4R (Figure 2.2) without
additional changes in the pneumococcal proteome that directly or indirectly impact capsule
synthesis. Expression of bifunctional protein GlmU (Table 2.2) was significantly downregulated.
This enzyme catalyzes the last two sequential reactions in the de novo biosynthetic pathway for
UDP-N-acetylglucosamine (UDP- GlcNAc). GlmU catalyzes the reaction that transfers an acetyl
group from acetyl coenzyme A to glucosamine 6-phosphate to synthesize acetylated glucosamine
6-phosphate. N-acetylglucosamine-6-phosphate deaminase (NagB) is an enzyme that catalyzes
the conversion of glucosamine 6-phosphate to fructose 6-phosphate and is known to regulate
GlmU (Rodriguez-Diaz, Rubio-Del-Campo, & Yebra, 2012). In ∆cadA expression of Nacetylglucosamine-6-phosphate deacetylase (NagA) and NagB, two enzymes involved in UDPGlcNAc degradation was significantly higher compared to TIGR4. Taken together, the net effect
of changes in the expression of GlmU, NagA and NagB would result in lower concentrations of
UDP-GlcNAc, a precursor for UDP- N-acetylmannosamine (ManNAc), which is a constituent of
serotype 4 CPS repeat unit, and could contribute to reduced CPS synthesis in ∆cadA.
2.4.3.3

Polyamine biosynthesis
Deletion of lysine decarboxylase in S. pneumoniae resulted in a significant decrease in

the expression of Lys9, Asd, DapA, DapB, Hom, DapH and SP_2096 involved in the
biosynthesis of lysine, the substrate for cadA (Table 2.2). Expression of N-carbamoylputrescine
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amidase which catalyzes the synthesis of putrescine from N-carbamoylputrescine in the arginine
and proline metabolism was significantly downregulated. Expression of NspC which catalyzes
the synthesis of spermidine from carbamoyl spermidine was also significantly downregulated
(Table 2.2). The net effect of these protein expression changes in polyamine biosynthesis
pathways, is expected to result in reduced intracellular concentrations of cadaverine, putrescine
and spermidine (Figure 2.3). We reported reduced intracellular concentrations of cadaverine,
putrescine and spermidine in ΔcadA (Shah et al., 2011) previously. Results from this study
explain this observed impact on intracellular polyamine concentrations in ΔcadA.

Figure 2.3

Impact of lysine decarboxylase on polyamine synthesis.

Impact of lysine decarboxylase on polyamine synthesis. Genes encoding the enzymes Lys9,
NspC, AguB and AguA that catalyze reactions in the polyamine biosynthesis pathways are
arranged as a single operon in the genome. Reactions that involve multiple steps are represented
by a broken arrow. Transcription of this operon is downregulated in ΔcadA. We identified
reduced expression of lys9, nspC, aguA and speE in ΔcadA compared to TIGR4 by qRT-PCR.
Expression of Lys9 and NspC proteins were reduced in lysine decarboxylase impaired
pneumococci.
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2.4.3.4

Peptidoglycan
The rigid, stable shape of bacteria is provided by the peptidoglycan layer which is made

of N-acetylmuramic acid-(β-1, 4)-N-acetylglucosamine (MurNAc-GlcNAc) disaccharides crosslinked by peptides. The peptidoglycan layer, teichoic acid (TA) and lipoteichoic acid (LTA)
constitute the cell wall of Gram-positive bacteria such as S. pneumoniae (Reichmann &
Grundling, 2011). Both LTA and TA contain phosphorylcholine (PC), which plays a major role
in S. pneumoniae adhesion and also forms attachment of choline binding surface proteins (CBPs)
(Molina et al., 2009). The peptidoglycan layer provides attachment for many structural
components including the polysaccharide capsule (William Wiley Navarre, 1999) and it is
important in the adhesion of S. pneumoniae to the host tissues. Our results show reduced
expression of penicillin-binding protein 2X (Table 2.2), which is involved in peptidoglycan
biosynthesis that contributes to bacterial cell division and growth (I. Schweizer, Peters,
Stahlmann, Hakenbeck, & Denapaite, 2014; Zhang et al., 2008). Choline kinase, an enzyme
which catalyzes the synthesis of PC from choline was downregulated in ΔcadA relative to
TIGR4. In some Gram-positive pathogens, choline kinase is known to be important for the
production of cell wall elements and LTA (Zimmerman & Ibrahim, 2017). PC is necessary for
the adherence of S. pneumoniae during the transition from colonization to invasive disease
(Molina et al., 2009). Reduced choline kinase expression in ΔcadA could also modulate
virulence.
2.4.3.5

Pentose Phosphate Pathway
The ability of bacterial pathogens to survive in the host largely depends on acquiring

nutrients and adapting their metabolism to different host microenvironments. Pneumococci have
the ability to utilize a variety of carbohydrates as carbon sources via Embden-Meyerhof-Parnas
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(EMP) pathway (glycolysis) and pentose phosphate pathway (PPP) (Herve Tettelin et al., 2001).
Pyruvate and ATP are the end products of glycolysis. The oxidative branch of PPP generates
ribulose 5-phosphate and reduced nicotinamide adenine dinucleotide phosphate (NADPH)
molecules while the non-oxidative branch generates a number of sugar phosphates that provide
precursors for nucleotide, amino acid and vitamin B6 synthesis. Our data supports increased
carbon flux through the non-oxidative branch of PPP due to the observed increase in the
expression of transketolase (Tkt), an enzyme that catalyzes the interconversion of sugarphosphates in the pathway Expression of all proteins SgaR2, SgaB2, SgaT2, including TktN and
TktC, encoded in a single regulon belonging to BgIG family transcriptional regulator is higher in
∆cadA (Table 2.2). We also identified a significantly higher expression for one of the two
general proteins of PTS (phosphotransferase system), phosphocarrier protein HPr (PtsH) which
could support the proper functioning of PTS transport systems in the BgIG regulon in ∆cadA. A
shift in metabolism towards PPP is often in response to oxidative stress to maintain
NADH/NADPH redox homeostasis and to synthesize ribose-5-phosphate for DNA repair
(Stincone et al., 2015).
2.4.3.6

3.3.6. Carbohydrate Metabolism
Our results show increased expression of proteins that are involved in galactose and

tagatose catabolism. Expression of LacB is higher in ΔcadA (Table 2.2) which generates the
substrate tagatose 6-phosphate for the enzyme LacD. Enzymatic action of LacB and LacD would
result in higher levels of glyceraldehyde 3-phosphate, which can be channeled into PPP by
transaldolase and transketolase. We identified reduced expression of catabolite control protein A
(CcpA), a protein that regulates carbon catabolite repression (CCR) in our lysine decarboxylase
mutant. CcpA is known to control the expression of a number of virulence factors in Gram
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positive bacteria (Warner & Lolkema, 2003). For instance, in S. pneumoniae, CcpA contributes
to sugar metabolism and virulence (Iyer, Baliga, & Camilli, 2005).

Measurement of Gene Expression in ΔcadA

2.4.4
2.4.4.1

Capsule biosynthesis
We did not identify major differences in the expression of proteins that catalyze different

steps in CPS synthesis. To determine whether CPS synthesis is regulated at the transcriptional
level, we compared cps4A mRNA expression between TIGR4 and ΔcadA by qRT-PCR. Our
results show a significant reduction in the expression of cps4A (Table 2.3), which could explain
reduced CPS synthesis in ΔcadA.

Table 2.3

Changes in gene expression in ΔcadA compared to TIGR4.
ΔcadA/TIGR4 (Fold

Gene

Description

p-Value
change)

Spermidine/putrescine ABC transporter,
potD

−2.0

1.93E-04

spermidine/putrescine-binding protein
speE

Spermidine synthase

−27.0

1.29E-06

cps4A

Capsular polysaccharide biosynthesis protein

−2.0

2.03E-07

lys9

Saccharopine dehydrogenase

−26.0

3.83E-12

nspC

Carboxynorspermidine decarboxylase

−34.0

4.70E-10

aguA

Agmatine deiminase

−30.0

2.87E-12
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2.4.4.2

Polyamine synthesis and transport
Our proteomics data identified significantly reduced expression of proteins involved in

the biosynthesis of putrescine, spermidine and cadaverine (Figure 2.2). The genes encoding
proteins NspC, Lys9, AguA and AguB are predicted to constitute a single operon in the genome
(Xizeng Mao et al., 2014). Based on our proteomics results, we expected to see reduced
expression of polyamine biosynthesis (lys9, aguA, and nspC) genes and our qRT-PCR data
shows reduced expression of these genes in ΔcadA (Table 2.3). Impaired lysine decarboxylase
also resulted in a significant reduction in the expression of spermidine synthase (Table 2.3).
Pneumococci can compensate for reduced polyamine synthesis by increasing the import of
extracellular polyamines. Extracellular polyamine uptake in pneumococci is predicted to be via a
single ABC transporter, organized as a four gene operon, potABCD (Ware, Watt, & Swiatlo,
2005). The proposed structure of the putrescine/spermidine transporter has PotD, an extracellular
substrate binding domain that binds polyamines, PotB, and PotC which form transmembrane
channels that transport polyamines and PotA that is a membrane associated cytosolic ATPase
(Ware et al., 2006). We did not detect polyamine transport proteins in our proteomics data. We
measured the expression of potD mRNA in ΔcadA and observed a significant decrease (Table
2.3), which would further contribute to reduced intracellular concentrations of putrescine and
spermidine, putative substrates for the PotABCD transporter.
2.5

Discussion
Polyamines are important for host-pathogen interactions during bacterial infections.

Polyamines in pathogenic bacteria play an important role in physiological stress responses and
adaptation to growth in vivo. Putrescine is a constituent of the cell wall in a number of Gramnegative bacteria, such as Salmonella enterica, E. coli and Proteus mirabilis (Jeremy A. Yethon,
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2000; Vaar, 1991), while cadaverine is covalently linked to the peptidoglycan layer of
Veillonella alcalescens (Kamio, 1987). Spermidine modulates autolysis and ion trafficking
across the cell membrane in S. pneumoniae, protecting pneumococci from cationic antimicrobial
compounds [7]. Cadaverine regulates porins that control the permeability of membranes [30],
and enables E. coli to survive acidic stress (Samartzidou, Mehrazin, Xu, Benedik, & Delcour,
2003). Current literature clearly demonstrates that deletion of polyamine synthesis and/or
transport in pathogenic bacteria (including pneumococci) leads to reduced virulence in animal
models (McDaniel & Swiatlo, 2016; Paterson, Blue, & Mitchell, 2006; Shah et al., 2011). To
date, studies that describe specific host innate immune mechanisms in vivo induced by
pathogenic bacteria with altered polyamine metabolism, or specific effects of impaired
polyamine metabolism on pathogen molecular mechanisms are largely unknown. A few
examples of specific roles of polyamines in bacterial pathogens include the following: in
intracellular pathogen Shigella, cadaverine is shown to be important for reducing enterotoxic
activity (Maurelli, Fernandez, Bloch, Rode, & Fasano, 1998), inhibiting trans-epithelial
migration of polymorphonuclear neutrophils, increasing survival in macrophages, and enhancing
antioxidant defenses in vitro (Fernandez et al., 2001). Salmonella typhimurium mutant deficient
in polyamine biosynthesis has reduced invasive potential and survival in epithelial cells in vitro
and is attenuated in a mouse model of typhoid fever (Duggan et al., 2011). In Yersinia pestis,
loss of intracellular spermidine and putrescine affects biofilm formation and biosynthesis
defective Y. pestis is ~500 times less virulent in a murine model of bubonic plague (Wortham,
Oliveira, Fetherston, & Perry, 2010). When Francisella. tularensis is cultured in the presence of
spermine or spermidine prior to macrophage infection assays, there is reduced pro-inflammatory
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response in vitro (Carlson et al., 2009). Thus, altered polyamine metabolism has varying impacts
on bacterial virulence.
Invasive infections caused by S. pneumoniae, a commensal in the nasopharynx, pose
significant risk to human health. The available polysaccharide-based conjugate vaccines are
effective in reducing vaccine serotypes in population, but ultimately lead to serotype replacement
(Charles Feldman and Ronald Anderson, 2014) from a reservoir of more than 90 capsular
serotypes (Weinberger et al., 2009). The critical role of the upper respiratory microbiota and the
consequence of its perturbation in various pathophysiological conditions mandates a cautious
approach to drug and vaccine discovery. Anti-virulence strategies that target genes/proteins that
are necessary for fitness during invasive infection can offer serotype-independent coverage
without impacting nasopharyngeal colonization, that is, disarm, but not eradicate, pneumococci
(McDaniel & Swiatlo, 2016). Specific aspects of bacterial physiology and metabolism that allow
pathogens to adapt to the host are a promising avenue for the discovery of novel therapeutics.
Intracellular polyamine concentrations are tightly regulated by biosynthesis, transport and
degradation. Polyamine transport and synthesis genes are conserved in pneumococci. Deletion of
the polyamine transport (potABCD) operon or spermidine synthase and lysine decarboxylase
biosynthesis genes had no impact on pneumococcal growth in vitro (Shah et al., 2011). However,
enhanced bacterial clearance in murine models of colonization, pneumococcal pneumonia, and
sepsis were seen with mutant strains (Shah et al., 2011). In a murine model of pneumococcal
pneumonia, ∆potABCD failed to elicit host defenses that are intact in TIGR4, and was cleared
more efficiently by opsonophagocytosis by neutrophils (Rai et al., 2016a). TIGR4 cultured in
vitro (in THY) had spermidine as the most abundant intracellular polyamine, followed by
cadaverine and putrescine (Shah et al., 2011). Polyamine transport and metabolism impaired
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∆potABCD, ∆cadA and ∆speE showed reduced levels of spermidine, cadaverine and putrescine,
relative to TIGR4. (Shah et al., 2011).
Here we report in vitro characterization of lysine decarboxylase deficient pneumococci.
Our results clearly demonstrate loss of CPS in ∆cadA. This loss of the capsule is specific to the
deletion of the cadA gene, as complementation of the wild type gene restored capsule,
comparable to that of TIGR4. Invasive pneumococcal serotypes can resist complement mediated
opsonophagocytosis by neutrophils due to the presence of the capsule (Hardy, Magee, Ventura,
Caimano, & Yother, 2001; Wortham et al., 2010). All three complement pathways are activated
for opsonophagocytosis (Brown, 1985; Hardy et al., 2001); classical, lectin and alternative.
Activation of the classical pathway is by antibody (including non-specific immunoglobulin M
(IgM) produced during infection), or by C-reactive protein (CRP), an acute phase protein. Steric
inhibition of the interaction between complement components and the Fc portion of
immunoglobulins by the capsule enables pneumococci to evade this host defense. The alternative
pathway is constitutively activated at low levels by complement protein C3b, and capsulemediated resistance to opsonophagocytosis also includes decreased cleavage of C3b to iC3b
(Paterson & Orihuela, 2010). Pneumococci regulate capsule expression as they invade host
tissues. In the initial stages of colonization of the nasopharynx, they express the capsule to evade
mucus, and in the subsequent stage of adhesion, the capsule is downregulated to expose surface
adhesins to adhere and colonize. The invasive phase requires upregulation of the capsule to resist
opsonophagocytosis (Shenoy & Orihuela, 2016). Some of the known regulatory mechanisms for
CPS synthesis involve phase variation (J. N. Weiser, Austrian, Sreenivasan, & Masure, 1994),
deletion of pgdA and adr, acetylases of peptidoglycan and increased transcription of cpsA
(Shainheit, Mule, & Camilli, 2014) and deletion of pyruvate oxidase (spxB) that all lead to
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increased CPS (Carvalho, Farshchi Andisi, et al., 2013), mutations in arcD that result in reduced
CPS (Gupta et al., 2013), and tyrosine phosphorylation of CpsBCD proteins that modulate CPS
levels (Echlin et al., 2016). Here, for the first time, we show that polyamines, specifically
cadaverine modulate CPS synthesis. Inactivation of lysine decarboxylase in pneumococci results
in reduced capsule synthesis. The mechanisms that result in reduced CPS synthesis are due to the
combinatorial effects on the regulation of UDP-GlcNAc synthesis and degradation (Figure 2.4)
that could reduce the availability of UDP-ManNAc of the CPS repeat unit in serotype 4
pneumococci with concomitant transcriptional downregulation of cps4A gene. A moderate
reduction in cpsA expression in TIGR4 capsule promoter mutant resulted in twofold reduction in
CPS (Shainheit et al., 2014). In ∆cadA, expression of cps4A saw a twofold reduction (Table 2.3),
which would be expected to have a greater impact on CPS synthesis. The intersection between
central metabolism and virulence is becoming evident for many bacterial pathogens including
pneumococci. As pneumococci sense and adapt to different host niches, they modulate capsule
synthesis which requires a shift in the metabolism towards increased synthesis of precursors for
CPS synthesis. A recent study showed that reduced acetyl-CoA levels result in loss of capsule
(Echlin et al., 2016), supporting the link between central metabolism and capsule formation.

35

Figure 2.4

Mechanisms for reduced capsule synthesis in lysine decarboxylase deficient
pneumococci.

Deletion of lysine decarboxylase in pneumococci results in reduced capsule compared to wild
type TIGR4 strain. Reduced capsule synthesis could be due to the reduced expression (shown in
red) of capsular polysaccharide biosynthesis gene cps4A, the first gene in the cps locus in S.
pneumoniae TIGR4 (A). The first four genes from the cps locus adjacent to the gene dexB that
are conserved in all pneumococcal serotypes are shown. Our proteomics data indicates shift in
central metabolism (B) from glycolysis (yellow box) to the non-oxidative branch of pentose
phosphate pathway (green box), due to increased expression (shown in blue) of transketolase
(Tkt,). Reactions that involve multiple steps are represented by a broken line. Reduced
expression of GlmU involved in the synthesis and increased expression of NagB involved in the
degradation of UDP-GlcNAc could result in reduced concentration of UDP-GlcNAc. UDPGlcNAc is a precursor for UDP-ManNAc, an acetylated sugar that is the constituent of the 4sugar repeat unit of capsular polysaccharide in capsular serotype 4 (open oval). The net effect of
the changes in pneumococcal gene and protein expression could result in the observed reduction
in capsule biosynthesis in ΔcadA.
Given the well-established role of polyamines in bacterial adaptation to oxidative stress
(Shah et al., 2011), the reduced intracellular polyamines due to reduced expression of enzymes
catalyzing synthesis (proteomics data, Table 2.2) and transport (qRT-PCR data, Table 2.3) could
explain the observed shift in metabolism that increases carbon flux through the pentose
phosphate pathway. Reduced uptake of iron and upregulation of manganese transporter proteins,
known pneumococcal virulence factors linked to oxidative stress response support this idea. It is
possible that increased oxidative stress in ∆cadA results in metabolic adaptation that diverts the
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energy from capsule production towards stress responses. With data presented here, it is difficult
to distinguish between correlation and causation due to impaired cadaverine synthesis. Future
studies that utilize additional omics approaches and data analysis in an integrated manner are
required to deconvolute the complexity of pneumococcal response to altered polyamine
metabolism. Although we have begun to identify some of the molecular mechanisms that are
responsive to polyamines in pneumococci that govern virulence, polyamine metabolism gene
annotations are limited in pneumococci. Our knowledge of polyamine metabolism in pathogenic
bacteria and specific effects of polyamines on bacterial translation relies heavily on studies from
E. coli. Basic biochemistry pertaining to substrate specificity of the transporters and biosynthesis
genes is yet to be determined. Our data shows that reduced expression of putrescine and
spermidine biosynthesis in ΔcadA could ultimately result in the altered intracellular polyamines
that we reported earlier (Shah et al., 2011). Future studies focused on determining individual
contribution of these polyamine biosynthesis genes to pneumococcal virulence are necessary for
a comprehensive description of the role of polyamine synthesis in pneumococcal pathogenesis.
Specific effects of polyamines on protein synthesis in bacteria are known. Studies in E. coli have
identified a “polyamine modulon”, a set of 17 genes whose translation is enhanced by
polyamines (Igarashi & Kashiwagi, 2015). Specific mechanisms by which polyamines increase
protein synthesis include formation of the initiation complex due to structural changes in in the
Shine-Dalgarno sequence and initiation codon AUG, initiation from inefficient initiation codon,
and +1 frame shifting and suppression of nonsense codons. Here we report altered expression of
a number of pneumococcal proteins in response to impaired lysine decarboxylase. It is possible
that some of these proteins are regulated by polyamines utilizing the mechanisms described in E.
coli. Future studies focused on understanding the specific mechanisms utilized by polyamines to
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impact protein expression can result in mechanistic insights into the impact of altered
metabolism on pneumococcal virulence. Despite these knowledge gaps, our previous work has
clearly established the importance of polyamine transport and synthesis genes in pneumococcal
pathogenesis. In this study we show that impaired polyamine synthesis results in reduced capsule
synthesis. This foundational knowledge at the intersection of polyamine metabolism and
pneumococcal virulence reinforces the need for future mechanistic studies focused on
developing novel therapeutics targeting polyamine metabolism in pneumococci.
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CHAPTER III
POLYAMINE SYNTHESIS EFFECTS CAPSULE EXPRESSION BY REDUCTION OF
PRECURSORS IN STREPTOCOCCUS PNEUMONIAE
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3.1

Abstract
Streptococcus pneumoniae (pneumococcus, Spn) colonizes the human nasopharynx

asymptomatically, but can cause infections such as otitis media, and invasive pneumococcal
disease such as community-acquired pneumonia, meningitis and sepsis. The success of Spn as a
pathogen can be attributed to its ability to synthesize and regulate capsular polysaccharide (CPS)
for survival in the host. S. pneumoniae downregulates CPS expression to expose adhesins and
colonize the host tissue, and increases CPS expression to inhibit complement, prevent antibody
deposition and resist opsonophagocytosis during invasive infection. At present, the mechanisms
of CPS regulation are not well-described and represent a bottleneck in the development of novel
therapeutics targeting the synthesis of this predominant virulence factor. We previously reported
that modulation of polyamine metabolic pathways, specifically, synthesis and transport impacts
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survival of Spn in murine models of colonization, pneumonia and sepsis. Recent studies from our
lab demonstrate that deletion of a putative polyamine biosynthesis gene (ΔcadA) in Spn TIGR4
results in the loss of the capsule. In this study, we characterized the transcriptome and
metabolome of ΔcadA and identified specific mechanisms that could explain the regulatory role
of polyamines in pneumococcal CPS biosynthesis. Our data indicate that impaired polyamine
synthesis impacts galactose to glucose interconversion via the Leloir pathway which limits the
availability of UDP-Galactose, a constituent of serotype 4 CPS, and UDP-N-acetylglucosamine
(UDP-GlcNAc), a nucleotide sugar precursor that is at the intersection of CPS and peptidoglycan
repeat unit biosynthesis. Reduced carbon flux through glycolysis, coupled with altered fate of
glycolytic intermediates further supports impaired synthesis of UDP-GlcNAc. A significant
increase in the expression of genes involved in the synthesis of glyceraldehyde 3-phosphate
(G3P) and transketolases support a shift in carbon flow towards pentose phosphate pathway
(PPP). Higher PPP activity could constitute oxidative stress responses in ΔcadA which warrants
further investigation. The results from this study clearly demonstrate the potential of polyamine
synthesis, targeted for cancer therapy in human medicine, for the development novel
prophylactic and therapeutic strategies for treating bacterial infections.

Keywords: Streptococcus pneumoniae, polyamines, capsule, Leloir pathway, glycolysis,
peptidoglycan, pentose phosphate pathway.
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3.2

Introduction
Streptococcus pneumoniae (pneumococcus) is a gram-positive bacterial pathogen that can

cause infections, such as sinusitis, otitis media, meningitis, septicemia and, most commonly,
community-acquired pneumonia (Greenwood, 1999; Musher, 1992). Children, elderly persons,
and immunocompromised individuals are more susceptible to pneumococcal infections (ACIP,
1997). Spn DNA methyltransferase genes undergo epigenetic modification by unknown
mechanism and contribute to phase variation, that enables this versatile pathogen to modulate
capsular polysaccharide (CPS) expression in response to either nasopharyngeal colonization or
invasion of sterile sites (J. Li et al., 2016; Manso et al., 2014). Pneumococcal capsule interferes
with opsonization and phagocytosis, and is also the basis for classification of nearly 100 identified
serotypes (K. A. Geno et al., 2015). Capsule biosynthesis in pneumococcus generally follows the
canonical Wzy-dependent pathway, which is common to the majority of the serotypes, with the
exception of two serotypes (3 and 37) that follow synthase-dependent mechanism. In Wzydependent mechanism, CPS repeat units are built on the inner side of the cytoplasmic membrane,
transported to the outer side by a flippase, further polymerized by a Wzy polymerase, then
covalently linked to the cell wall peptidoglycan (Eberhardt et al., 2012). Synthase-dependent CPS
biosynthesis depends on the activities of synthase enzyme for the initiation, polymerization and
transport, with the resulting capsule linked to the cell membrane via phosphatidylglycerol (Cartee,
Forsee, & Yother, 2005). The capsule biosynthesis locus is located between the dexB and aliA
genes in the pneumococcal genomes and constitutes a single operon with genes cpsA-O, depending
on serotype. Proteins encoded by the cps operon carry out various enzymatic functions such as
ligation, phosphorylation, glycosyl transfer, polymerization, membrane translocation and most
importantly, nucleotide sugar biosynthesis (Bentley et al., 2006). Although pneumococcal capsules
are well characterized, the molecular mechanisms that regulate CPS biosynthesis are limited.
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Transcriptional regulation of cps expression is reported to involve cpsA (Hanson, Lowe,
& Neely, 2011), the first gene of the cps locus, and the promoter sequence upstream of cpsA has
been shown to be essential for optimal expression of capsular genes and levels of CPS (Wen et
al., 2015). A phosphatase and kinase complex (cpsB and cpsCD) are also essential in the
regulation and biosynthesis of CPS (Morona et al., 2004). Recently, a link between regulation of
tyrosine kinase (Cps2D) by adenylate kinase and a proportional change in the level of CPS was
established in serotype 2 (Ghosh et al., 2018). Competence protein (ComE) has been reported to
be a transcriptional regulator of the cps locus in pneumococcus, where ComE negatively
regulates capsule expression and virulence (Zheng et al., 2017). In addition to transcriptional
regulation, recent advances in the study of pneumococcal capsule biosynthesis have identified effects on
central metabolism that impact CPS. Uracil deprivation is reported to reduce the expression of CPS

(Carvalho et al., 2018). An arginine/ornithine antiporter, arcD, has also been reported to regulate
CPS biosynthesis by unknown mechanisms (Gupta et al., 2013). Pneumococcal serotypes that
have acetylated sugars in the CPS utilize pyruvate to produce acetyl-CoA. Impaired pyruvate
oxidase, an important enzyme in the production of acetyl-CoA, has been shown to lead to
reduction of capsule (Echlin et al., 2016). Although, these multiple regulatory pathways have an
impact on CPS synthesis, the exact molecular mechanisms that control the levels of CPS are
largely unknown, as a comprehensive description of the regulatory framework for the expression
of this critical virulence factor is still a work in progress.
Polyamines such as spermidine, putrescine, and cadaverine are ubiquitous, poly cationic,
aliphatic hydrocarbons with amino groups that regulate a number of cellular processes (Bae,
Lane, Jansson, & Richardson, 2018). Intracellular polyamine concentrations are tightly regulated
by transport (uptake/efflux), biosynthesis, and catabolism. We have shown that isogenic deletion
of cadA, a gene that encodes a putative lysine decarboxylase that catalyzes the conversion of
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lysine to cadaverine, a polyamine, resulted in an attenuated phenotype in murine models of
pneumococcal colonization, pneumonia, and sepsis (Shah et al., 2011). Characterization of S.
pneumoniae TIGR4 ΔcadA showed a loss of capsule (Nakamya et al., 2018), which in part, could
be due to transcriptional downregulation of cps4A, the first gene in the cps operon. Expression
proteomics of ΔcadA indicated a shift in central metabolism that could limit the availability of
precursors for CPS synthesis. However, due to limited proteome coverage, we failed to identify
specific molecular mechanisms of regulation of CPS synthesis in polyamine synthesis deficient
pneumococci. To identify pneumococcal pathways responsive to polyamine synthesis that
regulate CPS synthesis, we compared the transcriptomic and metabolomic profiles of S.
pneumoniae TIGR4 and ΔcadA strains. Our results show that deletion of cadA results in further
reduction of the expression of genes encoding putrescine, spermidine and spermine biosynthesis
as well as the amino acid lysine. The ability to convert UDP-Glucose to UDP-Galactose (UDPGal) through Leloir pathway was reduced in ΔcadA, which can result in reduced incorporation of
UDP-Gal into the repeat unit of CPS and also reduce the carbon flux through glycolysis. RNASeq data indicated that glyceraldehyde 3-phosphate (G3P) is routed through the pentose
phosphate pathway (PPP) that could result in increased nucleotide synthesis. Observed changes
in the expression of genes in the amino and nucleotide sugar metabolism are expected to result in
reduced intracellular levels of UDP-N-acetylglucosamine (UDP-GlcNAc), a precursor for three
N-acetylated nucleotide sugars in serotype 4 capsule repeat unit. Impaired Leloir pathway and
UDP-GlcNAc synthesis will limit the availability of CPS precursors. Changes in the metabolism
in ΔcadA, such as reduced glycolytic activity, altered UDP-GlcNAc metabolism and lysine
synthesis could impact the assembly of peptidoglycan (PG) repeat unit disaccharide and
pentapeptide. Polymerization of PG repeat units constitutes the cell wall which provides
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attachment for the capsule. In summary, using RNA-Seq and metabolomics, we identified
specific mechanisms in polyamine synthesis deficient pneumococci, that limit the availability of
precursors for the CPS and cell wall peptidoglycan repeat unit synthesis. This study is the first
report on the impact of altered polyamine metabolism, often reported as a target for cancer
therapy in human medicine, on bacterial pathogenesis. The results from this study clearly
demonstrate the potential of targeting polyamine synthesis in bacteria for the development novel
prophylactic and therapeutic strategies.
3.3
3.3.1

Materials and methods
Bacterial strains and growth conditions
Streptococcus pneumoniae serotype 4 strain TIGR4 and ΔcadA were used in this study.

All strains were grown in Todd-Hewitt broth supplemented with 0.5% yeast extract (THY) or on
5% sheep blood agar plates (BAP) in 5% CO2. Generation of ΔcadA and initial characterization
of CPS is described elsewhere (Nakamya et al., 2018). All strains were grown to mid-log phase
(O.D600 nm 0.4) and cells were pelleted, for extraction of total RNA and metabolites. Colony
forming units (CFU) were enumerated to ensure comparable number of working cells.

3.3.2

RNA sequencing
Total RNA was isolated and purified from mid-log phase cultures of TIGR4 and ΔcadA

grown in THY (n = 3) using the RNeasy Midi Kit and QIAcube (Qiagen, Valencia, CA). The
quality was analyzed by an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Libraries for RNA-Seq were prepared with the KAPA RNA Hyper Kit with RiboErase (KAPA
Biosystem, Wilmington, MA) with 5 µg RNA as input. The workflow consists of rRNA
removal, cDNA generation, end repair to generate blunt ends, A-tailing, adaptor ligation and
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PCR amplification. Different adaptors were used for multiplexing samples in one sequencing
run. Library concentrations and quality were measured using Qubit ds DNA HS Assay Kit (Life
Technologies, Carlsbad, CA) and Agilent Tapestation (Agilent Technologies, Santa Clara, CA).
Sequencing was performed on an Illumina Hiseq 3000 for a single read 50 run. Data quality
check was done on Illumina SAV. De-multiplexing was performed with Illumina Bcl2fastq2 v
2.17. Analysis to remove failed reads, mapping of the short sequence reads to Streptococcus
pneumoniae TIGR4 reference genome, and identification of differentially expressed genes were
performed with RNA-Seq tool of CLC Genomic Workbench 11 (Qiagen, Valencia, CA). Briefly,
single end reads of both wild type and mutant were mapped to S. pneumoniae TIGR4 genome
using CLC proprietary read mapper, counted with EM estimation algorithm, and differentially
expressed genes were identified based on the fold change generated by the edgeR algorithm.
Fold change with false discovery rate (FDR) ≤ 0.05 was accepted to be significant. RNA-Seq
raw data and metadata reported in this study are available at NCBI GEO with the accession
number GSE130511. The differentially expressed genes were analyzed by integrating multiple
bioinformatics resources such as KEGG (Kanehisa et al., 2012), UniProt (UniProt Consortium,
2018), STRING (Szklarczyk et al., 2019), DAVID (Huang da et al., 2009) and EcoCyc (Keseler
et al., 2017) to infer biological functions altered in Streptococcus pneumoniae serotype 4
harboring a gene deletion in a putative lysine decarboxylase.

3.3.3

UPLC–HRMS Untargeted Metabolomics Analysis
S. pneumoniae TIGR4 and ΔcadA strains were cultured in THY (mid-log phase, ~109

CFU, n=5) and transferred onto a 0.2 µm Whatman polycarbonate membrane filter by vacuum
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filtration. The membranes were flash-frozen in liquid nitrogen and stored at -80 ⁰C until further
use. Metabolites from bacteria collected on membrane filters were extracted by placing the filters
into petri dishes with 1.3 mL of extraction solvent pre-chilled to 4 ⁰C (40:40:20 HPLC grade
methanol, acetonitrile, water with 0.1% formic acid). The extraction was allowed to proceed for
15 min at -20 ⁰C. The membranes were flipped over and rinsed with the extraction solvent. The
extraction solvent was transferred to 2.0 mL centrifuge tubes and an additional 300 µL of
extraction solvent was added to each membrane. The membranes were compressed and rinsed to
extract the remaining cells and the extraction solvent was transferred to a centrifuge tube. The
centrifuge tubes with extraction solution were centrifuged for 5 min (16,100 x g) at 4 ⁰C to
remove the cell debris and the supernatant was transferred to new 2.0 mL vial. The residual cells
were resuspended with 100 µL of extraction solvent. Extraction was allowed to proceed for
another 15 min at -20 ⁰C, centrifuged for 5 min (16,100 x g) at 4 ⁰C to remove any remaining
cells and the supernatant was collected. Vials containing ~1.7 mL of the total supernatant were
dried under a stream of N2 and solid residue was resuspended in 300 µL of sterile water and
transferred to 300 µL autosampler vials. Samples were immediately placed in autosampler trays
for mass spectrometric analysis.
Samples placed in an autosampler tray were kept at 4 ⁰C. A 10 µL aliquot was injected
through a Synergi 2.5-micron reverse-phase Hydro-RP 100, 100 x 2.00 mm LC column
(Phenomenex, Torrance, CA) kept at 25 ⁰C. The eluent was introduced into the MS via an
electrospray ionization source conjoined to an Exactive™ Plus Orbitrap Mass Spectrometer
(Thermo Scientific, Waltham, MA) through a 0.1 mm internal diameter fused silica capillary
tube. The mass spectrometer was run in full scan mode with negative ionization mode with a
window from 85 – 1000 m/z with a method adapted from Lu et al., 2010 (Lu et al., 2010). The
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samples were run with a spray voltage of 3 kV. The nitrogen sheath gas was set to a flow rate of
10 psi with a capillary temperature of 320 ⁰C. AGC (acquisition gain control) target was set to
3e6. The samples were analyzed with a resolution of 140,000 and a scan window of 85 to 800
m/z from 0 to 9 min and 110 to 1000 m/z from 9 to 25 min. Solvent A consisted of 97:3 water:
methanol, 10 mM tributylamine, and 15 mM acetic acid. Solvent B was methanol. The gradient
from 0 to 5 min is 0% B, from 5 to 13 min is 20% B, from 13 to 15.5 min is 55% B, from 15.5 to
19 min is 95% B, and from 19 to 25 min is 0% B with a flow rate of 200 µL/min.
Files generated by Xcalibur (RAW) were converted to the open-source mzML format
(Martens et al., 2011) via the open-source msconvert software as part of the ProteoWizard
package (Chambers et al., 2012). Maven (mzroll) software, Princeton University (Michelle F.
Clasquin, Melamud, & Rabinowitz, 2012; Melamud, Vastag, & Rabinowitz, 2010) was used to
automatically correct the total ion chromatograms based on the retention times for each sample.
(M. F. Clasquin, Melamud, & Rabinowitz, 2002; Melamud et al., 2010). Metabolites were
manually identified and integrated using known masses (± 5 ppm mass tolerance) and retention
times ( ≤ 1.5 min). Unknown peaks were automatically selected via Maven's automated peak
detection algorithms. We used a database of 275 metabolites verified using exact m/z and known
retention times, expanded from the original database of Lu et al., 2010 (Lu et al., 2010) as
additional standards become available. The statistical analysis on metabolite peak intensity post
CFU normalization was done by MetaboAnalyst 4.0 (Chong et al., 2018). We used quantile
normalization that has been reported to be highly efficient in normalizing metabolite variations
from mass spectrometry to normalize our data (Lee et al., 2012). Significant differences in
metabolite peak intensity between ΔcadA and TIGR4 were identified by a T-test at an adjusted
FDR of 0.05 (B. Li et al., 2017). Sparse partial least squares-discriminant analysis (sPLS-DA)
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was used for the statistical data presentation. We used KEGG (Kanehisa et al., 2012) and
EcoCyc (Keseler et al., 2017) to infer metabolic pathways in S. pneumoniae TIGR4 represented
by our untargeted metabolomics data.
3.3.4

Measurement of pyruvic acid
To measure the glycolytic pathway activity, we estimated the concentration of secreted

pyruvate, the end product of glycolysis, using the Pyruvic Acid Assay Kit (Megazyme, Ireland)
following manufacturer’s protocols. Briefly, mid-log phase cultures of TIGR4 and ΔcadA were
pelleted at 6000 x g for 5 min. 10 µL of supernatant was added to a mixture of 240 µL distilled
water, 20 µL of assay buffer and 10 µL of assay solution 2 containing NADH. 10 µL of provided
assay standard solution and 10 µL of distilled water were used in place of supernatant for the
standard mix and blank mix, respectively. The mixtures were incubated for 2 min at room
temperature (25 °C). Addition of 2 µL of solution 3 containing D-LDH was used in initiating
pyruvate quantification reaction. After a reaction time of 3 min, the absorbance was read at 340
nm. Excreted pyruvate was estimated using the formula below:
Pyruvate (g/L) = (∆Asample/∆Astandard) x g/L standard, where ∆A is the absorbance
measurement. The amount of pyruvate produced by S. pneumoniae TIGR4 and ΔcadA strains
was normalized using estimated pneumococcal total protein according to the BCA method
(Smith et al., 1985), and the result presented as pyruvate (ng)/ protein (µg).
3.3.5

Estimation of Surface Exposed Phosphocholine
Fluorescence-activated cell sorting (FACS) comparison of surface exposed

phosphocholine levels between the wild type and ΔcadA strains was performed (Shainheit et al.,
2014) to validate our reported loss of CPS and higher expression of choline binding proteins in
ΔcadA (Nakamya et al., 2018). Briefly, 300 µL of mid-exponential-growth-phase bacteria were
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pelleted and washed in 1X PBS. Pellets were resuspended in 100 µL of unconjugated IgA,
Kappa from murine myeloma anti-phosphocholine (Sigma-Aldrich, St. Louis, MO) at 1:100 in
1X PBS and incubated on ice for 30 min. The binding reaction was stopped with 500 µL of 1X
PBS and centrifuged at 4,000 x g for 5 min. Pellets were resuspended in 100 µL of phycoerythrin
(PE)-conjugated rat anti-mouse IgA secondary antibody (ThermoFisher Scientific, Waltham,
MA) at 1:100 in PBS and incubated at 4 ⁰C, in the dark, for 30 min. Staining reactions were
stopped with 500 µL PBS, and products were pelleted and resuspended in 300 µL of 2%
paraformaldehyde (PFA). Samples were collected (10,000 events), analyzed and plotted using an
Attune Acoustic Focusing Cytometer (Life Technology, Foster City, CA).

3.4
3.4.1

Results
Effect of cadA deletion on pneumococcal gene expression
RNA-Seq-based comparative transcriptome analysis of S. pneumoniae TIGR4 and ΔcadA

identified significant changes in the expression of 432 genes, of which 179 were downregulated,
and 253 were upregulated in ΔcadA. Biological functions and pathways represented by genes
responsive to impaired putative lysine decarboxylase gene are discussed in the following sections
and shown in Tables 1-4.
3.4.1.1

Impaired polyamine synthesis reduces the expression of genes that regulate
intracellular concentrations of precursors for capsular polysaccharide (CPS)
synthesis
S. pneumoniae TIGR4 genes responsive to impaired polyamine synthesis have functions

that are directly involved in the metabolism and transport of CPS precursors (Table 3.1). The
repeat unit of serotype 4 polysaccharide structure has the following sugars: UDP-Galactose
(UDP-Gal), UDP-N-acetylmannosamine (UDP-ManNAc), UDP-N-acetylfucosamine (UDP49

FucNAc) and UDP-N-acetylgalactosamine (UDP-GalNAc) (K. A. Geno et al., 2015; Jones,
Currie, & Forster, 1991). Our results show that the expression of genes involved in the synthesis
and availability of sugar precursors in the repeat unit is significantly altered in ΔcadA.
Expression of alpha-galactosidase (aga), which cleaves galactose from raffinose and melibiose
(Rosenow, Maniar, & Trias, 1999), is downregulated (Table 3.1). Galactokinase (galK) and
galactose-1-phosphate uridylyltransferase 2 (galT2), the genes encoding key enzymes of Leloir
pathway, a predominant route for galactose catabolism and generation of UDP-Gal, are
significantly downregulated. We observed downregulation of sialidase B (nanB), an enzyme that
catalyzes the cleavage of terminal sialic acid from host glycoconjugates to ultimately generate
UDP-ManNAc. Genes that encode fuculose kinase and fuculose phosphate aldolase are
upregulated in ΔcadA. These enzymes are responsible for the degradation of fucose, a sugar
component of CPS repeat unit structure. Glycerone 3-phosphate produced from fucose
degradation can be converted by a triosephosphate isomerase directly to G3P, an intermediate of
glycolysis and PPP (Higgins, Suits, Marsters, & Boraston, 2014). Our data also shows the upregulation
of a putative fucose operon repressor (SP_2168) that could inhibit fucose utilization. All genes
encoding the phosphotransferase system (PTS) IIA-D components specific for the import of Nacetylgalactosamine, a sugar that is part of the CPS repeat unit, are downregulated.
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Table 3.1

Differentially expressed genes in ΔcadA from capsule biosynthesis pathways.

Gene

Locus Tag

Description

Fold Change

Aga

SP_1898

Alpha-galactosidase

-2.7

galK

SP_1853

Galactokinase

-5.0

galT2

SP_1852

Galactose-1-phosphate uridylyltransferase 2

-5.9

nanB

SP_1687

Sialidase B

-3.7

SP_2167

SP_2167

Putative L-fuculose kinase fucK

4.1

fucA

SP_2166

L-fuculose phosphate aldolase

3.7

SP_2168

SP_2168

Putative fucose operon repressor

1.9

SP_0321

SP_0321

PTS system, IIA component

-2.4

SP_0323

SP_0323

PTS system, IIB component

-3.7

SP_0324

SP_0324

PTS system, IIC component

-3.7

SP_0325

SP_0325

PTS system, IID component

-3.5

glgB

SP_1121

1,4-alpha-glucan branching enzyme

2.1

glgC

SP_1122

Glucose-1-phosphate adenylyltransferase

1.7

glgD

SP_1123

Glycogen biosynthesis protein

1.6

glgA

SP_1124

Glycogen synthase

1.7

malP

SP_2106

Maltodextrin phosphorylase

-2.1

malQ

SP_2107

4-alpha-glucanotransferase

-2.8

exp5

SP_0758

PTS system glucose-specific EIICBA component

-1.6

SP_1795

SP_1795

Putative sucrose-6-phosphate hydrolase

-3.0

glmS

SP_0266

Glutamine--fructose-6-phosphate aminotransferase

-1.6

nagA

SP_2056

N-acetylglucosamine-6-phosphate deacetylase

2.9

nagB

SP_1415

Glucosamine-6-phosphate deaminase

3.9

pyrR

SP_1278

Bifunctional protein PyrR

-1.9

SP_1163

SP_1163

Putative acetoin dehydrogenase, beta subunit

-1.5

SP_1164

SP_1164

Putative acetoin dehydrogenase, alpha subunit

-1.4

Genes that encode enzymes that ultimately control the intracellular concentrations of
UDP-GlcNAc are differentially expressed in ΔcadA (Table 3.1, Figure 3.1). Expression of a
glycogen synthesis operon (glgBCDA) which converts glucose 1-phosphate to glycogen was
upregulated, while the expression of malP, which reverses this anabolic process was
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downregulated. This in turn will limit the availability of glucose for the biosynthesis of UDPGlcNAc, an important substrate for epimerases that catalyze the biosynthesis of the sugars in the
repeat unit of CPS. UDP-GlcNAc is converted to UDP-ManNAc and UDP-GalNAc by UDP-Nacetylglucosamine-2-epimerase and UDP-glucose 4-epimerase, respectively (Chen et al., 2018;
Emily J. Kay, 2016). UDP-GlcNAc can also be converted to UDP-FucNAc in a multi-step
reaction involving SP_0358-60 protein (Emily J. Kay, 2016). Genes that are involved in the
degradation of maltose to glucose (malQ), import of glucose into the cell (exp5), and the
generation of glucose 6-phosphate and fructose 6-phosphate from sucrose (SP_1795), are
downregulated ΔcadA. Glucose, glucose 6-phosphate and fructose 6-phosphate, the first three
intermediates of glycolysis, are precursors for UDP-GlcNAc. We also observed downregulation
of glmS which encodes a glutamine—fructose-6-phosphate aminotransferase that converts
fructose 6-phosphate to glucosamine 6-phosphate in UDP-GlcNAc biosynthesis, and
upregulation of nagA and nagB, also at protein level (Nakamya et al., 2018), that convert UDPGlcNAc intermediate to fructose 6-phosphate. The net effect of gene expression changes
described could be reduced concentrations of the saccharides that constitute the repeat unit that
ultimately results in reduced CPS in ΔcadA (Figure 3.1).
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Figure 3.1

Impaired polyamine synthesis in S. pneumoniae impacts the availability of
precursors for capsule (CPS) synthesis.

Characterization of a putative lysine decarboxylase deletion strain of S. pneumoniae TIGR4 by
RNA-Seq and metabolomics identified changes (blue represents increase and red represents
decrease) in the genes (italicized) and metabolites in the deletion strain relative to the wild type
that could explain the previously reported loss of capsule. The deletion strain is impaired in the
interconversion of UDP-Glucose and UDP-Gal via the Leloir pathway (grey square) due to the
reduced expression of galk and galT2 genes, that can reduce the incorporation of UDP-Galactose
into the repeat unit structure of serotype 4 capsule (open white oval). Carbon flux through
glycolysis (yellow oval) is reduced in ΔcadA confirmed by the accumulation of glucose 6phosphate and NAD+, intermediates of the pathway and reduced levels of the end product
pyruvate. Enzymatic reactions are shown as black arrows and multi-step reactions are
represented by a broken arrow. Upregulation of N-acetylglucosamine-6-phosphate deacetylase
(NagA*) and Glucosamine-6-phosphate deaminase (NagB*) that could degrade intermediate of
UDP-GlcNAc, at the protein level, was earlier reported and was observed at the RNA level in
this study. Reduced synthesis of UDP-GlcNAc due to reduced expression of glmS and increased
degradation due to higher expression of nagA and nagB will limit the availability of this
nucleotide sugar substrate for epimerases that synthesize all three acetylated UDP-sugars of the
repeat unit. Accumulation of orotate indicates impaired ability to synthesize UTP, a precursor
for UDP-GlcNAc synthesis. The net effect of these changes in metabolism in ΔcadA result in the
reduced availability of precursors for CPS synthesis (red rectangle).
We further identified downregulation of pyrR, a gene that encodes a bifunctional enzyme
that regulates the interconversion of uracil and uridine monophosphate (UMP). Uracil is known
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to be a metabolic regulator of CPS biosynthesis in pneumococcus (Carvalho et al., 2018). In
addition, UMP is the precursor for UTP that is essential for the activation of saccharides in the
repeat unit as it provides UDP required to form UDP-sugar. There was also lower expression of
pyruvate dehydrogenase complex (SP_1163 and SP_1164) responsible for the production of
acetyl-CoA that are needed for the acetylation of sugars in the repeat unit of TIGR4.
3.4.1.2

Impaired polyamine synthesis regulates the expression of genes involved in the
synthesis of peptidoglycan and choline-binding proteins
In previous work, we reported that deletion of cadA, which encodes putative lysine

decarboxylase, resulted in significantly reduced expression of penicillin-binding protein 2X
(PBP2x) and choline kinase (Pck), proteins involved in peptidoglycan (PG) and teichoic acid
biosynthesis (Nakamya et al., 2018). In this study, we identified reduced expression of genes
encoding a glutamine transporter complex: glnH, glnP and glnQ in ΔcadA (Table 3.2).
Glutamine is known to be directly involved in the crosslinking of PG. It serves as an important
cofactor in the amidation of glutamate to iso-glutamine in the PG disaccharide-pentapeptide
repeat unit, a substrate of penicillin binding protein (Zapun et al., 2013). Genes that encode
biosynthesis of amino acids lysine (asd, dapA and lys9), alanine (SP_1994), and D-glutamate
from L-glutamate (murI), that are components of the PG repeat unit, are all downregulated in
polyamine synthesis deficient pneumococci. Reduced expression of genes that control
intracellular concentrations of UDP-GlcNAc described in the previous section could also
negatively impact the PG and, ultimately, cell wall biosynthesis. UDP-GlcNAc is an essential
intermediate molecule in PG biosynthesis. It is one of the disaccharide components of the
peptidoglycan repeat unit, and also a precursor for the biosynthesis of N-acetylmuramic acid
(MurNAc), the second sugar of the repeat unit (Figure 3.2). These results indicate that polyamine
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biosynthesis regulates pneumococcal cell wall biosynthesis, a structure to which the
pneumococcal capsule is attached (T. R. Larson & J. Yother, 2017) (Figure 3.2).

Table 3.2
Gene

Differentially expressed genes in ΔcadA involved in peptidoglycan and choline
binding protein synthesis, and carbon utilization pathways.
Locus Tag

Description

Fold Change

Peptidoglycan Biosynthesis
glnH

SP_0609

Amino acid ABC transporter, amino acid-binding protein

-1.6

glnP

SP_0607

Amino acid ABC transporter, permease protein

-1.5

glnQ

SP_0610

Amino acid ABC transporter, ATP-binding protein

-1.7

asd

SP_1013

Aspartate-semialdehyde dehydrogenase

-5.4

dapA

SP_1014

4-hydroxy-tetrahydrodipicolinate synthase

-4.8

lys9

SP_0919

Saccharopine dehydrogenase

-26.4

SP_1994

SP_1994

Aminotransferase, class I

-1.4

murI

SP_1881

Glutamate racemase

-1.7

Choline Binding Protein Synthesis
pspA

SP_0117

Pneumococcal surface protein A

2.3

cbpA

SP_2190

Choline binding protein A

1.8

cbpI

SP_0069

Choline binding protein I

1.5

pcpA

SP_2136

Choline binding protein PcpA

2.3

Carbon Utilization Pathways
SP_0877

SP_0877

PTS system, fructose specific IIABC components

2.6

SP_0645

SP_0645

Putative PTS system IIA component

3.1

SP_0646

SP_0646

Putative PTS system, IIB component

2.6

SP_0647

SP_0647

Putative PTS system, IIC component

2.6

lacD

SP_1190

Tagatose 1,6-diphosphate aldolase

1.9

lacC

SP_1191

Tagatose-6-phosphate kinase

1.9
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Table 3.2

Differentially expressed genes in ΔcadA involved in peptidoglycan and choline
binding protein synthesis, and carbon utilization pathways (continued).

lacB

SP_1192

Galactose-6-phosphate isomerase subunit

1.7

lacA

SP_1193

Galactose-6-phosphate isomerase subunit

1.8

tktC

SP_2127

Transketolase, C-terminal subunit

97.9

tktN

SP_2128

Transketolase, N-terminal subunit

94.1

SP_2129

SP_2129

Putative PTS system, IIC component

81.5

SP_2130

SP_2130

Putative PTS system, IIB component

68.7
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Figure 3.2

Impact of impaired polyamine synthesis on peptidoglycan biosynthesis.

The peptidoglycan (PG) repeat unit structure in pneumococci constitutes a disaccharide
(hexagon) composed of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc)
that is linked to a L-alanine (L-Ala), D-Glutamate (D-Glu), L-Lysine (L-Lys), D-alanine (DAla), and D-alanine pentapeptide (light green rectangle). RNA-Seq based comparative
transcriptome analysis of ΔcadA, impaired in polyamine synthesis and the wild type S.
pneumoniae TIGR4 identified gene (italicized) expression changes (increase in blue and
decrease in red) that could impact the PG repeat unit synthesis and cross-linking. Enzymatic
reactions are shown as black arrows and multi-step reactions are represented by a broken arrow.
Reduced synthesis of UDP-GlcNAc due to reduced expression of malP, glmS, and its increased
breakdown due to higher expression of nagA, nagB, and glgBCDA operon, will impact PG
synthesis. Reduced expression of SP_1994 that converts pyruvate to alanine, murI that convert
L-Glu to D-Glu, and lysine biosynthesis genes (dapA, lys9 and asd) will limit the availability of
these three amino acids in PG pentapeptide synthesis. Crosslinking of the PG repeat unit requires
conversion of D-Glu to iso-glutamine using glutamine as a co-factor. Impaired glutamine import,
due to reduced expression of glnHPQ was observed in ΔcadA. The overall impact of polyamine
synthesis impairment is altered cell wall biosynthesis (red oval), due to specific effects on PG
synthesis. Cell wall provides the point of structural attachment for the capsule (black oval) in S.
pneumoniae.
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Impaired polyamine synthesis impacts expression of genes encoding pneumococcal
surface protein A, choline-binding proteins (CBP) A and I, and PcpA which were upregulated in
ΔcadA. These data suggest that deletion of cadA does not only mediate loss of the capsule and
expose CBPs on the cell surface, but also enhances the expression of CBPs. Our earlier report
indicated that there is no significant difference in the ability of ΔcadA to colonize the murine
nasopharynx with respect to the parent strain (Shah et al., 2011). In this study, the observed
upregulation of expression of CBPs could represent a response to genetic cue by pneumococcal
defense machinery to enhance adherence and colonization, to overcome the expected clearance
by opsonophagocytosis due to the reported loss of capsule. Comparison of surface exposed
phosphocholine (PC) using an IgA anti-phosphocholine antibody and FACS assay indicates
higher signal for PC with ΔcadA compared to the wild type strain (Figure B.1), validating the
reported increase in the expression of choline binding proteins at the RNA and protein levels
(Nakamya et al., 2018).
3.4.1.3

Impaired polyamine synthesis results in increased carbon flux through PPP
Proteomics analysis of polyamine synthesis deficient ΔcadA strain indicated a putative

shift in central metabolism favoring PPP (Nakamya et al., 2018). Expressions of genes
responsive to cadA deletion include those that belong to carbon utilization pathways (Table 3.2).
We observed upregulation of fructose specific PTS system IIABC components, which catalyze
the conversion of fructose to fructose 1-phosphate that ultimately generates G3P, an intermediate
of Glycolysis/PPP. This upregulation could limit the availability of fructose for the synthesis of
UDP-GlcNAc. Deletion of cadA also resulted in the upregulation of putative PTS system IIA-C
component genes and lacDCBA, genes involved in the import and conversion of galactose via
tagatose to G3P. The net effect of these gene expression changes is expected to increase G3P
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levels in ΔcadA (Figure 3.3), an intermediate of glycolysis and PPP. Activation of PPP and
utilization of G3P in this pathway is supported by upregulation of transketolase genes, both Cand N-terminal subunits tktC and tktN, which encode these enzymes of PPP, consistent with our
earlier report of significant upregulation of transketolases at the protein level (Nakamya et al.,
2018). Putative PTS system, IIBC components, which play a role in the conversion of Lascorbate to xylulose-5-phosphate, an intermediate of PPP, are also upregulated, supporting
higher PPP activity in ΔcadA compared to the wild type strain, and corroborate our earlier findings of a
shift in central carbon flux at the protein level (Nakamya et al., 2018).

Figure 3.3

Impaired polyamine synthesis results in increased carbon flow through the pentose
phosphate pathway (PPP).

RNA-Seq based transcriptome analysis of S. pneumoniae TIGR4 that harbors a gene deletion in
a putative lysine decarboxylase, identified significant upregulation of genes (italicized, blue) in
carbohydrate metabolism that indicate increased G3P, an intermediate of glycolysis, and its
utilization in PPP. Enzymatic reactions are shown as black arrows and multi-step reactions are
represented by a broken arrow. Increased expression of genes in metabolic pathways catalyzing
the conversion of galactose (SP_0645-7, lacDCBA), fructose (SP_0877), fucose (fucA,
SP_2167), and N-acetylglucosamine 1-phosphate (GlcNAc1P, nagA, nagB) to G3P with
concomitant higher expression of transketolase C and N subunits (tktC, tktN) supports the
increased metabolic flux through PPP.
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3.4.1.4

Impaired polyamine synthesis alters the expression of pneumococcal virulence
factors and stress response
Expression of genes encoding branched chain amino acid transporters livH, livM, livG

and livF is downregulated in ΔcadA (Table 3.3). These transporters have been shown to
contribute to pneumococcal virulence in a murine model of pneumonia and septicemia
(Basavanna et al., 2009). We also observed downregulation of metQ that encodes methionine
ABC transporter lipoprotein in ΔcadA. Although the exact mechanism is not known, loss of
methionine transporter MetQ has been shown to lead to an attenuated phenotype in a murine
model of pneumococcal pneumonia and it is reported to delay invasive disease (Saleh et al.,
2014). We observed decreased expression of trehalose PTS system, IIABC components and
putative dextran glucosidase in polyamines synthesis deficient pneumococci (Table 3.3) which
could negatively impact oxidative stress responses and the availability of glucose. Trehalose is a
disaccharide containing two molecules of glucose. It is known to act as a free radical scavenger
and protect yeast against oxidative stress generated by H2O2 and iron (Benaroudj, Lee, &
Goldberg, 2001; Jiang, Liu, Chi, Hu, & Chi, 2018). We also observed increase in the expression
of manganese ABC transporter operon (psaBCA), a pneumococcal virulence factor. Evidence of
role of manganese in complex with antioxidant and other biomolecules in the detoxification of
reactive oxygen species has been well documented (Culotta & Daly, 2013). Increased expression
of the manganese transporter could constitute changes in oxidative stress response in ΔcadA.
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Table 3.3
Gene

Differentially expressed genes of known virulence factors, stress response and
polyamine biosynthesis in ΔcadA.
Locus Tag

Description

Fold Change

Virulence
livH

SP_0750

Branched-chain amino acid ABC transporter, permease protein

-1.5

livM

SP_0751

Branched-chain amino acid ABC transporter, permease protein

-1.6

livG

SP_0752

Branched-chain amino acid ABC transporter, ATP-binding protein

-1.7

livF

SP_0753

Branched-chain amino acid ABC transporter, ATP-binding protein

-1.6

metQ

SP_0149

Lipoprotein

-1.7

SP_1883 SP_1883

Putative dextran glucosidase

-28.1

SP_1884 SP_1884

Trehalose PTS system, IIABC components

-26.2

Stress Response

psaB

SP_1648

Manganese ABC transporter, ATP-binding protein

2.7

psaC

SP_1649

Putative manganese ABC transporter, permease protein

2.7

psaA

SP_1650

Manganese ABC transporter substrate-binding lipoprotein

2.7
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Table 3.3

Differentially expressed genes of known virulence factors, stress response and
polyamine biosynthesis in ΔcadA (continued).

Polyamine Biosynthesis
aguA

SP_0921

Putative agmatine deiminase

-25.7

aguB

SP_0922

Carbon-nitrogen hydrolase family protein

-19.7

nspC

SP_0920

Carboxynorspermidine decarboxylase

-27.5

speE

SP_0918

Polyamine aminopropyltransferase

-41.5

3.4.1.5

Impact of impaired polyamine synthesis on the expression of two component
regulatory systems (TCSs)
Two component regulatory systems (TCSs) are composed of a histidine kinase sensor

protein and a regulatory response protein that are involved in signal transduction and adaptation
of living organisms to changing environment. A total of 13 TCSs, commonly denoted as TCS0113, and 1 orphan regulator not coupled to a histidine kinase have been identified in pneumococcal
genomes (Lange et al., 1999; Throup et al., 2000). Pneumococcal TCSs are implicated in adaptive
responses to the changes in host environment ranging from different anatomical sites, competency,
environmental stress, antimicrobials and nutrition availability that ultimately regulate
pneumococcal pathogenesis (Gomez-Mejia, Gamez, & Hammerschmidt, 2018). Expression of
TCS01, TCS05, TCS06, TCS09, TCS11 and TCS12 is significantly altered in ΔcadA with respect
to TIGR4 suggesting a possible role for polyamines whether upstream or downstream of TCSs
(Table 3.4).
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Differentially expressed two component system genes in ΔcadA.

Table 3.4
Gene

Locus

Fold Change

TCS

Role

comDE

SP_2235/6

-1.7/-2.0

TCS12

Competence and virulence

ciaRH

SP_0798/9

-1.7/-1.8

TCS05

Competence, virulence and antibiotics

SP_2000/1

SP_2000/1

-1.5/-1.7

TCS11

No known impact on virulence

SP_0661

SP_0661

1.3

TCS09

Transition from lung to blood

SP_2193

SP_2193

1.4

TCS06

Transcriptional regulator of CbpA

SP_1632/3

SP_1632/3

1.6/1.4

TCS01

No known impact on virulence

3.4.2
3.4.2.1

Metabolic profile of putative lysine decarboxylase deficient S. pneumoniae
Impact of cadA deletion on metabolites in glycolysis and capsule biosynthesis
pathways
Untargeted metabolomics of TIGR4 and ΔcadA strains identified significant differences

in the concentration of 10 metabolites (Table 3.5, Figure 3.4). We observed accumulation of
glucose 6-phosphate, an intermediate of glycolysis, indicating that flux through glycolysis is
interrupted in ΔcadA. Accumulation of glucose 6-phosphate reduces the available fructose 6phosphate that can be converted to UDP-GlcNAc, which is a precursor of repeat units in type 4
CPS. The levels of NAD+ are higher in ΔcadA suggesting that glucose in multi-step reactions
through G3P is not being converted to pyruvate. NAD+ is required for the interconversion of G3P
and 1,3-bisphosphoglycerate in the glycolytic pathway for generating pyruvate. Inhibition of
glycolysis, a pathway that provides precursor for the biosynthesis of three out of four saccharides
of the capsule repeat unit in ΔcadA could explain reduced CPS in this strain.
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Significant fold changes in the intracellular levels of metabolites of ΔcadA.

Table 3.5

Metabolites

Fold Change

Xanthosine

4.2

Trehalose 6-phosphate

-2.5

IMP

2.5

Glucose 6-phosphate

2.2

Orotate

2.1

L-Argininosuccinate

2.0

Ophthalmate

1.8

N-Acetylglutamine

1.5

Salicylate

1.5

NAD

Figure 3.4

+

2.0

Comparison of the metabolite profiles of S. pneumoniae TIGR4 and ΔcadA.

Mass spectrometry based untargeted metabolomics analysis (n=5) was performed with the wild
type and polyamine synthesis deficient strain ΔcadA. Peak intensity values of identified
metabolites were analyzed by Metaboanalyst 4.0 to identify significant changes in expression.
(A) Clustering of samples within the sPLS-DA principal component of the wild type strain
TIGR4 (green) and deletion mutant strain ΔcadA (pink) indicate significant metabolic
differences between the two strains. (B) sPLS-DA loading plot of TIGR4 and ΔcadA with top
ranked metabolites with significant differences in intracellular concentrations between the strains
is shown.
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Pyruvate is the terminal product of glycolysis and comparison of secreted pyruvate
(Figure 3.5) showed that its concentration is significantly low in ΔcadA (4.66 ± 1.91 ng
pyruvate/µg protein) compared to TIGR4 (10.71 ± 2.68 ng pyruvate/µg protein). Reduced levels
of pyruvate in ΔcadA confirm reduced glycolytic activity in polyamine synthesis impaired
pneumococci and support transcriptome analysis that indicates reduced availability of precursors
for CPS synthesis. An addition mechanism that also has implications for CPS synthesis is the
accumulation of orotate in ΔcadA, which suggests negative regulation of UTP synthesis. Orotate
is an intermediate in the de novo biosynthesis of uracil, and uracil can yield UTP in a series of
reversible reactions via the salvage pathway. UTP is essential to produce UDP-sugars which are
substrates for the enzymes of CPS synthesis. Uracil is proposed to be a signaling molecule for
CPS biosynthesis (Carvalho et al., 2018). Changes in the intracellular metabolite concentrations
support the role of polyamine synthesis in modulating capsule biosynthesis.
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Figure 3.5

Measurement of secreted pyruvic acid from Streptococcus pneumoniae TIGR4 and
ΔcadA.

Secreted pyruvate in a putative lysine decarboxylase deficient ΔcadA strain and Spn TIGR4 was
measured using Pyruvic Acid Assay Kit (Megazyme, Ireland) according to the manufacturer’s
protocols. Results show that secreted pyruvate levels in ΔcadA were ~60 % lower compared to
the wild type strain. This data suggests that the glycolytic pathway is impaired in the polyamine
synthesis deficient pneumococci.
3.4.2.2

Impact of cadA on metabolites involved in stress response and polyamine
biosynthesis
Metabolomics analysis also showed that the concentration of trehalose 6-phosphate (T6P)

is reduced in ΔcadA (Table 3.4). Trehalose has been shown to protect enzymes against the
damaging effect of H2O2 and heat (Asad, Torabi, Fathi-Roudsari, Ghaemi, & Khajeh, 2011). It
has also been reported to have a protective role against oxidative stress in pathogenic
mycobacteria (Kalscheuer & Koliwer-Brandl, 2014). Consequently, putative lysine
decarboxylase gene cadA could be crucial for pneumococcal stress responses indirectly through
the regulation of trehalose metabolism. The level of L-arginosuccinate, an intermediate of
synthesis of arginine, a precursor for the biosynthesis of putrescine and spermidine, was higher
in the mutant strain. This observation supports the predicted reduced synthesis of putrescine and
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spermidine in ΔcadA by reduced expression of polyamine biosynthesis genes such as aguA,
aguB, speE and nspC identified by RNA-Seq (Table 3.3 and Figure 3.6). According to the
database of prokaryotes operons (DOOR) (X. Mao et al., 2014), aguA, aguB, speE and nspC
constitute a single operon and could be under the regulation of cadA that is immediately
upstream of this operon in the same direction of transcription.
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Figure 3.6

Intersection between polyamine biosynthesis, carbohydrate metabolism and
capsule in pneumococci

Interconnected metabolic pathways in a putative lysine decarboxylase synthesis deficient strain
of S. pneumoniae TIGR4 (ΔcadA) analyzed by RNA-Seq and metabolomics identified specific
molecular mechanisms that could result in reduced intracellular levels of the constituents of
serotype four capsule and peptidoglycan (PG) repeat structures. Enzymatic reactions are shown
as black arrows and multi-step reactions are represented by a broken arrow. Changes in gene
(italicized) and metabolite levels in ΔcadA relative to wild type strain are shown (red represents
decrease and blue represents increase). Deletion of cadA results in reduced expression of genes
encoding biosynthesis pathways of polyamines such as putrescine, spermidine and spermine and
precursor amino acid lysine. Accumulation of arginosuccinate, an intermediate for the
biosynthesis of arginine supports the notion of overall reduction in polyamine synthesis in
ΔcadA. Impaired polyamine synthesis renders pneumococci incapable of UDP-Glucose to UDPGalactose interconversion i.e., Leloir pathway (grey square), that could reduce the carbon flux
through glycolysis (yellow rectangle). Despite increased carbon flux towards glyceraldehyde 3phosphate (G3P), a glycolytic intermediate, through tagatose metabolism, changes in the levels
of metabolites of glycolysis indicate reduced carbon flux. RNA-Seq data indicated that G3P is
routed through the pentose phosphate pathway (green square), and enhanced PPP activity will
result in increased nucleotide synthesis. Changes in amino and nucleotide sugar metabolism
(blue square) will result in reduced intracellular levels of UDP-GlcNAc, a precursor for three Nacetylated nucleotide sugars in serotype 4 capsule repeat unit (open oval). Impaired Leloir
pathway and UDP-GlcNAc synthesis will limit the availability of CPS precursors. Changes in
metabolism in ΔcadA, such as reduced glycolytic activity, altered UDP-GlcNAc metabolism and
lysine synthesis impact the assembly of PG repeat unit (open rectangle) disaccharide and
pentapeptide (light green rectangle). Polymerization of PG repeat units generates cell wall which
provides attachment for the capsule.
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3.5

Discussion
Polyamines are ubiquitous polycationic molecules found in all three domains of life

(Michael, 2016b). They are involved in diverse biological processes ranging from protein
synthesis, nucleic acid stability, cellular growth, stress responses, and pathogenicity (Gevrekci,
2017). The polyamine intracellular concentration is tightly regulated by 3 distinct mechanisms:
biosynthesis, majorly by the activities of ornithine decarboxylase and putative lysine
decarboxylase, then transport, by ATP binding cassette proteins or antiport system, and
degradation by polyamine oxidases (Miller-Fleming et al., 2015). Polyamine modulation of hostpathogen interactions has been leveraged and successfully targeted in the design of therapeutics,
primarily against protozoan pathogens (Phillips, 2018). 2-(difluoromethyl)-DL-ornithine
(DFMO), an analog of ornithine and inhibitor of polyamine biosynthesis that interacts
irreversibly with ornithine decarboxylase (ODC) has been approved for the treatment of human
African trypanosomiasis (Yun, Priotto, Tong, Flevaud, & Chappuis, 2010). Recent advances in
cancer research has implicated modulation of polyamine metabolism in chemotherapy/prevention due to the requirement of polyamines in cell proliferation (Flynn & Hogarty,
2018).
Limited serotype coverage of the existing pneumococcal vaccines coupled with genomic
plasticity and enhanced antimicrobial resistance mandate the development of novel treatment and
prevention strategies (Balsells, Guillot, Nair, & Kyaw, 2017; Berical, Harris, Dela Cruz, &
Possick, 2016; Cherazard et al., 2017). The current conjugate polysaccharide vaccine efficacy
against pneumococcal meningitis and otitis media is limited. Therefore, highly immunogenic
protein antigens common to all serotypes that could elicit immunological memory in infants are
attractive vaccine targets, and a large number of potential protein vaccine candidates highly
conserved in most pneumococcal serotypes such as PspA, PsaA, PhpA PhtB PcsB and StkP are
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reported in the scientific literature (Pichichero, Khan, & Xu, 2016). Regulation of polyamine
transport and synthesis has enormous potential for the discovery of novel interventions for
pneumococcal colonization, and invasive diseases. We reported that polyamine transport protein,
PotD, is a potential vaccine candidate as immunization with this protein provides protection
against systemic pneumococcal infection (Shah & Swiatlo, 2006) and colonization (Shah et al.,
2009) in mice. Immunization with recombinant PotD is reported to reduce pneumococcal
nasopharyngeal colonization in a mouse model (Converso, Goulart, Rodriguez, Darrieux, &
Leite, 2017). Our studies showed that impaired polyamine transport (ΔpotABCD) and synthesis
(ΔspeE, ΔcadA) results in attenuation of virulence of S. pneumoniae in murine models of
colonization, pneumonia and sepsis (Shah et al., 2011). We showed that S. pneumoniae TIGR4
ΔpotABCD is more susceptible to neutrophil killing, possibly due to the loss of neutrophil
inhibitor serpinA1, or an increase in reactive oxygen species in host cells (Rai et al., 2016b).
Studies have shown that impaired spermidine synthesis results in the delay of onset of autolysis
(Potter & Paton, 2014), and deletion of arginine transporter arcD of the arginine deiminase
system results in loss of CPS (Gupta et al., 2013), and reduced virulence (Schulz et al., 2014).
Delving further into role of polyamine biosynthesis in pneumococcal pathogenesis, for the first
time, we demonstrated that impaired polyamine synthesis results in reduced capsule in S.
pneumoniae and likely explains the observed attenuation in vivo (Nakamya et al., 2018).
In this study, integrating the transcriptomics and metabolomics approaches, we identify
specific mechanisms which polyamine could employ, individually or collectively, in regulating
capsule biosynthesis and virulence in pneumococcal serotype 4 impaired in polyamine synthesis,
due to an isogenic deletion of a putative lysine decarboxylase (ΔcadA) for cadaverine synthesis.
Our results identified the Leloir pathway of galactose catabolism, as a crucial mechanism
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impaired in ΔcadA (Table 3.1, Figure 3.1). Leloir pathway is the only pathway for the
interconversion of galactose and glucose (Frey, 1996). Impairment of Leloir pathway limits the
availability of the UDP-Galactose, one of the 4 sugars that constitute serotype 4 capsule repeat
unit structure. Furthermore, galactose is reported to be the most abundant sugar in the host
nasopharynx (Blanchette et al., 2016), and the ability to metabolize this important
monosaccharide has been directly correlated to pneumococcal colonization and virulence (Paixao
et al., 2015). Therefore, this study indicates that galactose catabolism in pneumococci is
regulated in a polyamine-dependent manner and impacts virulence. Deletion of catabolite control
protein A (ΔccpA) in serotype 2 background has been reported to alter carbon utilization
pathways and capsule attachment to the cell wall (S. M. Carvalho, T. G. Kloosterman, O. P.
Kuipers, & A. R. Neves, 2011). Although growth and amount of capsule of ΔccpA was
comparable to that of wild type D39, majority of the capsule (~94%) in ΔccpA was found in a
loose form when cultured in a chemically defined medium with galactose as a carbon source.
Therefore, CCPA regulated galactose metabolism is important for the attachment of
pneumococcal CPS to cell wall. In THY growth medium that provides diverse carbon source,
although RNA-Seq did not identify significant changes in the expression of ccpA, our earlier
report identified a significant downregulation of CcpA at the protein level in ΔcadA (Nakamya et
al., 2018), indicating that CcpA is part of polyamine gene regulatory network.
Additional mechanisms identified in this study that could abrogate CPS biosynthesis
include impaired glycolysis, altered amino sugar biosynthesis and upregulation of pentose
phosphate pathway that could collectively affect the levels of UDP-GlcNAc and ultimately the
UDP-charged sugars required for CPS synthesis. The terminal product of glycolysis, pyruvate,
and pyruvate dehydrogenase complex (SP_1163 and SP_1164) genes encoding enzymes of one
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of the pathways for the conversion of pyruvate to acetyl-CoA are downregulated in ΔcadA
compared to TIGR4 (Table 3.1, Figure 3.6). Reduced pyruvate will affect CPS production since
pyruvate itself is a component of serotype 4 capsule structure (Emily J. Kay, 2016) and its
conversion to acetyl-CoA is essential for the acetylation of monosaccharides in capsule repeat
unit structure. Deletion of pyruvate oxidase (spxB) and pyruvate dehydrogenase complex
resulted in reduced levels of acetyl-CoA and CPS in serotype 4 pneumococci (Echlin et al.,
2016). Reduced levels of pyruvate in ΔcadA reported in this study cannot be attributed to
transcriptional downregulation of pyruvate oxidase, as we did not identify any significant
changes in the expression of spxB by qRT-PCR.
Gene expression changes in ΔcadA in this study indicate that polyamines can negatively
regulate peptidoglycan synthesis in pneumococci (Table 3.2, Figure 3.2). Since capsule is
tethered to the cell wall structure of pneumococcus via direct glycosidic linkage between glucose
end and UDP-GlcNAc in PG (Thomas R. Larson & Janet Yother, 2017), changes in PG could
result in the reported loss of capsule in ΔcadA. Changes in PG has implications for the
susceptibility of pneumococcus to antibiotics such penicillin that target cell wall synthesis.
Expression of two component system TCS05 (ciaR) that controls and enhances pneumococcal
resistance to cell wall targeting antibiotics such as β-lactams (Guenzi, Gasc, Sicard, &
Hakenbeck, 1994) and its sensor ciaH was downregulated in ΔcadA. Recent reports show that
CiaRH interacts with PBP2x to confer penicillin resistance in serotype 19A (Inga Schweizer et
al., 2017). Reduced expression of ciaRH in this study, combined with the downregulation of
PBP2x protein reported earlier (Nakamya et al., 2018), indicates that polyamines could be
modulating susceptibility to antibiotics in pneumococcus. Significant decrease in the expression
of TCS12 (comDE) (Table 3.4) that controls pneumococcal competence and virulence, and
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increased expression of TCS06, a transcriptional regulator of CbpA (Ma & Zhang, 2007), could
contribute to the loss of in vivo fitness (Shah et al., 2011) and upregulation of choline binding
protein expression at RNA (Table 3.2) and protein levels (Nakamya et al., 2018). Impaired
polyamine synthesis affected expression of three additional TCSs in ΔcadA. There was an
increase in the expression of TCS01, while TCS11 was downregulated. TCS01 and TCS11 are
predicted to be involved in resistance to antibiotics (Gomez-Mejia et al., 2018). There was a
marginal increase in the expression of TCS09, that is required for the transition of pneumococcus
from lung to blood, in a serotype dependent manner (Blue & Mitchell, 2003). The six TCSs
identified in this study (Table 3.4) as differentially expressed in ΔcadA represent ~46% of the 13
TCSs in pneumococcal genomes. Therefore, polyamines could be master regulators in
pneumococci via their interaction with TCSs and can impact virulence. Alternatively,
polyamines could be part of the downstream regulatory network of the TCSs. Deciphering this
complex polyamine/TCS regulatory network is necessary for rational vaccine/small molecule
intervention strategies that target polyamine metabolism.
E. coli polyamine modulon, that constitutes genes whose expression is upregulated by
polyamines at the level of translation is well characterized (Igarashi & Kashiwagi, 2015).
Specific mechanisms of translational control by polyamines include proper positioning of the
Shine-Dalgarno sequence relative to the start codon, initiation on inefficient initiation codons,
and suppression of stop codons, due to their interactions with mRNA. A total of 20 genes
identifies as part of polyamine modulon in E. coli are reported to enhance cell proliferation and
viability, biofilm formation and ability to detoxify reactive oxygen species (Igarashi &
Kashiwagi, 2018). However, altered polyamine metabolism mediated regulation of gene
expression is a recently identified area of pneumococcal physiology, with implications for
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pneumococcal pathogenesis. Therefore, polyamine metabolism is an attractive avenue for the
discovery of novel therapeutics, analogous to the recent findings on modulation of polyamine
synthesis and transport pathways for cancer therapy (Damiani & Wallace, 2018). With the
reported link of CcpA to regulation of TCS07 and TCS12 (Sandra M. Carvalho, Tomas G.
Kloosterman, Oscar P. Kuipers, & Ana Rute Neves, 2011), establishment of CcpA as
pneumococcal global regulator of carbohydrate metabolism (Iyer et al., 2005), polyaminemediated changes in expression of CcpA, (Nakamya et al., 2018) and altered galactose
metabolism reported in this study, ccpA could constitute a polyamine modulon in pneumococcus
that warrants future research and validation. Further analysis of the detailed molecular
mechanisms of individual polyamines and their impact on specific pneumococcal genes is
required to build the knowledge base pertaining to ‘function due to interactions with targeted
molecules’, analogous to studies on polyamine metabolism in E. coli (Igarashi & Kashiwagi, 2015).
This present study focuses on intersection of polyamine synthesis, pneumococcal
metabolic pathways and capsule biosynthesis. It clearly establishes that polyamine synthesis is
required for CPS synthesis in pneumococci. Since polyamine synthesis genes are well conserved
in all pneumococcal genomes (Shah et al., 2011), this pathway is an attractive avenue for
discovering novel preventive or therapeutic strategies. Specific mechanisms such as impaired
galactose utilization, reduced glycolysis, and altered UDP-N-acetylglucosamine synthesis, in
polyamine synthesis deficient pneumococci, limit the availability of precursors for the CPS and
cell wall peptidoglycan repeat unit synthesis (Figure 3.6), and contribute to reduced virulence.
Future studies focusing on uncovering the regulatory network of pneumococcal polyamine
homeostasis are warranted for leveraging the therapeutic potential of this important metabolic
pathway for limiting the spread of this versatile human pathogen.
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CHAPTER IV
SP_0916 IS AN ARGININE DECARBOXYLASE THAT CATALYZES THE SYNTHESIS OF
AGMATINE, WHICH IS CRITICAL FOR CAPSULE BIOSYNTHESIS IN
STREPTOCOCCUS PNEUMONIAE.
Moses B. Ayoola, Mary F. Nakamya, Leslie A. Shack, Seongbin Park, Juhyeon Lim, Jung Hwa
Lee, Matthew K. Ross, Hyungjin Eoh and Bindu Nanduri
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4.1

Abstract
The global burden of invasive pneumococcal diseases, including pneumonia and sepsis,

caused by Streptococcus pneumoniae, a Gram-positive bacterial pathogen, remains a major
global health risk. The success of pneumococcus as a pathogen can be attributed to its ability to
regulate the synthesis of capsular polysaccharide (CPS) during invasive disease. We previously
reported that deletion of a putative lysine decarboxylase (ΔSP_0916) in pneumococcal serotype
4 (TIGR4) results in reduced CPS. SP_0916 locus is annotated as either an arginine or a lysine
decarboxylase in pneumococcal genomes. In this study, by biochemical characterization of the
recombinant SP_0916, we determined the substrate specificity of SP_0916 and show that it is an
arginine decarboxylase (SpeA). We also show that deletion of the polyamine transporter
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(potABCD) predicted to import putrescine and spermidine results in reduced CPS, while deletion
of spermidine synthase (ΔspeE) for the conversion of putrescine to spermidine had no impact on
the capsule. Targeted metabolomics identified a correlation between reduced levels of agmatine
and loss of capsule in ΔspeA and ΔpotABCD, while agmatine levels were comparable between
the encapsulated TIGR4 and ΔspeE. Exogenous supplementation of agmatine restored CPS in
both ΔpotABCD and ΔspeA. These results demonstrate that agmatine is critical for regulating the
CPS, a predominant virulence factor in pneumococci.

4.2

Introduction
Streptococcus pneumoniae (pneumococcus, Spn) is a Gram-positive bacterium that

causes invasive diseases such as pneumonia, meningitis, and sepsis (Schuchat et al., 2001).
Pneumococci as pathobionts express virulence factors including lipoproteins, choline-binding
proteins, histidine kinases, and most importantly, capsular polysaccharide (CPS). CPS is a key
virulence factor that is the basis for the description of more than 97 serotypes and the target of
current vaccines (Gamez et al., 2018). The ability to regulate CPS synthesis is critical for
pneumococcal adaptation to different host niches and its success as a commensal and pathogen.
Pneumococci can modulate their CPS by a complex phenomenon known as phase variation as
well as other independent mechanisms (J. Li & Zhang, 2019; Manso et al., 2014). Despite
decades of research, a comprehensive understanding of CPS regulation in Spn remains elusive.
A single CPS biosynthesis gene cluster is located between the dexB and aliA genes in the
genome of the majority of pneumococcal serotypes (Llull, Munoz, et al., 1999). The first four
genes of the CPS operon, cpsABCD, are reported to be essential for capsule production (Bender,
Cartee, & Yother, 2003; Morona et al., 2004). However, expression of cpsA as a surrogate for the
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CPS operon is independent of capsule phenotypic change during phase variation (LeMessurier,
Ogunniyi, & Paton, 2006). The role of tyrosine phosphorylation remains contradictory as it has
been shown to both enhance and inhibit capsule biosynthesis (Bender et al., 2003; Morona et al.,
2004). Competence protein ComE has been reported to be a negative transcriptional regulator of
CPS (Zheng et al., 2017). In recent years, the intersection between bacterial physiology and
pathogenesis has garnered a lot of attention. For example, expression of pyruvate oxidase (spxB)
results in reduced CPS during colonization (Overweg et al., 2000), while mutations in spxB
increase CPS and transcription of cpsA (Carvalho, Farshchi Andisi, et al., 2013). Deletion of
arginine transport in pneumococcal serotype 2 results in a reduced capsule and reduced virulence
in an otitis media model of infection (Gupta et al., 2013). On the other hand, impaired arginine
transport had no impact on CPS in serotype 4, indicating that these effects could be serotype
dependent (Schulz et al., 2014). The precise relationship between arginine metabolism and CPS
remains to be established. Uracil, a precursor for pyrimidine biosynthesis, has also been
proposed as a regulator of capsule biosynthesis (Carvalho et al., 2018; Carvalho, Kuipers, &
Neves, 2013). A recent report indicates that different carbon sources in the growth medium
impact capsule thickness in pneumococci (Troxler et al., 2019), however no single metabolite is
conclusively linked to the regulation of CPS in pneumococci. We previously reported that altered
polyamine metabolism impacts CPS in pneumococci (Ayoola et al., 2019; Nakamya et al., 2018).
Polyamines, such as putrescine, spermidine, cadaverine, and spermine, are ubiquitous,
polycationic, aliphatic hydrocarbons that regulate a number of cellular processes (Gevrekci,
2017), and their intracellular concentrations are tightly regulated by transport, biosynthesis and
catabolism (Miller-Fleming et al., 2015). In eukaryotic systems, polyamines are critical for cell
proliferation and are being targeted for treatment in certain types of cancers (R. A. Casero, Jr.,
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Murray Stewart, & Pegg, 2018a). While polyamines are reported to be dispensable for growth in
some bacteria (Chattopadhyay, Tabor, & Tabor, 2009), they are implicated in pathogenesis. For
example, cadaverine reduces the enterotoxin activity of Shigella flexneri (Maurelli et al., 1998)
and inhibits its phagolytic activity, thereby preventing the spread of this pathogen (Fernandez et
al., 2001). Polyamines have also been shown to be essential for biofilm formation, a critical step
in the pathogenesis of Yersinia pestis (Patel et al., 2006).
Polyamine biosynthesis and transport genes are well conserved in most prokaryotes
including multiple pneumococcal serotypes (Shah et al., 2011). Our previous work indicates that
impaired polyamine biosynthesis by the deletion of a putative lysine decarboxylase (ΔSP_0916),
spermidine synthase (∆speE), and the polyamine transporter (∆potABCD) in pneumococci did
not affect in vitro growth but resulted in an attenuated phenotype in vivo (Nakamya et al., 2018;
Shah et al., 2011). We recently demonstrated that deletion of SP_0916 results in reduced capsule
and metabolic reprogramming that alters the carbon flux and could limit the availability of
precursors for CPS synthesis (Ayoola et al., 2019; Nakamya et al., 2018). Despite its relevance to
pneumococcal virulence, predicted function of the enzyme encoded by SP_0916 is inconsistent.
SP_0916 is predicted to encode an arginine or a lysine decarboxylase. The current annotation in
TIGR4 is that of a lysine decarboxylase. The locus corresponding to SP_0916 in D39 is
annotated to be an arginine decarboxylase, involved in spermidine synthesis (through indirect
evidence), and is essential for the onset of autolysis (Potter & Paton, 2014). Pyridoxal-dependent
decarboxylases in the polyamine biosynthesis pathways, such as SP_0916, belong to a family of
enzymes with broad substrate specificity that can utilize arginine/lysine/ornithine. Therefore,
definitive biochemical data is needed to determine the substrate specificity of SP_0916.
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In this study, we determined the substrate specificity of SP_0916 for definitive annotation
of this gene. We also evaluated the impact of the deletion of polyamine transporter (∆potABCD)
and spermidine synthase (∆speE) on CPS, which are also reported to be attenuated in vivo. We
measured intracellular concentrations of polyamines and precursors of polyamine synthesis in
∆SP_0916, ∆potABCD, and ∆speE, and correlated these with the capsular phenotype. Our results
show that SP_0916 is an arginine decarboxylase (SpeA). Impaired polyamine transport in S.
pneumoniae TIGR4 results in reduced CPS, while deletion of spermidine synthase had no
impact. Reduced intracellular concentration of agmatine, an intermediate in the
putrescine/spermidine synthesis pathway, correlates with reduced CPS expression in ∆speA and
∆potABCD. Exogenous supplementation of agmatine restores capsule in ΔspeA and ΔpotABCD.
In summary, we demonstrate that SP_0916, an important virulence gene from polyamine
biosynthesis pathway, is an arginine decarboxylase, and that the reaction product agmatine is
critical for capsule biosynthesis in pneumococci. Future studies focused on the identification of
specific mechanisms by which agmatine regulates CPS are warranted to decipher the polyamineCPS regulatory network in bacteria.
4.3
4.3.1

Materials and methods
Bacterial Strains and Growth Conditions
Streptococcus pneumoniae serotype 4 strain (TIGR4) (Tettelin et al., 2001) and

polyamine synthesis- (ΔSP_0916 and ΔspeE) and transport- (ΔpotABCD) deficient strains
(Nakamya et al., 2018; Rai et al., 2016b; Shah et al., 2011) were used in this study. Bacteria were
grown in Todd-Hewitt broth supplemented with 0.5% yeast extract (THY), a rich medium with
polyamines to mimic growth in vivo or on 5% sheep blood agar plates (BAP) in 5% CO2. An
isogenic deletion strain of TIGR4 deficient in speE was generated by polymerase chain reaction
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(PCR)-ligation mutagenesis as described previously. Primers were designed (Table 4.1) to
amplify genomic segments upstream and downstream of speE from TIGR4 chromosomal DNA
which were joined by gene splicing, and insertion of the chloramphenicol resistance gene (cat)
amplified from pIMAY (Monk, Shah, Xu, Tan, & Foster, 2012) by overlap extension (SOEing)
PCR (Nakamya et al., 2018; Rai et al., 2016b; Thornton, 2016). The recombinant product was
transformed into TIGR4 as described previously (Bricker & Camilli, 1999). Transformants were
selected on BAP with chloramphenicol (10 μg/mL) and speE gene deletion was confirmed by
sequencing. Complement strains of ΔpotABCD and ΔspeE were generated by cloning potABCD
and speE genes amplified from the TIGR4 genome into the pABG5 vector and transformation of
appropriate deletion strains. Transformants were selected on BAP with kanamycin (50 μg/mL)
and confirmed by PCR.
Table 4.1

List of Primers used in this study.

Primer

Sequence *(5'→3')

Experiment

speE Upstream FP

GAGCACGGCAAAAAGCCC

Mutagenesis

speE upstream RP

CTGCCAAAGCATAATGGGATCCTCCAATCGCTTGACGATTTCCG

Mutagenesis

cat FP

ATCCCATTATGCTTTGGCAG

Mutagenesis

cat RP

TTATAAAAGCCAGTCATTAGGCC

Mutagenesis

speE Downstream FP

GGCCTAATGACTGGCTTTTATAAATGTTGCCCAAGTATGTTGAGG

Mutagenesis

AC
speE Downstream RP

TTAGTCCACCATTTGTGGATTTTCA

Mutagenesis

SP_0916-F BamHI

AATTGGATCCAAAGAGTTAGATCAAAACCAAGCCCCAATTTATG

Expression

SP_0916-R XhoI

AATTCTCGAGTTGACTTTTCTTATAGTTTGTCTTTCTCTTAATAAC

Expression

GTTG

*underlined sequence complementary to Streptococcus pneumoniae TIGR4 chromosomal DNA
4.3.2
4.3.2.1

Enzyme assay
Cloning, expression, and purification of SP_0916
The SP_0916 locus encodes a protein of 491 amino acids with a predicted molecular

weight of ~54kDa. This gene (SP_0916) was amplified from chromosomal DNA of S.
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pneumoniae TIGR4 by PCR using primers with BamHI and XhoI (Table 4.1) restriction sites.
The PCR product was restriction digested and cloned into the pET-28a (+) vector
(MilliporeSigma, Burlington, MA) with 6 x -His tag at the C-terminus. The resulting
recombinant expression vector pET-28a (+):SP_0916 was transformed into the E. coli strain
BL21(DE3), which was grown in 100 mL of Luria Bertani medium containing 30 µg/mL
kanamycin and 3% ethanol at 37°C to an OD600nm of 0.6 and induced with 1.0 mM 1-thio-β-Dgalactopyranoside (IPTG). Five hours post induction, cells were harvested by centrifugation at
3,000 × g for 20 min at 4°C, and the cell pellet was stored at -20°C until further use. The frozen
pellet was thawed on ice and resuspended in B-PER reagent buffer (Thermo Fisher Scientific,
Waltham, MA, USA) at 4 mL/g of pellet, with 2 µL of benzonase nuclease (Sigma-Aldrich, St.
Louis, MO), and 10 µL protease inhibitor/mL (Thermo Fisher Scientific, Waltham, MA, USA),
and incubated for 15 min at room temperature.
The cell debris was removed by centrifugation at 15,000 × g for 5 min and the lysate was
loaded onto a HisPur Cobalt Spin Column (Thermo Fisher Scientific, Waltham, MA, USA).
After washing with equilibration/wash buffer containing 100 mM imidazole, the bound proteins
were eluted with 500 mM imidazole in elution buffer. The purified protein was desalted using
Sephadex G-25 PD-10 column (GE Healthcare, Chicago, IL, USA) equilibrated with PBS. All
purification steps were performed at 25°C. The quality of purification was evaluated by
visualizing the protein by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDSPAGE) and staining with Coomassie brilliant blue R-250 (Bio-Rad, Hercules, CA, USA). Protein
estimation was done according to the BCA method using the Pierce BCA Protein Assay kit and
following manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA, USA).
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4.3.2.2

Enzyme kinetics assay
To evaluate the decarboxylase activity of recombinant SP_0916, the rates of

substrate/product conversions of arginine/agmatine, lysine/cadaverine, and ornithine/putrescine
were assessed by a liquid chromatography-mass spectrometry (LC-MS) method. The enzyme
(final concentration of protein 50 µg/mL) was mixed with increasing concentration of substrate
(0.01-10 mM) in 50 mM Tris-HCl buffer (pH 8.0) containing 2.5 mM MgSO4 and 0.6 mM
pyridoxal 5'-phosphate (PLP). The reactions were incubated for 15 min at 37°C in dark and
terminated with 12.5 µL of 70% (w/v) perchloric acid. After sitting on ice for at least 10 min, the
samples were neutralized with 25 µL of 10 N KOH and extracted twice with 1 mL of 1-butanol.
The pooled organic layer was dried under nitrogen gas and reconstituted with 100 µL of aqueous
10 mM ammonium acetate containing n-heptylamine as an internal standard.
Analysis of the extracts was performed on a Surveyor LC-MS system (MSQ, Thermo
Fisher Scientific, San Jose, CA, USA). The analytical column used was a Phenomenex Synergi
Fusion-RP (150 × 3 mm, 4 µm, 80 Å) set at a column temperature of 30°C. The mobile phases
consisted of (A) aqueous 10 mM ammonium acetate, (B) acetonitrile containing with 0.1% v/v
formic acid, and (C) aqueous 10 mM ammonium acetate containing with 0.1% v/v formic acid.
The gradient program was 0 min (95% A, 5% B), 0.75 min (95% A, 5% B), 5 min (20% B, 80%
C), 9 min (20% B, 80% C), 11 min (40% B, 60% C), 15 min (95% A, 5% B) and 22 min (95%
A, 5% B). The flow rate was 0.5 mL/min and the column eluate directed into the mass
spectrometer using heated electrospray ionization in positive ion mode. Optimum cone voltage
was determined for each analyte by post-column infusion of the individual compounds into a
50% A/50% B blend of mobile phase being pumped at a flow rate 0.5 mL/min. The MSQ
conditions were set as follows: probe temperature, 400 °C; capillary voltage, 3.5 kV; nitrogen
nebulizer pressure, 80 psi. Xcalibur software was employed for data acquisition and processing.
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For quantification, calibration standards were prepared ranging from 0.01 to 10 mM. Calibration
curves were constructed for agmatine, cadaverine and ornithine. The change in velocity with
increase in substrate concentrations was fitted with Sigma Plot v. 12 to estimate the kinetic
parameters using the Michaelis–Menten equation by non-linear regression method and all
experiments were carried out with three independent replicates. The kinetic parameters turnover
number (kcat), Michaelis-Menten constant (Km) and catalytic efficiency (kcat/Km) were obtained.
4.3.3

Targeted metabolomics
We performed targeted metabolomics to measure polyamines, precursors and

intermediates of polyamine biosynthesis and degradation. Wild type (WT) TIGR4, ΔSP_0916,
ΔpotABCD and ΔspeE cells cultured in THY (mid-log phase, n=8) were washed twice in PBS to
remove possible polyamine contamination from the growth medium, and collected separately
onto a Whatman polycarbonate membrane, 0.2 µm by vacuum filtration (Thermo Scientific,
Rockford, IL). The membranes were flash-frozen in liquid nitrogen and stored at -80 °C until
further use. Polyamines and other metabolites were extracted from the cells on the membranes
with 40:40:20 (v/v/v) acetonitrile:methanol:water, and 100 mM formic acid by incubation at -20°
C for 15 min and subsequent centrifugation (16000 x g, 5 min, 4 °C). The supernatant was
filtered through a Spin-X column (16,000 x g, 10 min, 4 °C) prior to mass spectrometry.
Metabolite differentiation and detection were performed using published protocols (Eoh & Rhee,
2013; Eoh et al., 2017). Liquid chromatography-mass spectrometry–based (LC-MS)
metabolomics analysis was performed with an Agilent Accurate Mass 6230 TOF coupled with
an Agilent 1290 LC system using a Cogent Diamond Hydride Type C column. Briefly, the
mobile phase consisted of the following: solvent A (ddH2O with 0.2% formic acid) and solvent B
(acetonitrile with 0.2% formic acid). The gradient used was as follows: 0–2 min, 85% B; 3–5
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min, 80% B; 6–7 min, 75% B; 8–9 min, 70% B; 10–11.1 min, 50% B; 11.1–14 min 20% B;
14.1–24 min 5% B followed by a 10 min re-equilibration period at 85% B at a flow rate of 0.4
ml/min. Mass axis dynamics was calibrated by continuous infusion of a reference mass solution
using an isocratic pump. This configuration achieved mass errors of 5 ppm, mass resolution
ranging from 10,000 to 25,000 (over m/z 121–955 atomic mass units), and 5 x log10 dynamic
range. Metabolite identities were searched for using a mass tolerance of <0.005 Da. Metabolite
concentrations from the 8 biological replicates were normalized to biomass based on
measurement of residual peptide content in individual samples using the Pierce BCA Protein
Assay kit (Thermo Scientific, Rockford, IL). Data were analyzed using Profinder B.07.00
software (Agilent Technologies, Santa Clara, CA). Extracted molecular features detected in the
mass analyzer were identified using accurate mass values and used to generate empirical
molecular formulae using an in-house metabolite database that included known intermediates,
amino acid precursors and polyamines and their derivatives. Statistical analysis of metabolite
peak intensity data was performed using MetaboAnalyst 4.0 (Chong et al., 2018). Data were
normalized (quantile), log transformed and significant fold change between WT and deletion
strains were identified by Student’s t-test (p ≤ 0.05).
4.3.4

Immunoblot estimation of pneumococcal total capsular polysaccharide
Total capsular polysaccharide (CPS) was quantified by immunoblot assays as described

earlier (Nakamya et al., 2018). An isogenic capsular variant of TIGR4 (T4R) in which the CPS
locus is replaced with the Janus cassette resulting in an unencapsulated phenotype (Fernebro et
al., 2004) was used as a negative control. Bacteria were cultured in THY supplemented with 10%
fetal bovine serum with or without agmatine (20 mM) to an OD600nm of 0.2. An aliquot of
bacterial culture was plated on BAP for colony forming unit (CFU) enumeration and 1 mL
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bacteria was stored at 2-8 °C until further use. The CFUs for all strains were ~9.0 x 107/mL. CPS
was extracted in a lysis buffer (4% deoxycholate, 50 µg/mL DNAse I and 50 µg/mL RNAse A)
at 37 °C for 10 min and centrifuged at 18,000 x g for 10 min. Supernatant (2 µL) was spotted on
a 0.2-µm-pore-size nitrocellulose membrane (Thermo Fisher Scientific, Waltham, MA, USA)
and oven dried at 60 °C for 15 min. The membranes were blocked and incubated with either a
mouse monoclonal antibody, a gift from Moon H. Nahm (Birmingham, AL, USA), or a rabbit
anti-serotype 4 polyclonal antibody (Cedarlane, Burlington, NC, USA) at 1:1000. Secondary
antibody for the monoclonal was horseradish peroxidase (HRP)-conjugated goat anti-mouse
antibody and for the polyclonal was HRP-conjugated goat anti-rabbit antibody (Thermo Fisher
Scientific, Waltham, MA, USA) at 1:10,000. Membranes were developed with enhanced
chemiluminescence detection (Thermo Fisher Scientific, Waltham, MA, USA) and scanned
using a ChemiDoc XRS+ with Image Lab software (Bio-Rad, Hercules, CA, USA).
4.3.5

Estimation of surface exposed phosphocholine
Comparison of surface exposed phosphocholine (PC) levels between the wild type and

polyamine metabolism deletion strains was performed as described previously (Ayoola et al.,
2019). Briefly, 300 µL of mid-exponential-growth-phase bacteria were pelleted and washed in
1X phosphate-buffered saline (PBS). Pellets were resuspended in 100 µL of unconjugated IgA,
Kappa from murine myeloma anti-phosphocholine (Sigma-Aldrich, St. Louis, MO) at 1:100 in
1X PBS and incubated on ice for 30 min. The binding reaction was stopped with 500 µL of 1X
PBS and centrifuged at 4,000 x g for 5 min. Pellets were resuspended in 100 µL of phycoerythrin
(PE)-conjugated rat anti-mouse IgA secondary antibody (Thermo Fisher Scientific, Waltham,
MA) at 1:100 in 1X PBS and incubated at 4 °C, in the dark, for 30 min. Staining reactions were
stopped with 500 µL PBS, and products were pelleted and resuspended in 300 µL of 2%
85

paraformaldehyde. Samples (10,000 events) were collected, analyzed, and plotted using an
Attune Acoustic Focusing Cytometer (Life Technology, Foster City, CA).
4.4
4.4.1

Results
SP_0916 encodes an arginine decarboxylase
Current genome annotation of S. pneumoniae TIGR4 in NCBI (Coordinators, 2016),

KEGG (Kanehisa, 2019) and STRING (Szklarczyk et al., 2019) databases indicate that SP_0916
encodes a putative lysine decarboxylase that catalyzes the synthesis of cadaverine in several
organisms, including humans. However, annotation in Biocyc database (Karp et al., 2017) and
work of Potter and Paton (Potter & Paton, 2014) indicate that SP_0916 encodes an arginine
decarboxylase that catalyzes the conversion of arginine to agmatine in the putrescine/spermidine
biosynthesis pathway. We determined the substrate specificity of SP_0916. Recombinant
SP_0916 containing a C-terminus 6 × His tag was overexpressed in the E. coli. SDS-PAGE
analysis of purified SP_0916 protein indicated a 54 kDa protein (Figure 4.1A). Using LC-MS to
measure reaction end products, the kinetic parameters of recombinant SP_0916 were determined
with the substrates arginine, lysine, and ornithine (Figure 4.1B). Estimation of kinetic parameters
using Michaelis-Menten equation show that SP_0916 is an arginine decarboxylase. The
Michaelis-Menten constant (Km) of SP_0916 with the substrates is ornithine (3.55 ± 0.28 mM) >
lysine (1.61 ± 0.28 mM) > arginine (0.11 ± 0.02 mM), indicating that arginine is the preferred
substrate of this decarboxylase; goodness of fit (R2) to the Michaelis-Menten model was 0.96,
0.91, and 0.99 for arginine, lysine, and ornithine, respectively. The catalytic efficiency (kcat/Km)
of SP_0916 for the conversion of arginine to agmatine (4.0 × 105 min-1mM-1) is ~24-fold greater
than that for the conversion of lysine to cadaverine (1.7 × 104 min-1mM-1) and ~83-fold greater
than the conversion of ornithine to putrescine (4.8 × 103 min-1mM-1). These results demonstrate
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that SP_0916 is an arginine decarboxylase and it will be referred to as SpeA in the following
sections.

Figure 4.1

Gel electrophoresis and enzyme kinetics of SP_0916.

(A) Overexpressed and purified recombinant SP_0916 was resolved by SDS-PAGE and stained
with Coomassie brilliant blue R-250 for visualization of the 54 KDa protein. The ladder lane on
the left is the protein marker showing the molecular mass standards. (B) Enzyme kinetics for the
conversion of arginine to agmatine, lysine to cadaverine, and ornithine to putrescine were
performed in triplicate using LC-MS. The change in velocity with increase in substrate
concentrations was fitted with Sigma Plot v.12 to estimate the kinetic parameters using the
Michaelis–Menten equation by non-linear regression method. The Km of SP_0916 with the
substrates is ornithine (3.55 ± 0.28 mM) > lysine (1.61 ± 0.28 mM) > arginine (0.11 ± 0.02 mM),
indicating that arginine is the preferred substrate of this decarboxylase. High catalytic efficiency
(kcat/Km) for the SP_0916-catalyzed conversion of arginine to agmatine (4.0 × 105 min-1mM-1)
compared to low kcat/Km for conversion of lysine to cadaverine (1.7 × 104 min-1mM-1) and
ornithine to putrescine (4.8 × 103 min-1mM-1) show that arginine is the preferred substrate for
SP_0916. kcat/Km values are obtained using the means for each kinetic parameter.
4.4.2

Impaired polyamine transport results in reduced CPS
To determine the impact of the deletion of spermidine synthase (ΔspeE) and the

polyamine transporter (ΔpotABCD) on CPS, if any, we estimated total CPS of deletion strains
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and wild type (WT) by immunoblot assays using a monoclonal anti-serotype 4 antibody.
Deletion of polyamine transport resulted in a reduced capsule in ΔpotABCD that is comparable
to the levels in T4R, an isogenic variant of TIGR4 that is unencapsulated (Figure 4.2A), and
ΔspeA (Nakamya et al., 2018). On the other hand, total CPS from ΔspeE is comparable to that of
WT TIGR4 (Figure 4.2A). Complementation of ΔpotABCD with a pABG5-potABCD construct
(ΔpotABCD (Comp)) fully restored CPS to the levels comparable to that of WT (Figure 4.2B).
Total CPS from ΔspeE and ΔspeE complement strain (pABG5-speE) were comparable, while
culture supernatants for all bacterial strains had no detectable CPS (data not shown). These
results clearly demonstrate that deletion of the polyamine transporter operon potABCD in S.
pneumoniae results in reduced CPS.

Figure 4.2

Immunoblot analysis of total CPS in WT, polyamine synthesis/transport deletion
and complemented strains.

All strains were cultured to mid-log phase and total capsular polysaccharide (CPS) isolated from
equal number of cells for each strain. Representative immunoblots using serotype 4 specific
antibody from three independent experiments are shown. (A). CPS from unencapsulated T4R,
TIGR4, ΔspeA (Nakamya et al., 2018), polyamine transport deficient ΔpotABCD and ΔspeE. (B)
CPS from T4R, TIGR4, ΔpotABCD and ΔpotABCD Complement.
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To corroborate changes in the capsule phenotype detected by the immunoblot assay, we
measured surface exposed phosphocholine (PC) by flow cytometry. Loss of capsule is expected to
render the cell surface more permeable to PC antibody, thereby increasing the detection of PC on
the cell surface. PC was more readily accessible in ΔpotABCD compared to ΔspeE and TIGR4,
confirming reduced levels of CPS in ΔpotABCD strain (Figure 4.3).

Figure 4.3

Measurement of surface-exposed phosphocholine in TIGR4 and deletion strains.

Pneumococci were grown to exponential phase and phosphocholine (PC) was measured by flow
cytometry. PC was stained with an unconjugated Kappa murine myeloma IgA antiphosphocholine antibody, followed by detection with a phycoerythrin-conjugated rat anti-mouse
secondary antibody. Samples were fixed in 2% paraformaldehyde and histogram heights read in
blue laser 2 channel (BL2-H) on an Attune Acoustic Focusing Cytometer. The gate was set based
on a negative control that was treated with secondary antibody only. Representative histogram
overlay plots, from three independent experiments, of the fluorescence intensity of murine
myeloma IgA antibody binding to exposed phosphocholine on TIGR4 (red), ΔspeE (yellow) and
ΔpotABCD (blue) are shown.
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4.4.3

Intracellular concentrations of polyamines and precursors/intermediates of
polyamine synthesis pathways
Deletion of polyamine transport and synthesis is expected to alter intracellular

concentrations of polyamines such as putrescine and spermidine. We measured polyamines,
amino acid precursors and intermediates of polyamine metabolism (Figure 4.4) in polyamine
biosynthesis (ΔspeA and ΔspeE) and transport (ΔpotABCD) deletion strains and the WT strain
using LC-MS. In addition to arginine, lysine, and ornithine, we also measured the intermediates
agmatine, methionine, precursor for co-factor decarboxylated S-adenosylmethionine, and NAcetylspermine and N-Acetylspermidine, which are degradative products of spermine and
spermidine, respectively (Figure 4.4). Our results show that intracellular concentration of
agmatine is significantly reduced in ΔspeA and ΔpotABCD, which have reduced CPS (Table
4.2). Agmatine is the product of arginine decarboxylation catalyzed by SpeA (Figure 4.4).
PotABCD transporter is predicted to import spermidine and putrescine in pneumococci and our
results show a significant reduction of these two polyamines in ΔpotABCD (Table 4.2).
Compared to WT, only N-Acetylspermine is higher in ΔpotABCD. Although biosynthesis does
not appear to compensate for the loss of transport, intact polyamine transport in ΔspeA and
ΔspeE helps maintain spermidine and putrescine levels (Table 2). Agmatine is among the most
affected metabolites in ΔpotABCD with ~59-fold reduction in intracellular concentration (Table
4.2). Similar to total CPS being comparable between WT and ΔspeE (Figure 4.2), all measured
metabolites including agmatine, are comparable between these two strains (Table 4.2), indicating
that maintaining agmatine levels is essential for CPS synthesis in Spn.
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Figure 4.4

Polyamine transport and synthesis pathways.

Cadaverine is synthesized by decarboxylation of lysine by putative lysine decarboxylase (LDC),
while CadB serves as an antiporter for cadaverine and lysine exchange. Arginine
decarboxylation by arginine decarboxylase (SpeA) generates agmatine, a precursor for
putrescine. Enzymatic activities of agmatine deiminase (AguA) and carbon-nitrogen hydrolase
family protein (AguB) convert agmatine to putrescine in two steps or agmatine directly to
putrescine by agmatinase (SpeB). The conversion of ornithine directly to putrescine by ornithine
decarboxylase (ODC) is considered to be the main evolutionary pathway of polyamine
biosynthesis in most organisms, but this gene is not currently annotated in pneumococcal
genomes (shown in red). Ornithine/arginine antiporter (ArcD) regulates intracellular
concentrations of arginine and ornithine. Putrescine can be converted to spermidine and
spermine in sequential steps using decarboxylated S-adenosylmethionine (dcSAM, catalyzed by
adenosylmethionine decarboxylase (AdoMetDC)) from methionine as a methyl donor by the
enzymatic activity of spermidine synthase (SpeE). Alternatively, putrescine can be converted to
carboxyspermidine and spermidine by carboxyspermidine dehydrogenase (CASDH), and
carboxyspermidine decarboxylase (NspC), respectively. Pneumococcal genomes encode a single
polyamine transporter (PotABCD) that is predicted to import spermidine and putrescine.
Polyamine catabolism includes acetylation and thereby sequestration by a polyamine
acetyltransferase (AT). Polyamine oxidase (APAO) that catalyzes the reverse reactions, i.e.,
generates free polyamines from acetylated forms (and other enzymes shown in red) are not
annotated in the genome, at present.
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Table 4.2

Significant changes in the levels of metabolites from polyamine synthesis
pathways in synthesis- and transport- impaired pneumococci relative to the WT
strain.

Compounds
ΔspeA/TIGR4 ΔpotABCD/TIGR4
Agmatine
-21.1
-58.6
Arginine
n.s
-1.9
Cadaverine
n.s
n.s
Lysine
n.s
-1.9
Methionine
1.7
n.s
N-Acetylspermidine
1.5
-8.2
N-Acetylspermine
2.1
1.9
Ornithine
n.s
-1.6
Putrescine
n.s
-2.2
S-adenosylmethionine
n.s
-1.7
Spermidine
1.7
-58.7
Spermine
n.s
n.s
n.s = no significant difference at p ≤ 0.05. The magnitude of change in the ratio and the direction
of change (i.e., positive for increase and negative for decrease) are shown. None of the
metabolite concentrations in ΔspeE were found to be significantly different than those in strain
TIGR4.
4.4.4

Agmatine is critical for capsule biosynthesis
Deletion of the polyamine transporter (ΔpotABCD) and arginine decarboxylase (ΔspeA)

(Nakamya et al., 2018) results in loss of CPS, while deletion of spermidine synthase (ΔspeE) has
no impact on the capsule (Figure 4.2). Measurement of intracellular polyamines, precursors of
synthesis and intermediates suggest a correspondence between reduced intracellular agmatine
and reduced CPS. To determine whether agmatine is critical for CPS production, we conducted
agmatine supplementation assays with ΔspeA and ΔpotABCD and estimated total CPS. The
minimum inhibitory concentration (MIC) of agmatine is 80 mM (data not shown). Agmatine
supplementation vs CPS restoration by immunoblot assay dose response measured at 5, 10, 20,
and 40 mM agmatine indicated that one quarter MIC (20 mM) restores CPS in ∆speA (Figure
B.2). Therefore, we carried out supplementation assays with 20 mM agmatine. Our results show
that one quarter MIC agmatine restores the encapsulated phenotype in ΔpotABCD and ΔspeA
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(Figure 4.5). Supplementation of an equivalent MIC (one quarter MIC) of putrescine (0.57 mM)
and spermidine (0.43 mM) failed to restore capsule in the ΔspeA strain that has an intact
polyamine transporter for the import of these polyamines (data not shown). However, it must be
noted that supplemented levels of agmatine (i.e., 5 mM) that were approximately 10 times the
amount of supplemented putrescine or spermidine also failed to restore capsule in the ΔspeA
strain.

Figure 4.5

Agmatine is critical for capsule biosynthesis in pneumococcus.

Total CPS isolated from ΔspeA and ΔpotABCD cultured in THY or THY supplemented with
agmatine (20mM of agmatine, a quarter of MIC) was spotted on a nitrocellulose membrane.
Probing with anti-serotype 4 specific antibody and a horseradish peroxidase (HRP)-conjugated
secondary antibody, the membrane was developed with enhanced chemiluminescence (ECL)
detection and scanned using a ChemiDoc XRS+ with Image Lab software (Bio-Rad, Hercules,
CA, USA). Agmatine successfully restored capsule in the two unencapsulated ΔspeA and
ΔpotABCD strains in three independent experiments.
4.5

Discussion
Modulation of polyamine synthesis and transport is being targeted for antiproliferative

therapy, given the absolute requirement of polyamines for growth of mammalian cells (R. A.
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Casero, Jr., Murray Stewart, & Pegg, 2018b). Recent studies demonstrate that polyamine
metabolism is at the interface of host-pathogen interactions during pathogenesis. Signature
tagged mutagenesis studies indicated that pneumococcal polyamine transport (potD) and
synthesis (SP_0916) are essential for pathogenesis (Hava & Camilli, 2002; Polissi et al., 1998).
Murine models of nasopharyngeal colonization and invasive disease confirm that polyamine
synthesis and transport genes are essential for virulence of pneumococci (Shah et al., 2011).
Immunization studies with PotD protein either alone (Shah et al., 2009; Shah & Swiatlo, 2006)
or in combination with other pneumococcal proteins (Converso et al., 2017; Min et al., 2012),
clearly establish that polyamine transport protein is a potent immunogen that affords protection
against colonization and invasive infections. Characterization of Spn TIGR4 ΔSP_0916 showed
that modulation of polyamine homeostasis by deletion of this synthesis gene results in reduced
capsule (Nakamya et al., 2018), which could explain the reported attenuation in vivo (Shah et al.,
2011). Although there is evidence for a strong link between polyamine metabolism and
pneumococcal virulence, specifically on CPS, there are many gaps in our knowledge.
Description of polyamine synthesis pathways in pneumococci is based on what is known
in E. coli. Polyamine synthesis occurs via decarboxylation of amino acids such as arginine,
ornithine, and lysine in multiple pathways (Figure 4.4). Putrescine synthesis from ornithine in a
single step reaction catalyzed by ornithine decarboxylase (ODC) is the predominant pathway in
eukaryotic systems and is not annotated in Spn. However, additional biosynthesis pathways exist
that convert arginine to putrescine in two consecutive enzymatic steps catalyzed by arginine
decarboxylase (SpeA) and agmatinase (SpeB) respectively. The current annotation of SP_0916
in TIGR4, the focus of this study, is inconsistent; it is described as either an arginine
decarboxylase or a lysine decarboxylase (CadA, synthesizes cadaverine from lysine) in
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pneumococcal genomes. For example, the locus corresponding to SP_0916 in D39 is annotated
to be an arginine decarboxylase, involved in spermidine synthesis (Potter & Paton, 2014). This
annotation is based on indirect experimental evidence, not by direct measurement of kinetics
with different substrates. In the absence of definitive experimental evidence, we used the status
quo at the time of publication (i.e., CadA) in our earlier work.
In this study, we undertook biochemical characterization of SP_0916, a well-documented
virulence gene in pneumococci (Hava & Camilli, 2002; Nakamya et al., 2018; Shah et al., 2011).
The biochemical characterization of recombinant SP_0916 reported here clearly demonstrates
that SP_0916 is indeed an arginine decarboxylase (SpeA), although it can utilize lysine and
ornithine substrates with significantly lower catalytic efficiency. However, the Km of SP_0916
with arginine (~100 µM) is three-fold higher than that of the E. coli ortholog (30 µM) (W. H. Wu
& Morris, 1973). While the data presented here annotates the enzymatic function of SP_0916, it
also illustrates the gaps in the annotation of pneumococcal genomes, which now appear to lack a
lysine decarboxylase. The pyridoxal-dependent decarboxylase family of enzymes that catalyze
the synthesis of polyamines are predicted to utilize multiple substrates. Additional pyridoxaldependent decarboxylases in the TIGR4 genome include SP_0166. Characterization of SP_0166
will help annotate polyamine synthesis pathways in Spn TIGR4.
Using capillary electrophoresis, we previously reported that intracellular levels of
spermidine, putrescine, and cadaverine were reduced in ΔspeA, ΔpotABCD, and ΔspeE
compared to WT TIGR4 strain. However, with this method, the differences we reported were
qualitative, as we could not attribute any significance to the identified differences (Shah et al.,
2011). Using a relatively more sensitive LC-MS approach, in this study we measured
intracellular concentrations of polyamines and precursors in polyamine metabolism impaired
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pneumococci. The metabolic profile of ΔspeA confirms that it encodes an arginine
decarboxylase, as agmatine levels are significantly depleted in this strain, while cadaverine levels
were comparable to that of the WT. Transport plays a significant role in meeting cellular needs
for polyamines and maintaining polyamine homeostasis. The single putative polyamine transport
operon, potABCD, annotated in pneumococcal genomes, is predicted to transport both putrescine
and spermidine from the extracellular matrix. The metabolic profile of ΔpotABCD confirms that
PotABCD is indeed a transporter that imports both spermidine and putrescine. Studies are
underway to determine the substrate specificity of PotABCD. Characterization of pneumococcal
surface in ΔpotABCD and ΔspeE indicates that loss of polyamine transport results in reduced
CPS, while deletion of spermidine synthesis has no impact on CPS. Since the WT and deletion
strains were cultured in a complete medium that provides polyamines, there is no additional
nutritional stress on the cells. Use of a rich medium that contains polyamines mimics host
microenvironments that have polyamines and allows one to determine the impact of a gene
deletion on a phenotype that is relevant in vivo, such as the capsule, despite the compensation by
transport and additional mechanisms that are yet to be identified. Although ΔspeE harbors a
deletion in spermidine synthesis, it may not constitute the predominant route for spermidine
synthesis (Potter & Paton, 2014), as the enzyme required to generate synthesis of decarboxylated
S-adenosylmethionine (Figure 4.4) is not annotated in pneumococcal genomes at present.
Nevertheless, speE has been shown to be important for spermidine synthesis. Furthermore,
transport could compensate for spermidine synthesis in ΔspeE (Table 4.2). Thus, spermidine
synthesis catalyzed by SpeE does not appear to be critical for CPS synthesis in Spn. Therefore,
the reported attenuation of this strain in murine models could involve capsule-independent
mechanisms. Characterization of Spn with genetic deletions in spermidine synthesis via
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carboxyspermidine will help determine the relative importance of this pathway in spermidine
synthesis and possibly in CPS regulation.
Agmatine levels were significantly reduced in both ΔspeA and ΔpotABCD (Table 4.2),
which had reduced capsule, and were comparable between WT and ΔspeE, which were
encapsulated. Exogenous supplementation with agmatine restores CPS, suggesting that agmatine
is critical for CPS biosynthesis. The concentration of agmatine used for supplementation is
neither a relevant pharmacological nor physiological dose. However, it is useful as a tool to
determine whether agmatine is necessary for CPS synthesis. Relatively high MIC for agmatine
compared to other polyamines such as putrescine and spermidine indicates inefficient transport
of agmatine in Spn. Although there is an arginine-agmatine antiporter in E. coli, agmatine uptake
systems in Spn are yet to be identified and characterized. Current annotation of Spn TIGR4
genome has SP_1001, a locus that encodes an amino acid permease family protein with the
potential to transport amino acids, polyamines and agmatine. Future studies to determine the
substrate specificity of SP_1001 are warranted.
Reduced levels of agmatine in ΔpotABCD could be due to significant reduction in the
intracellular concentration of arginine, the precursor for this intermediate in polyamine
biosynthesis (Table 4.2). Pneumococcus is an arginine auxotroph that largely depends on an
extracellular source of this essential amino acid and the genome encodes ArcD, an arginineornithine antiporter. Deletion of arcD in serotype 2 has been reported to inhibit pneumococcal
capsule synthesis by an unknown mechanism, and virulence during colonization and
establishment of otitis media infection (Gupta et al., 2013). This reported loss of CPS in ΔarcD
could involve adverse effects on spermidine/putrescine synthesis, specifically agmatine synthesis
from arginine. It is likely that ΔpotABCD has to ration the available arginine between polyamine
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biosynthesis and other competing pathways that utilize this amino acid. Reduced arginine in
ΔpotABCD could contribute to reduced levels of putrescine and spermidine by biosynthesis,
apart from the direct impact due to loss of import of these two polyamines. We previously
reported the importance of pneumococcal polyamine transport in inhibiting the host response
(Rai et al., 2016b). Recombinant PotD protein affords protection against invasive pneumococcal
disease in murine models (Converso et al., 2017; Shah et al., 2009; Shah & Swiatlo, 2006).
Studies with unencapsulated strains show that polyamine transport is not required for
colonization or infection of the host tissues (Pipkins, Bradshaw, Keller, Swiatlo, & McDaniel,
2017), although equivalent information on the contribution of polaymine synthesis remains
unexplored.
Agmatine and its role in eukaryotic systems (Piletz et al., 2013) is well documented, with
the neuroprotective role and the ability to trigger the innate immune response being the most
studied (Kotagale, Taksande, & Inamdar, 2019; Paulson et al., 2014). There is evidence to
suggest that agmatine reduces glycolysis, increases gluconeogenesis and fatty acid oxidation, and
ultimately causes weight reduction in rats (Nissim et al., 2014). In Pseudomonas aeruginosa,
agmatine regulates biofilm formation (Williams et al., 2010) and inhibits inflammatory response
by host immune cells (McCurtain, Gilbertsen, Evert, Williams, & Hunter, 2019). A recent report
demonstrates the essential role of E. coli-derived agmatine in regulating metabolism, specifically
fatty acid metabolism via interaction with metformin in Caenorhabditis elegans (Pryor et al.,
2019). Therefore, it is likely that in pneumococci, agmatine regulates CPS, probably by
modulating glycolysis and/or fatty acid metabolism that impacts availability of precursors for
CPS synthesis, as we reported earlier (Ayoola et al., 2019). This metabolic reprogramming could
involve regulation by a number of transcription factors including catabolite control protein A
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(CCPA) and CodY, which sense the metabolic state and regulate polyamine pathways that
ultimately impact CPS.
In conclusion, this study determines the substrate specificity of SP_0916 and
demonstrates that it is an arginine decarboxylase that catalyzes the synthesis of agmatine.
Agmatine is an intermediate in the putrescine/spermidine biosynthesis pathway, and is critical
for regulating CPS in pneumoccci. Deletion of polyamine transport has adverse effect on the
capsule, a critical virulence factor in pneumococci, that could explain the reported attenuation in
vivo. Modulation of polyamine homeostasis impacts pneumococcal virulence. A comprehensive
description of polyamine metabolic pathways is warranted to leverage this system for developing
novel theraputic strategies for treating pneumococci, which poses risk to human health
worldwide.
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CHAPTER V
DIFLUOROMETHYLORNITHINE (DFMO) AND AMXT 1501 INHIBIT CAPSULE
BIOSYNTHESIS IN PNEUMOCOCCI.

Moses B. Ayoola, Leslie A. Shack, Jung Hwa Lee, Juhyeon Lim, Hyungjin Eoh, Edwin Swiatlo,
Otto Phanstiel IV and Bindu Nanduri

5.1

Abstract
Polyamines are small cationic molecules that have been linked to various cellular

processes including replication, translation, stress response and recently, capsule regulation in
Streptococcus pneumoniae (Spn, pneumococcus). Pneumococcal associated diseases such as
pneumonia, meningitis and sepsis are some of the leading causes of death worldwide and capsule
remains the principal virulence factor of this versatile pathogen. The α-difluoromethylornithine
(DFMO), an irreversible inhibitor of the committed step of the canonical polyamine biosynthesis
pathway catalyzed by ornithine decarboxylase has long history in modulating cell growth,
polyamine levels, and disease outcome in eukaryotic systems. Recent evidence show that DFMO
could also target the alternative polyamine biosynthesis pathway via arginine decarboxylation.
However, compensation for the inhibited biosynthesis by increase in polyamine uptake from
extracellular matrices has been reported in some organisms. Here, we examined the potential
capsule crippling ability of DFMO and possible synergistic effect of a polyamine transport
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inhibitor, AMXT 1501, on pneumococci. We further characterized the changes in pneumococcal
metabolites in response to DFMO and measured the impact of DFMO on amino acid
decarboxylase activities. Our findings show that DFMO could inhibit pneumococcal polyamine
and capsule biosynthesis as well as decarboxylase activities, although, at a high concentration.
We did not identify synergistic effects of DFMO and AMXT 1501 on CPS synthesis. In
summary, this study demonstrates that utility of DFMO is pneumococcal capsule inhibition.
Identifying small molecule that are similar to DFMO, and at low concentration, that could target
peculiar pathway such as capsule biosynthesis which is not found in the host would be a
promising way for the eradication of the diverse and pathogenic pneumococcal strains.
5.2

Introduction
Polyamines are positively charged biogenic amines that regulate a number of cellular

processes via their interactions with negatively charged molecules such as nucleic acids and
proteins, and phospholipids (Bachrach, 2005). The canonical pathway for polyamine
biosynthesis in both eukaryotes and prokaryotes involves sequential actions of arginase and
ornithine decarboxylase (ODC) that convert arginine to ornithine, and ornithine to putrescine,
respectively. Addition of the aminopropyl moiety of decarboxylated S-adenosylmethionine to
putrescine and spermidine by spermidine/spermine synthase generates spermidine and spermine,
respectively. Decarboxylases from polyamine biosynthesis pathways including, ODC, are
pyridoxal-5′-phosphate-dependent (PLP) enzymes and ODC is known to catalyze the first and
rate limiting step in polyamine synthesis in eukaryotes. When treated with αdifluoromethylornithine (DFMO), an irreversible inhibitor of ODC, cells are typically depleted
of putrescine and spermidine (Silva, Cirenajwis, Wallace, Oredsson, & Persson, 2015). Since
polyamines are critical for eukaryotic cell proliferation, DFMO has a forty-year history in
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clinical research, mostly in anti-cancer studies (R. A. Casero, Jr. et al., 2018a; Gerner &
Meyskens, 2004). The combined therapy of DFMO and AMXT 1501, a novel polyamine
transport inhibitor, was recently shown to be more effective in the treatment of neuroblastoma
(Laura D. Gamble et al., 2019) and in delaying the progression autoimmune encephalomyelitis
(R. Wu et al., 2020) than single therapies.
The ability of DFMO to inhibit cell proliferation has found application in the treatment of
African trypanosomiasis (Kroubi, Karembe, & Betbeder, 2011). DFMO also has FDA approval
in the form of Vaniqa cream to inhibit unwanted facial hair growth in women (Jackson et al.,
2007; Wolf et al., 2007). In addition, DFMO inhibits the growth of fungi such as Colletotrichum
truncatum and Cochliobolus carbonum, which are economically important pathogens of soybean
and sweet corn, respectively (Valdes-Santiago, Cervantes-Chavez, Leon-Ramirez, & RuizHerrera, 2012). Despite the numerous reports on the role of DFMO in eukaryotes as key
polyamine chemical modulator, there are relatively few reports on its application in prokaryotes,
especially in bacterial physiology and pathogenesis.
Experimental evidence shows that DFMO treatment induces oxidative stress in H. pylori
and reduces the toxin-associated virulence factor in this pathogen that affects the human
digestive tract (Sierra et al., 2019). DFMO treatment of Streptococcus pneumoniae
(pneumococcus, Spn) serotype 3 (WU2) s that harbors a deletion in potD, a gene that encodes
polyamine transport binding domain protein, resulted in impaired growth (Ware et al., 2006).
Although, deletion of potD alone had no impact on growth in WU2 strain. However, deletion of
arginine decarboxylase (ADC/speA) that synthesizes agmatine, an intermediate from the
putrescine/spermidine biosynthesis pathway in serotype 4 pneumococci results in the inhibition
of capsular polysaccharide (CPS) synthesis (Ayoola et al., 2020; Nakamya et al., 2018).
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Exogenous supplementation of agmatine restores capsule, indicating that reduced intracellular
levels of this polyamine due to impaired synthesis are critical for CPS regulation (Ayoola et al.,
2020). The capsule is the principal virulence factor in pneumococcus, the most common bacterial
etiology of otitis media, sepsis and community acquired pneumonia globally (HenriquesNormark & Tuomanen, 2013). Capsule is necessary for escape from host opsonophagocytosis
(Catherine Hyams et al., 2013) and the basis for the classification of the known100 serotypes
based on distinct polysaccharide compositions (Ganaie et al., 2020).
Apart from inhibition of ODC activity that impedes putrescine synthesis, DFMO has also
been shown to inhibit ADC activity (Tassoni, Awad, & Griffiths, 2018) that synthesizes
agmatine. Therefore, in this study, we hypothesized that inhibition of polyamine biosynthesis by
DFMO could impact capsule synthesis. Using multiple pneumococcal serotypes that follow the
conventional Wzy-dependent (2, 4 and 19F) and the uncommon synthase- dependent pathway
(serotype 3) for capsule biosynthesis (Janet Yother, 2011), we show that DFMO inhibits CPS
synthesis in Spn. Metabolomics analysis of DFMO treated Spn identified reduced precursors and
sugars that constitute the CPS repeat unit, similar to our earlier reports on the inhibition of CPS
by genetic manipulation i.e. deletion of speA gene (Ayoola et al., 2019). We also show that
agmatine supplementation restores capsule in DFMO treated pneumococci. Thus, the signature
of polyamine mediated regulation of CPS is conserved between the two approaches to impair
synthesis: chemical (this study) and genetic (∆speA). Inhibition of polyamine transport with
AMXT 1501, had no impact on CPS on majority of pneumococcal serotypes. We did not identify
synergistics effects of DFMO and AMXT 1501 on CPS synthesis. Serotype independent
chemical inhibition of polyamine synthesis by DFMO with its adverse effect on CPS identified
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here holds promise for developing novel therapeutics that could incapacitate most or all the
virulent pneumococcal serotypes, by modulating polyamine homeostasis.
5.3
5.3.1

Materials and methods
Characterization of α-Difluoromethylornithine (DFMO) impact on pneumococcal
growth
S. pneumoniae serotype 4 (TIGR4), 2 (D39), 19F (EF3030) and 3 (WU2) (200 µL, ~105

colony forming units/mL (CFU/mL) were cultured in Todd Hewitt broth supplemented with
yeast extract (THY). Supplementation with DFMO over a two-fold dilution series from 100 to
0.2 µg/µL (i.e., 574 to 1.1 mM) or without DFMO (viability control) was carried out in triplicate
in a 96-well plate and incubated at 37 ºC (5% CO2) in a Cytation™ 5 cell imaging multi-mode
reader (BioTek, Winooski, VT). Change in optical density at 600 nm (OD600) was measured
every hour for a period of 24 hr and used to determine the minimum inhibitory concentration
(MIC) of DFMO for each serotype. Impact of DFMO on bacterial growth was evaluated by
GrowthRates 4.0 software (Hall, Acar, Nandipati, & Barlow, 2014). To determine whether
DFMO at sub-MIC is inhibiting cell replication and growth or killing the pneumococcal cells, all
strains (5 mL, ~105 CFU/mL) were cultured in the presence or absence of ½ MIC DFMO. OD600
was measured every hour and CFU were enumerated on a blood agar plate (BAP) every 2 hours
over an 8hr incubation period.
5.3.2

Impact of DFMO and AMXT 1501 on the capsule in pneumococcal serotypes
S. pneumoniae TIGR4, D39, EF3030 and WU2 (5 mL, ~105 CFU/mL) were cultured in

the absence or presence of DFMO and AMXT 1501 at varying final concentrations of ½, ¼, and
⅛ MIC to OD600 0.2-0.3 either individually or together to estimate the synergistic effect (AMXT
MIC = 14.8 µM). Capsular polysaccharides (CPS) were extracted and estimated in triplicate, as
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described previously (Nakamya et al., 2018) with slight modification. Briefly, CPS was extracted
in a lysis buffer (4% deoxycholate, 50 µg/mL DNAse I and 50 µg/mL RNAse A) at 37 °C for 10
min and centrifuged at 18,000 x g for 10 min. Supernatant (2 µL) was spotted on a 0.2-µm-poresize nitrocellulose membrane (Thermo Fisher Scientific, Waltham, MA, USA) and oven dried at
60 °C for 15 min. The membranes were blocked with different types of antisera for capsule
detection: antisera type- 4 (for TIGR4), 2 (for D39), polyclonal (for EF3030) and 3 (for WU2)
(Cedarlane, Burlington, NC). A conjugated polyclonal goat anti-rabbit IgG-HRP (Agilent
Technologies, Santa Clara, CA) was used for enhanced chemiluminescence (ECL) detection in
all the strains (Thermo Fisher Scientific, Waltham, MA, USA) and scanned using a ChemiDoc
XRS+ with Image Lab software (Bio-Rad, Hercules, CA, USA). Densitometry analysis of the
immunoblot was done with NIH ImageJ software (Schneider, Rasband, & Eliceiri, 2012).
5.3.3

Agmatine supplementation of DMFO treated pneumococci
We determined the impact of varying concentrations of DFMO (⅛ to ½ MIC) on CPS in

all serotypes (2, 4, 19F, and 3) used in this study. Agmatine (¼ MIC, 20mM) supplementation
was performed with serotype 2 (D39) treated with DFMO (⅛ MIC, 34 mM). D39 (~105
CFU/mL, 5mL) cultures were treated with ⅛ MIC DFMO alone, ¼ MIC agmatine (Agm) alone,
a combination of ⅛ MIC DFMO and ¼ MIC Agm, and control sample without DFMO/Agm
(untreated). CPS was extracted as described in the previous section and immunoblot analysis
with type 2 antisera was performed to estimate total CPS.
5.3.4

Metabolomics of DFMO treated pneumococci
S. pneumoniae TIGR4 (10 mL, n=5) was cultured in the absence or presence of DFMO to

a final concentration of 137 mM (½ MIC) to OD600 0.4-0.5. Cells were harvested (5,000 × g, 10
min, 4 ºC), re-suspended in extraction solvent (40% acetonitrile, 40% methanol, 20% water with
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formic acid (0.1 M)) and transferred to bead-beater tubes (MP Biomedicals, Irvine, CA). Cells
were lysed using a FastPrep-24™ Classic (45 sec, 6.5 m/s, RT, 3 times) (MP Biomedicals,
Irvine, CA) and incubated on ice (5 min after each spin). Lysates were clarified (6,000 × g, 5
min, 4 ºC), and metabolite differentiation and detection were performed using published
protocols (Eoh & Rhee, 2013; Eoh et al., 2017). Liquid chromatography-mass spectrometry–
based (LC-MS) metabolomics analysis was performed with an Agilent Accurate Mass 6230 TOF
coupled with an Agilent 1290 LC system using a Cogent Diamond Hydride Type C column.
Briefly, the mobile phase consisted of the following: solvent A (ddH2O with 0.2% formic acid)
and solvent B (acetonitrile with 0.2% formic acid). The gradient used was as follows: 0–2 min,
85% B; 3–5 min, 80% B; 6–7 min, 75% B; 8–9 min, 70% B; 10–11.1 min, 50% B; 11.1–14 min
20% B; 14.1–24 min 5% B followed by a 10 min re-equilibration period at 85% B at a flow rate
of 0.4 ml/min. Mass axis dynamics was calibrated by continuous infusion of a reference mass
solution using an isocratic pump. This configuration achieved mass errors of 5 ppm, mass
resolution ranging from 10,000 to 25,000 (over m/z 121–955 atomic mass units), and 5 x log10
dynamic range. Metabolite identities were searched for using a mass tolerance of <0.005 Da.
Metabolite concentrations from the 5 biological replicates were normalized to biomass based on
measurement of residual peptide content in individual samples using the Pierce BCA Protein
Assay kit (Thermo Scientific, Rockford, IL). Data were analyzed using Profinder B.07.00
software (Agilent Technologies, Santa Clara, CA). Extracted molecular features detected in the
mass analyzer were identified using accurate mass values and used to generate empirical
molecular formulae using an in-house metabolite database that included known intermediates,
amino acid precursors and polyamines and their derivatives. Statistical analysis of metabolite
peak intensity data was performed using MetaboAnalyst 4.0 (Chong, Soufan et al. 2018). Data
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were normalized (quantile), log transformed and significant fold change between WT and
deletion strains were identified by Student’s t-test (p ≤ 0.05).
5.3.5

Inhibition of decarboxylase activity by DFMO and DFMA
SP_0916 (serotype 4) encodes an ADC that has marginal ODC and lysine decarboxylase

(LDC) activities (Ayoola et al., 2020). We determined the impact of DFMO (ODC inhibitor)
and α-difluoromethylarginine (DFMA, ADC inhibitor) on the decarboxylase activities of
SP_0916. BL21(DE3) cells expressing recombinant His tag SP_0916 were lysed with B-PER
reagent buffer (Thermo Fisher Scientific, Waltham, MA, USA), lysate separated by loading unto
HisPur Cobalt Spin Column (Thermo Fisher Scientific, Waltham, MA, USA), desalted using
Sephadex G-25 PD-10 column (GE Healthcare, Chicago, IL, USA), and protein concentration
estimated using the Pierce BCA Protein Assay kit (Thermo Fisher Scientific, Waltham, MA,
USA).
SP_0916 enzyme (50 µg/ml protein) was mixed with 10 mM substrate (arginine, lysine
or ornithine) in the reaction mixture (500 µL reaction volume, 50 mM Tris-HCl, pH 8.0) that
contains 2.5 mM MgSO4 and 0.6 mM PLP. DFMO was made by diluting in water to 3-900 mM
and adding it to the reaction mixture after 5 min preincubation at 37°C in dark. DFMA was made
in a similar manner but was diluted in water to 0.3-1000 µM. The enzyme and inhibitor were
incubated at 37°C for 15 min in dark and the reaction terminated with 12.5 µL of 70% (w/v)
perchloric acid. After incubation on ice for 15 min, the samples were neutralized with 25 µL of
10 N KOH and extracted with 1 mL of 1-butanol. The organic layer was dried under nitrogen gas
and reconstituted with 100 µL of water containing n-heptylamine as an internal standard.
Analysis of the extracts was performed on a Surveyor LC-MS system. 5 µL of reconstitution was
injected to the LC-MS system for detection of the products (agmatine, cadaverine or putrescine).
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Enzyme activity without inhibitor is referred to as a control activity. All experiments were
performed in triplicate. The concentration of inhibitor that inhibited 50% of the control activity
(IC50 value) was determined by varying the concentration of the indicated DFMO or DFMA and
measuring the decarboxylase activity. Sigma Plot v. 12 was used to fit the curve through the
points and IC50 values were interpolated from the fitted curve.
5.4
5.4.1

Result
Impact of DFMO on pneumococcal growth
DFMO is an irreversible inhibitor of ODC and polyamine synthesis in eukaryotic

systems. DFMO is a cytostatic agent i.e., capable of causing cell death or inhibiting cell
replication. Here, the susceptibility of four different pneumococcal serotypes: 4 (TIGR4), 2
(D39), 19F (EF3030) and 3 (WU2) to DFMO was examined to determine the growth permissible
concentration. Our results show that the minimum inhibitory concentration (MIC) for all four
serotypes is the same, at 274 mM (Figure 5.1). At ½ MIC DFMO, (137mM), D39 and WU2
strains exhibited a longer lag phase and a lower maximal O.D compared to viability controls
(Figure 5.1). However, analysis of growth curves with GrowthRates did not identify any
significant differences between the growth rate of all serotypes tested in the presence or absence
of DFMO (data not shown).
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Figure 5.1

Susceptibility of pneumococci to DFMO

Growth of TIGR4, D39, EF3030 and WU2 strains was measured in the absence/presence of
DFMO (0 to 274 mM) in a plate reader at 1 hr interval for a period of 24 hr. Growth of untreated
strain i.e., viability control is shown in blue. Growth in the presence of minimum inhibitory
concentrations (MIC) of DFMO (274 mM) is shown in red while growth at ½ MIC DFMO (137
mM) is shown in green.
Since the focus of this work is to identify the impact of DFMO on CPS of growing
bacteria, we determined the impact of ½ MIC DFMO on viability. Viability curves at ½ MIC
DFMO indicate bacteriostatic effect of DFMO on all the pneumococci strains (Figure 5.2).
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Figure 5.2

Impact of DFMO on pneumococci viability/replication.

Optical density vs. colony forming unit (CFU/mL) of TIGR4, D39, EF3030 and WU2 treated
with DFMO (orange, Conc) with respect to the untreated (blue) show bacteriostatic effect of
DFMO in all serotypes.
5.4.2

DFMO and AMXT 1501 inhibit the CPS in pneumococci
There is growing evidence that polyamines play a critical role in capsule regulation. We

reported that deletion of either polyamine biosynthesis (Nakamya et al., 2018) or transport
(Ayoola et al., 2020) inhibits pneumococcal capsule production. Here, we examined the impact
of DFMO, an inhibitor of polyamine synthesis, and AMXT 1501, a polyamine transport
inhibitor, on capsule biosynthesis. Our results show that total CPS in TIGR4, D39, EF3030, and
WU2 is significantly reduced (Figure 5.3) at a growth permissible concentration of DFMO (½
MIC, 137 mM). AMXT 1501 had an impact on CPS only in serotype 2. Densitometry analysis of
the immunoblot (Schneider et al., 2012) indicates approximately 85, 71, 84 and 39 % capsule
loss in TIGR4, D39, EF3030 and WU2, respectively, compared to untreated controls while there
was 61 % loss in D39 treated with AMXT 1501. These results show that DFMO inhibits capsule
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biosynthesis in a serotype-independent manner, although the inhibition is to a relatively smaller
proportion in serotype (WU2) that follows synthase mechanism of CPS synthesis. Lower
concentrations of DFMO (< 137mM) failed to inhibit the CPS in serotypes 4, 19F and 3.
However, CPS synthesis was inhibited in D39 ⅛ MIC (34 mM) DFMO (data now shown). D39
CPS synthesis was inhibited at ½ MIC AMXT 1501 (Figure B.3). These results indicate that
serotype 2 (D39) is more susceptible to CPS inhibition by chemicals.

Figure 5.3

DFMO inhibition of the capsule synthesis is serotype independent.

Immunoblots for total CPS were performed with serotype specific antibody (type: 4 for TIGR4,
2 for D39, polyclonal serum for EF3030, and 3 for WU2) and secondary polyclonal goat antirabbit IgG-HRP treatment followed by enhanced chemiluminescence (ECL) detection was used
to estimate total CPS in each of the treated and untreated pneumococcal serotypes Exposure to ½
MIC DFMO resulted in reduced capsule in all the strains.
5.4.3

Impact of DFMO on pneumococcal metabolome
To identify metabolic pathways targeted by DFMO, we performed mass spectrometry-

based metabolomics analysis of TIGR4 and TIGR4 treated with ½ MIC DFMO. We identified
significant changes in the intracellular concentrations of 36 metabolites (Table 5.1). DFMO
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treatment resulted in significant reduction in the polyamines putrescine, spermidine, and
cadaverine. (Table 5.1). Reduced level of acetylated form of spermidine (N-Acetylspermidine) is
consistent with the depletion of spermidine. Furthermore, there is significant accumulation of Sadenosylmethionine (SAM), an aminopropyl donor for the conversion of putrescine to
spermidine. Accumulation of 5,10-methylenetetrahydrofolate indicates that homocysteine is not
being converted to methionine and tetrahydrofolate (THF) which led to their depletion.
Methionine is the precursor of S-adenosylmethionine suggesting a feedback inhibition of the
synthesis of this amino acid by SAM. Reduced level of agmatine, the product of arginine
decarboxylation, corroborates the fact that DFMO does not only inhibit canonical pathway for
polyamine biosynthesis via ODC, but also the alternative pathway catalyzed by ADC. Arginine,
the precursor amino acid in the alternative pathway for putrescine/spermidine synthesis is not
affected while ornithine is depleted. Both lysine and cadaverine, precursor and product of LDC
are reduced. Changes in the intracellular levels of polyamines appears to repress Leloir pathway,
as seen by reduction in the concentrations of galactose 1-phosphate, UDP-galactose and UDPglucose. UDP-galactose is the donor of galactose, one of the four repeating unit sugars in
serotype 4 CPS. Significant accumulation of Glucose 6-phosphate and depletion of fructose 6phosphate, glyceraldehyde 3-phosphate, pyruvate and NADH indicate impaired glycolysis with
possible upregulation of pentose phosphate pathway (PPP). Glucose 6-phosphate is the direct
and pivotal intermediate of glucose that is at the intersection of glycolysis and PPP, while
fructose 6-phosphate links glycolysis to nucleotide sugar biosynthesis (Figure 5.4). Implication
of changes in the Leloir and glycolysis pathways is the depletion of glucosamine 6-phosphate
(GlcN6P) and UDP-N-acetyglucosamine (UDP-GlcNAc) in the nucleotide sugar biosynthesis.
UDP-GlcNAc is the substrate of epimerase for the formation UDP-N-acetylgalactosamine, UDP112

N-acetylmannosamine and UDP-N-acetylfucosamine which are the precursors for the remaining
three repeat unit sugars in serotype 4 CPS. Our results show significant depletion of UDP-Nacetylgalactosamine and UDP-N-acetylmannosamine with a modest accumulation of UDP-Nacetylfucosamine. Significant depletion of UDP-N-acetylmuramic acid, precursor for
peptidoglycan cell wall to which capsule is attached, and UMP/UDP that provide UDP for
nucleotide sugars was also observed. Accumulated 6-phosphogluconate can generate increased
levels of NADPH in PPP, and 5-phospho-α-D-ribose 1-diphosphate (PR5P) in the nucleotide
synthesis pathway. This observation is supported by depletion of sedoheptulose 7-phosphate and
glyceraldehyde 3-phosphate that favors ribose 5-phosphate synthesis, and ultimately PR5P
formation. NADPH is important for redox balance under stress condition while PR5P is involved
in nucleotide synthesis for DNA repair. These observations coupled with the depleted GSSG and
GSH that protect cells against oxidative damage suggest possible relationship between loss of
capsule and oxidative stress in a polyamine dependent manner. DFMO treatment affects
polyamine levels, capsule precursors biosynthesis, oxidative stress response, and repair
mechanisms in pneumococci (Figure 5.4). Overall, metabolomics signature in DFMO treated
Spn provides evidence for the loss of capsule in DFMO treated cells.

113

Table 5.1

Significant changes in the metabolites of S. pneumoniae TIGR4 in response to
DFMO.
Metabolites

TIGR4+DFMO /TIGR4

Functions

Spermidine
Putrescine
Spermine
Cadaverine
Arginine
Ornithine
Lysine
Methionine

-3.1
-1.9
26.6
-1.5
1.1
-1.3
-1.7
-1.8

Agmatine

-2.0

5,10-methylenetetrahydrofolate

4.4

Tetrahydrofolate

-1.4

S-adenosylmethionine

64.2

N-Acetylspermidine

-1.6

Polyamine
Polyamine
Polyamine
Polyamine
Polyamine biosynthesis precursor
Polyamine biosynthesis precursor
Polyamine biosynthesis precursor
Polyamine biosynthesis
intermediate
Polyamine biosynthesis
intermediate
Polyamine biosynthesis
intermediate
Polyamine biosynthesis
intermediate
Polyamine biosynthesis
intermediate
Polyamine catabolism
intermediate

Galactose 1-phosphate
UDP-Glucose
UDP-Galactose

-16.8
-66.5
-66.5

Leloir Pathway
Leloir Pathway
Leloir Pathway/Capsule precursor

Glucose 6-phosphate
Fructose 6-phosphate
Glyceraldehyde 3-phosphate
Pyruvate
NADH

10.6
-16.8
-308.6
-1.74
-358.8

Glycolysis/PPP
Glycolysis
Glycolysis
Glycolysis
Glycolysis

Glucosamine 6-phosphate
UDP-N-acetylglucosamine

-21.0
-18.9

Nucleotide sugar biosynthesis
Nucleotide sugar biosynthesis

UDP-N-acetylgalactosamine
UDP-N-acetylmannosamine
UDP-N-acetylfucosamine
Fucose

-18.9
-18.9
2.3
-1.3

Capsule precursor
Capsule precursor
Capsule precursor
Capsule precursor
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Table 5.1

Significant changes in the metabolites of S. pneumoniae TIGR4 in response to
DFMO (continued).

UDP-N-acetylmuramic acid

-259.2

Peptidoglycan biosynthesis

UMP
UDP

-2.1
-53.1

Pyrimidine synthesis
Pyrimidine synthesis

6-Phosphogluconate
Sedoheptulose 7-phosphate
NADPH

7.8
-13.5
25.1

Pentose phosphate pathway
Pentose phosphate pathway
Pentose phosphate pathway

5-phospho-α-D-ribose 1diphosphate (PRPP)
GSH
GSSG

3.8

Nucleotide synthesis

-23.2
-41.3

Stress Response
Stress Response
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Figure 5.4

DFMO impacts polyamine synthesis, carbohydrate metabolism, capsule
biosynthesis, and oxidative stress responses in pneumococci.

Significant accumulation of metabolites is shown in blue, depletion is shown in red, while black
represents no detected change. Multi-step reactions are represented by a broken arrow. DFMO
treatment inhibits agmatine, cadaverine, putrescine and spermidine synthesis. UDP-Galactose
production via Leloir pathway is inhibited. Impaired glycolytic pathway activity results in
reduced glucosamine 6-phosphate (GlcN6P) and ultimately UDP-N-acetylglucosamine (UDPGlcNAc), a precursor for sugars in serotype 4 CPS repeat unit (open oval). Altered UDPGlcNAc also impacts UDP-N-acetylmuramic acid (UDP-MurNAc) availability for peptidoglycan
assembly (open rectangle) which is the site of attachment of capsule. Redirection of glucose via
glucose 6-phosphate from glycolytic pathway to pentose phosphate pathway, and subsequent
increase in NADPH and 5-phospho-α-D-ribose 1-diphosphate (PRPP) could indicate increased
oxidative stress response and repair in DFMO treated cells.
5.4.4

Agmatine reverses the effect of DFMO on CPS
Although DFMO is widely known and reported to target ornithine decarboxylase (ODC),

recent report shows that DFMO could also target arginine decarboxylase that catalyzes the
conversion of arginine to agmatine (Tassoni et al., 2018). Metabolic profile of DFMO treated
Spn shows significantly reduced levels of agmatine (Figure 5.4), the product of ADC activity.
Furthermore, we recently showed that exogenous supplementation of agmatine (¼ MIC, 20 mM)
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restores CPS in the ∆speA (Ayoola et al., 2020), a strain that harbors a deletion in the gene
encoding ADC. Therefore, agmatine could possibly counteract capsule inhibition by DFMO.
Since D39 is more susceptible to chemical inhibition of CPS, we used this strain to determine the
impact of exogenous supplementation of agmatine in DFMO treated cells. Addition of ¼ MIC
agmatine restored capsule in D39 treated with ⅛ MIC (34 mM) DFMO (Figure 5.5).
Furthermore, agmatine was able to restore capsule loss by polyamine transport inhibitor, AMXT
1501 (Figure B.3).
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Figure 5.5

Agmatine reverses the capsule inhibitory effect of DFMO in Serotype 2
pneumococci.

Total CPS isolated from serotype 2 (D39) cultured in THY, THY supplemented with DFMO (⅛
MIC, 34 mM) alone, agmatine (¼ MIC, 20mM) alone, and DFMO (⅛ MIC) with agmatine (¼
MIC) was spotted on a nitrocellulose membrane. Probing with anti-serotype 2 specific antibody
and a horseradish peroxidase (HRP)-conjugated secondary antibody, the membrane was
developed with enhanced chemiluminescence (ECL) detection and scanned using a ChemiDoc
XRS+ with Image Lab software (Bio-Rad, Hercules, CA, USA). Untreated pneumococcal D39 is
shown to be encapsulated. ⅛ MIC DFMO treatment inhibits the capsule production while ¼ MIC
agmatine alone does not impact the capsule. Addition of ¼ MIC agmatine in DFMO (⅛ MIC)
treated cells restored capsule in D39.
5.4.5

DFMO and DFMA inhibit the decarboxylase activities of arginine decarboxylase
Depletion of intracellular agmatine in DFMO treated pneumococcus suggests that this

compound could target the arginine decarboxylase (ADC) that catalyzes the conversion of
arginine to agmatine. Although arginine is the preferred substrate, pneumococcal ADC has ODC
and LDC activities (ref). Here, we determine the IC50 i.e., the concentration of an inhibitor
required to reduce enzymatic activity by 50% for DFMO with recombinant ADC. Our data
shows that DFMO IC50 for agmatine (75.1 ± 5.5 mM) > putrescine (26.6 ± 4.1 mM) > cadaverine
(8.2 ± 0.2 mM) (Figure 6 (a)). This result indicates that DFMO inhibits all the decarboxylase
activities of ADC, albeit, at high concentration. Furthermore, we evaluated the IC50 of αdifluoromethylarginine (DFMA) that is a specific inhibitor of ADC. IC50 of DFMA with
cadaverine (56.6 ± 11.9 µM) > putrescine (40.5 ± 11.6 µM) > agmatine (1.1 ± 0.1 µM) (Figure 6
(b)).
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Figure 5.6

DFMO and DFMA inhibit ADC.

We determined DFMO/DFMA IC50 values for the following reactions catalyzed by ADC:
arginine to agmatine, lysine to cadaverine, and ornithine to putrescine. Enzyme activity without
inhibitor is referred to as a control activity. LC_MS based estimation of IC50 was determined by
varying the concentration of the indicated inhibitor (a) DFMO or (b) DFMA and measuring the
decarboxylase activity. Sigma Plot v. 12 was used to fit the curve through the points and IC50
values were interpolated from the fitted curve. Our data shows that DFMO IC50 for agmatine
(75.1 ± 5.5 mM) > putrescine (26.6 ± 4.1 mM) > cadaverine (8.2 ± 0.2 mM) while IC50 of αdifluoromethylarginine (DFMA) that is specific for arginine decarboxylase show that cadaverine
(56.6 ± 11.9 µM) > putrescine (40.5 ± 11.6 µM) > agmatine (1.1 ± 0.1 µM).

5.5

Discussion
DFMO is a suicide inhibitor of eukaryotic ornithine decarboxylase (ODC) and has been

studied extensively for its antiproliferative effects in different disease conditions involving
uncontrolled cell growth. DFMO has been shown to curtail the growth of Trypanosoma brucei and
is an FDA approved treatment for African sleeping sickness. In addition, DFMO is currently being
used in different cancer treatment and prevention trials (LoGiudice, Le, Abuan, Leizorek, &
Roberts, 2018; Sholler et al., 2018). As a competitive inhibitor of ODC, DFMO acts by blocking
the biosynthesis of the polyamine putrescine, and results in depletion of intracellular putrescine.
Over time DFMO also affects the intracellular levels of spermidine and spermine. Polyamines
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resulting from activities of ODC are essential for cell replication, protein translation, and have
antioxidant activities among a host of other known biological functions (Bae et al., 2018; Gevrekci,
2017; J. H. Liu, Wang, Wu, Gong, & Moriguchi, 2015). We earlier reported reduced in vivo fitness
of polyamine transport and synthesis deficient pneumococci (Shah et al., 2011).
Pneumococci are causative agents of mild to severe infection including otitis media,
pneumonia, and sepsis. Modulation of polyamine synthesis (specifically speA for agmatine
synthesis from arginine) and transport, via gene deletion, inhibits capsule synthesis (Ayoola et al.,
2020; Ayoola et al., 2019; Nakamya et al., 2018). In this study, we evaluated the effect of DFMO
as a polyamine synthesis inhibitor in pneumococci. Our findings indicate that DFMO inhibits CPS
in multiple pneumococcal serotypes (Figure 5.3). Capsule biosynthesis is generally via
polymerization of about 2 to 8 simple and/or nucleotide sugars (K. A. Geno et al., 2015).
Metabolomics analysis shows that DFMO initiated depletion of 3 precursors out of the 4 sugars in
the repeat unit of serotype 4 capsule examined in this study. Metabolomics analysis also identified
pathways that are negatively impacted by DFMO (Figure 5.4), and these results are similar to our
previous report on the impact of inhibition of polyamine synthesis by deletion of ADC in serotype
4 (Ayoola et al., 2019). The net effect of the identified changes in the metabolome upon exposure
to DFMO ultimately translate to reduced availability of precursors for CPS. Although, metabolic
changes such as depleted levels of uracil (Carvalho et al., 2018) or acetyl-CoA (Echlin et al., 2016)
that resulted in loss of capsule have been reported, however, they are not serotype independent as
we observed with polyamine synthesis modulation by DFMO.
The extent of capsule inhibition by DFMO appears to depend on the type of CPS synthesis
pathways. DFMO is more effective against the serotypes that utilize Wzy-dependent pathway,
which is responsible for the CPS synthesis in all pneumococci with the exception of only two
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strains (Janet Yother, 2011). Our data also indicates subtle differences in serotype susceptibility
of CPS inhibition by DFMO, as serotype 2 CPS was inhibited with relatively lower concentrations
of DFMO compared to other strains. In addition, we examined possible synergism between DFMO
and polyamine transport inhibitor, AMXT 1501. Contrary to what was reported in the eukaryotic
system (L. D. Gamble et al., 2019; Hayes et al., 2014; R. Wu et al., 2020), no synergism was
observed between the two compounds in pneumococci with respect to capsule inhibition. AMXT
1501 at MIC had no impact on CPS in serotypes 4, 3 and 19F although serotype 2 CPS synthesis
was inhibited by this eukaryotic polyamine transport inhibitor. The mechanisms that render
serotype 2 CPS synthesis high sensitivity modulation of polyamine homoeostasis by chemical
manipulation are yet to be established. Although, DFMO inhibits capsule biosynthesis in all the
tested pneumococcal serotypes at a sublethal dose, this dose is tens of millimolar and not a
physiological concentration. The safe dosage of DFMO for use in human is around 1.0 g/m2/day
(~1 to 2 mM) (Sholler et al., 2018). Even in D39, the concentration that inhibits CPS is 34 mM.
Although this DFMO concentration is also not in the physiological range, it allowed us to perform
exogenous supplementation assays with polyamine substrates that can compete with this
competitive inhibitor of ODC. Nevertheless, DFMO is useful as a tool to dissect the mechanisms
at the intersection of altered polyamine synthesis and inhibition of CPS. Initial assessment of
additional polyamine inhibitor, DFMA, shows that it could inhibit at a micromolar range, however,
its full characterization is beyond the scope of this work. Furthermore, We previously reported that
agmatine, the precursor for putrescine is critical for CPS synthesis (Ayoola et al., 2020). Here, we
have shown that agmatine can reverse DFMO inhibition of CPS in serotype 2. Taken together,
DFMO/Agmatine represent a CPS OFF/ON switch that can help identify novel CPS regulatory
mechanisms governed by intracellular polyamine levels. Thus, DFMO serves as an important tool
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to dissect the mechanisms at the intersection of altered polyamine synthesis and inhibition of CPS.
Initial assessment of additional polyamine inhibitor, DFMA, shows that it could inhibit in the
micromolar range, however, its full characterization is beyond the scope of this work.
Apart from reduced agmatine levels, additional signature of DFMO inhibition identified
in this study include the accumulation of SAM and THF which are consistent with reports on the
effect of DFMO inhibition of polyamine biosynthesis (Robert A. Casero, Jr., 2013; Witherspoon,
Chen, Kopelovich, Gross, & Lipkin, 2013). Reduced putrescine and spermidine are in accordance
with the functional role of DFMO in blocking the catalysis of ornithine to putrescine, and
subsequently to spermidine. The N-acetylspermidine level is also low in DFMO-treated TIGR4
indicating that the synthesis and accumulation of spermine is being favored over catabolic
degradation of spermine to spermidine. Studies have shown that DFMO does not impact spermine
concentration in eukaryotic cells (Dorhout et al., 1995; Silva et al., 2015). The reasons for
accumulation of spermine are not known at present. We speculate that this preference for
accumulating spermine and not recycling it back to spermidine could be part of pneumococcal
defense against oxidative stress. Polyamines are known antioxidants, therefore, depletion of
spermidine, putrescine and cadaverine will most likely cause elevated levels of oxidants. Also,
catabolism of polyamines such as spermine is known to generate reactive oxygen species in the
form of hydrogen peroxide which may cause additional stress to the system (Miller-Fleming et al.,
2015).
We hypothesize that reduced levels of polyamines and known antioxidants (Ha et al.,
1998; G. Y. Liu et al., 2005), in response to DFMO treatment shuts down energy consuming
capsule production and redirects carbon flux through PPP to generate NADPH to combat oxidative
stress. An elevated level of reduced glutathione (GSH) and depleted level of oxidized glutathione
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(GSSG) in DFMO treated cells have been reported earlier (Hunter, Deen, & Marton, 1987; Ibanez
et al., 2015). Here, we observed a reduced level of GSH and GSSG in DFMO-treated cells. The
glutathione system is important for redox homeostasis. Therefore, these results indicate higher
levels of reactive oxygen species and stress due to loss of intracellular polyamines in DFMOtreated pneumococci. The significantly higher levels of 5-phospho-α-D-ribose 1-diphosphate
(PRPP), the key molecule in nucleotide biosynthesis, suggests that an activated repair mechanism
may be triggered in response to DFMO to maintain the physiology of the pneumococcal cells.
In recent years, evidence shows that DFMO inhibitory effect extends beyond impeding
ODC activity and includes arginine decarboxylase (ADC) in the alternative pathway for polyamine
biosynthesis (Tassoni et al., 2018). In addition, DFMO was shown to inhibit the activity of arginase
in a colon cancer study and recent clinical trial for early treatment of Alzheimer’s disease (Alber,
McGarry, Noto, & Snyder, 2018; Selamnia, Mayeur, Robert, & Blachier, 1998). Significant
reduced level of agmatine in the DFMO treated cells in this study confirmed that DFMO indeed
inhibits arginine decarboxylase activity in bacteria. Initial characterization of impact of DFMO on
amino acid decarboxylase activities shows that it could inhibit ornithine, arginine, and lysine
decarboxylation reactions. However, current annotations of pneumococcal genomes are still
missing specific the genes that encode ODC and LDC enzymes. S. pneumoniae TIGR4 genome
has two additional genes, SP_0166 and SP_0920 that are annotated with PLP dependent
decarboxylase activities. Biochemical characterization of enzymes encoded by these two genes is
warranted for the annotation of polyamine biosynthesis genes in Spn.
In conclusion, we showed that chemical inhibition of polyamine synthesis with DFMO,
results in reduced CPS. Since polyamine synthesis is found in both host and pathogen but CPS
synthesis is specific to the pathogen, deconvoluting the DFMO/agmatine regulation of CPS can
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help identify specific target in Spn for therapeutic intervention for limiting the spread of this
pathogen.
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CHAPTER VI
CONCLUSION
Mechanisms of capsule regulation are not well understood till date and represent a
bottleneck in the design of therapeutics that target proteins that regulate the synthesis of this
important virulence factor. This dissertation work is innovative as it shows for the first time that
polyamines synthesis in pneumococci is an important regulator of central metabolism with broad
effects on virulence factor expression, including capsule. Deletion of a polyamine biosynthesis
gene, SP_0916, resulted in an unencapsulated phenotype which could explain the reported
attenuation in vivo. Characterization of ∆SP_0916 by multiple omics methods identified specific
pneumococcal mechanisms that are responsive to impaired polyamine biosynthesis that include
impaired glycolysis and Leloir pathway that generate capsule precursors, and downregulation of
peptidoglycan biosynthesis.
Existing annotation of SP_0916 is inconsistent, as it has been described as a lysine
decarboxylase (LDC) or an arginine decarboxylase (ADC). Biochemical characterization of the
protein encoded by SP_0916 establishes that it is an ADC. Furthermore, exogenous
supplementation with agmatine, a product of ADC activity, restores capsule in ∆SP_0916 and in
polyamine transport deficient pneumococci. Agmatine regulates CPS synthesis in pneumococci
through mechanisms that warrant further investigation.
Chemical inhibition of polyamine synthesis with DFMO results in loss of capsule, in a
serotype independent manner. DFMO inhibits eukaryotic ornithine decarboxylase (ODC), an
enzyme that is unannotated in pneumococcal genomes at present. Agmatine restores CPS in
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DFMO treated pneumococci. Although the concentration of DFMO and agmatine used in
pneumococci are not in the physiological range, DFMO/agmatine represent a CPS OFF/ON
switch, that can be utilized to study CPS regulatory mechanisms that are polyamine dependent.
A eukaryotic polyamine transport inhibitor, AMXT 1501, inhibits CPS that is restored by
agmatine. These results demonstrate that polyamine mediated regulation is conserved between
genetic and chemical modulation of polyamine pathways. Furthermore, mechanisms of CPS
regulation are shared between altered polyamine synthesis and transport.
Since polyamine biosynthesis and transport genes are well conserved across multiple
pneumococcal serotypes, understanding polyamine-CPS dynamics could help identify novelserotype independent antimicrobial targets for pneumococci eradication. This work will serve as
a pivot for establishing polyamines as global regulators of pneumococcal virulence, and aid
modulation of polyamine metabolic pathways for developing novel therapies.
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Table A.1

Significant changes in ∆cadA protein expression compared to TIGR4

Gene

ΔcadA/
TIGR4

Fisher's
Exact Test
(P-Value)

Iron-compound ABC transporter

fhuD

-50.0

< 0.00010

A0A0H2UPS5

Aspartate-semialdehyde dehydrogenase

Asd

-25.0

< 0.00010

A0A0H2UPL6

Saccharopine dehydrogenase

lys9

-25.0

< 0.00010

P18791

oppA

-25.0

< 0.00010

P63957

Oligopeptide-binding protein
D-alanine--poly(phosphoribitol) ligase
subunit 2

dltC

-11.1

< 0.00010

Q97R25

4-hydroxy-tetrahydrodipicolinate synthase

dapA

-10.0

< 0.00010

A0A0H2UPT3

N-carbamoylputrescine amidase

SP_0922

-10.0

0.0001

A0A0H2URS4

Aminotransferase, class I

SP_1994

-10.0

< 0.00010

A0A0H2XFA2

Lysozyme

lytC

-5.0

0.00014

A0A0H2UPS0

nspC

-5.0

0.032

A0A0H2URJ7

Carboxynorspermidine decarboxylase
Sugar ABC transporter, sugar-binding
protein

rafE

-5.0

0.053

Q97S61

Ribosome maturation factor RimP

rimP

-5.0

0.019

Q97QU4

50S ribosomal protein L21

rplU

-5.0

0.032

A0A0H2UPW9

Glycosyl transferase, group 1

SP_1076

-5.0

0.011

A0A0H2URS6

Putative dextran glucosidase DexS

SP_1883

-5.0

< 0.00010

A0A0H2USB7

Uncharacterized protein

SP_2209

-5.0

0.032

A0A0H2UQT1

Alpha-amylase

Amy

-3.3

0.053

A0A0H2URT4

Sucrose phosphorylase

gtfA

-3.3

0.053

Q97RS9

Lysine--tRNA ligase

lysS

-3.3

0.008

Q97RW5

miaA

-3.3

0.053

pdxT

-3.3

0.053

pstB2

-3.3

0.017

P67684

tRNA dimethylallyltransferase
Pyridoxal 5'-phosphate synthase subunit
PdxT
Phosphate import ATP-binding protein
PstB 2
Putative ribosome biogenesis GTPase
RsgA

rsgA

-3.3

0.053

A0A0H2UNE6

Cof family protein

SP_0286

-3.3

0.011

A0A0H2URC5

Uncharacterized protein

SP_1793

-3.3

< 0.00010

A0A0H2URU7

Uncharacterized protein
ABC transporter, ATP-binding/permease
protein

SP_2045

-3.3

0.053

SP_2073

-3.3

0.0031

ccpA

-2.5

0.0042

P63895

Catabolite control protein A
4-hydroxy-tetrahydrodipicolinate
reductase

dapB

-2.5

0.014

P14677

Penicillin-binding protein 2x

pbp2X

-2.5

0.024

Accession
Number

Description

A0A0H2UPT5

Q97PX3
Q97Q34

A0A0H2US37
A0A0H2URS9
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A0A0H2URK8

Trehalose PTS system, IIABC
components

SP_1884

-2.5

< 0.00010

Q97NE7

N-acetyldiaminopimelate deacetylase

SP_2096

-2.5

0.046

A0A0H2US65

Ribosomal subunit interface protein

yfiA

-2.5

0.036

Q97R16

Serine hydroxymethyltransferase

glyA

-2.0

< 0.00010

A0A0H2UQJ0

Choline kinase

pck

-2.0

0.031

P65241

Ribose-phosphate pyrophosphokinase 2

prs2

-2.0

0.0039

A0A0H2UMX9

Conserved domain protein

SP_0097

-2.0

< 0.00010

A0A0H2UMY5

Uncharacterized protein

SP_0098

-2.0

0.00055

A0A0H2UN46

SP_0182

-2.0

0.018

Q97NE6

MccC family protein
2,3,4,5-tetrahydropyridine-2,6dicarboxylate N-acetyltransferase

dapH

-1.7

0.003

Q97R46

Bifunctional protein GlmU

glmU

-1.7

0.0017

A0A0H2UP66

Lactate oxidase

lctO-2

-1.7

< 0.00010

A0A0H2UR69

mvaS

-1.7

0.012

oppB

-1.7

0.017

P0A4M7

Hydroxymethylglutaryl-CoA synthase
Oligopeptide transport ATP-binding
protein
Oligopeptide transport system permease
protein

oppF

-1.7

0.011

Q97QX6

Phosphoenolpyruvate carboxylase

ppc

-1.7

0.00079

A0A0H2UP36

Uncharacterized protein

SP_0670

-1.7

< 0.00010

A0A0H2UPF3

Lipoprotein

SP_0845

-1.7

< 0.00010

O54537

Glucose-6-phosphate 1-dehydrogenase

zwf

-1.7

0.0033

P63413

Acetate kinase

ackA

-1.4

0.038

Q54796

Glucan 1,6-alpha-glucosidase

dexB

-1.4

0.048

Q97PW6

Glycine--tRNA ligase beta subunit

glyS

-1.4

0.0087

A0A0H2UPG3

gor

-1.4

0.034

Q97NF1

Glutathione reductase
Glycerol-3-phosphate dehydrogenase
[NAD(P)+]

gpsA

-1.4

0.051

Q97NC9

Histidine--tRNA ligase

hisS

-1.4

0.021

A0A0H2UQH0

Homoserine dehydrogenase

hom

-1.4

0.033

P65536

ndk

-1.4

0.051

oppD

-1.4

0.024

Q97PX2

Nucleoside diphosphate kinase
Oligopeptide transport ATP-binding
protein
Pyridoxal 5'-phosphate synthase subunit
PdxS

pdxS

-1.4

0.046

A0A0H2URN4

Glutamyl-aminopeptidase

pepA

-1.4

0.00027

A0A0H2UNE1

Aminopeptidase C

pepC

-1.4

< 0.00010

Q97S34

Phenylalanine--tRNA ligase beta subunit

pheT

-1.4

0.015

P65239

Ribose-phosphate pyrophosphokinase 1

prs1

-1.4

0.036

Q97ST4

UPF0210 protein SP_0239

SP_0239

-1.4

0.024

P18766

P0A2U8
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A0A0H2UQG0

SP_1356

-1.4

0.038

A0A0H2UQW7

Amidohydrolase family protein
Oxidoreductase, pyridine nucleotidedisulfide, class I

SP_1588

-1.4

< 0.00010

P22976

Probable transketolase

tkt

-1.4

< 0.00010

Q97Q48

Alanine--tRNA ligase

alaS

-1.3

0.025

O69076

ATP-dependent zinc metalloprotease FtsH

ftsH

-1.3

0.054

A0A0H2UQY4

galE-1

-1.3

0.031

Q97SQ9

UDP-glucose 4-epimerase
Glutamine--fructose-6-phosphate
aminotransferase [isomerizing]

glmS

-1.3

0.0041

P64297

GMP synthase [glutamine-hydrolyzing]

guaA

-1.3

0.018

P0A3M9

L-lactate dehydrogenase

ldh

-1.3

< 0.00010

P29849

Maltodextrin phosphorylase

malP

-1.3

0.03

Q97RC8

Xaa-Pro dipeptidyl-peptidase

pepX

-1.3

0.036

A0A0H2UNL5

Formate acetyltransferase

pfl

-1.3

0.036

P0C2J9

Pneumolysin

ply

-1.3

0.028

Q97R51

Foldase protein PrsA

prsA

-1.3

0.017

A0A0H2UNS2

Uncharacterized protein

SP_0443

-1.3

0.054

A0A0H2UP44

Elongation factor Tu family protein

SP_0681

-1.3

0.047

Q97SU1

Adenylate kinase
Capsular polysaccharide biosynthesis
protein Cps4J
Capsular polysaccharide biosynthesis
protein CpsC
PTS system, mannose-specific IIAB
components

adk

1.3

0.043

cap4J

1.3

0.0035

cpsC

1.3

0.053

manL

1.3

0.0056

lacD

1.4

0.037

A0A0H2URV3

Tagatose 1,6-diphosphate aldolase
N-acetylglucosamine-6-phosphate
deacetylase

nagA

1.4

0.032

A0A0H2UPY6

Putative pullulanase

SP_1118

1.4

0.033

A0A0H2UQW0

Non-heme iron-containing ferritin

SP_1572

1.4

< 0.00010

Q97RQ6

DegV domain-containing protein SP_0742

SP_0742

1.5

0.026

A0A0H2URX2

Alcohol dehydrogenase, zinc-containing

SP_2055

1.5

< 0.00010

A0A0H2US28

SP_2132

1.5

0.046

Q97PM1

Uncharacterized protein
GTP-sensing transcriptional pleiotropic
repressor CodY

codY

1.6

0.035

A0A0H2UQC6

Flavodoxin

fld

1.6

0.016

P35592

Oligopeptide-binding protein AliA

aliA

1.7

< 0.00010

P95829

Chaperone protein DnaK

dnaK

1.7

< 0.00010

Q97Q31

Phosphate-binding protein PstS 1
Sugar ABC transporter, ATP-binding
protein

pstS1

1.7

0.013

msmK

1.8

0.00022

A0A0H2UNF8
Q97SJ6
A0A0H2UN99
Q97QL3

A0A0H2UQW6
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A0A0H2UNE3

Protein translocase subunit SecY

secY

1.8

P35597

Probable cation-transporting ATPase exp7

exp7

1.9

0.011

P65159

Dihydroxy-acid dehydratase

ilvD

1.9

< 0.00010

Q97QL1

Galactose-6-phosphate isomerase subunit LacB

lacB

2.1

0.00066

Q97Q16

Glucosamine-6-phosphate deaminase

nagB

2.1

0.018

A0A0H2UQ78

Uncharacterized protein

SP_1230

2.1

0.017

A0A0H2UR34

Isochorismatase family protein

SP_1583

2.2

0.032

A0A0H2UP17

Putative PTS system, IIB component

SP_0646

2.3

0.0025

A0A0H2UQP9

SP_1471

2.3

0.048

P0A4G2

Putative oxidoreductase
Manganese ABC transporter substrate-binding
lipoprotein

psaA

2.4

< 0.00010

P65121

Translation initiation factor IF-1

infA

2.6

0.023

A0A0H2UNM7

Cell wall surface anchor family protein

SP_0463

2.8

< 0.00010

A0A0H2UNT6

Cell wall surface anchor family protein

SP_0462

3.1

0.033

A0A0H2UPM4

Pyrimidine-nucleoside phosphorylase

pyn

3.2

0.0066

A0A0H2US53

DltD protein

dltD

3.4

0.0024

A0A0H2UQN8

Putative oxidoreductase

SP_1472

3.4

0.0077

A0A0H2URT5

Penicillin-binding protein 2A

pbp2A

3.8

0.00041

Q97R22

tdk

5.3

0.012

A0A0H2UR84

Thymidine kinase
Manganese ABC transporter, ATP-binding
protein

psaB

6.8

< 0.00010

A0A0H2USC9

Phosphate transport system permease protein

pstC

7.0

0.0022

A0A0H2URG7
A0A0H2UPR0
[2]

Glycosyltransferase Gtf1

gtf1

7.1

0.0022

Cluster of Uncharacterized protein

SP_1003

7.5

< 0.00010

A0A0H2UR93

Uncharacterized protein

SP_1768

8.5

0.00039

A0A0H2UMU8

PTS system, IIB component

SP_0061

11.0

< 0.00010

A0A0H2UMY0

ABC transporter, substrate-binding protein

SP_0092

18.0

< 0.00010

A0A0H2UP55

Serine protease, subtilase family

SP_0641

19.0

< 0.00010

A0A0H2UQ34

Phosphocarrier protein HPr

ptsH

21.0

< 0.00010

A0A0H2US11

Ascorbate specific PTS, EIIC component

sgaT2

31.0

< 0.00010

A0A0H2USF7

Ascorbate specific PTS, EIIB component

sgaB2

33.0

< 0.00010

P0A2V8

Phosphate import ATP-binding protein PstB 3

pstB3

36.0

< 0.00010

P0C2M5

pstS2

41.0

< 0.00010

P0A3Y7

Phosphate-binding protein PstS 2
Phosphate-specific transport system accessory
protein PhoU homolog

phoU

43.0

< 0.00010

A0A0H2US62

Transketolase, N-terminal subunit

tktN

46.0

< 0.00010

A0A0H2US23

Transketolase, C-terminal subunit

tktC

67.0

< 0.00010

A0A0H2URY8

Transcriptional regulator, BglG family

SP_2131

84.0

< 0.00010
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0.0034
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Figure A.1

Measurement of surface exposed phosphocholine in S. pneumoniae TIGR4 and
ΔcadA.

TIGR4 and ΔcadA strains were grown to exponential phase and surface exposed phosphocholine
(PC) was measured by FACS method. PC was stained with an unconjugated Kappa murine
myeloma IgA anti-phosphocholine antibody, followed by detection with a phycoerythrinconjugated rat anti-mouse secondary antibody. Samples were fixed in 2% paraformaldehyde and
read on an Attune Acoustic Focusing Cytometer. A representative histogram plot of the
fluorescence intensity of murine myeloma IgA antibody binding to exposed phosphocholine on
TIGR4 and ΔcadA is shown. The gate was set based on a negative control that was treated with
secondary antibody only.

Figure A.2

Exogenous supplementation of agmatine restores capsule in arginine
decarboxylase deficient pneumococci.

Total CPS isolated from unencapsulated T4R, encapsulated TIGR4, ΔspeA cultured in THY or
THY supplemented with 5, 10, 20 and 40 mM of agmatine was normalized to CFU and spotted
on a nitrocellulose membrane. Probing with anti-serotype 4 specific antibody and a horseradish
peroxidase (HRP)-conjugated secondary antibody, the membrane was developed with enhanced
chemiluminescence (ECL) detection and scanned using a ChemiDoc XRS+ with Image Lab
software (Bio-Rad, Hercules, CA, USA). While there is partial restoration of CPS at 5 and 10
mM agmatine, 20 mM agmatine fully restores CPS in ΔspeA.
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Figure A.3

Exogenous supplementation of agmatine restores capsule in AMXT 1501 treated
D39

Total CPS isolated from untreated encapsulated D39, D39 supplemented with AMXT 1501
alone, and D39 treated with AMXT 1501 and ¼ (20 mM) of agmatine was normalized to CFU
and spotted on a nitrocellulose membrane. Probing with anti-serotype 2 specific antibody and a
horseradish peroxidase (HRP)-conjugated secondary antibody, the membrane was developed
with enhanced chemiluminescence (ECL) detection and scanned using a ChemiDoc XRS+ with
Image Lab software (Bio-Rad, Hercules, CA, USA). Loss of capsule by AMXT 1501 was fully
restored by agmatine.
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